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QUILL ON SCALPEL
This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

The Treatment of Osteogenic Sarcoma
The management of osteogenic sarcoma
has undergone many alterations in recent
years. There have been many changes in
adjunctiv e chem otherapy and an
increased emphasis on limb-sparing sur
gery rather than amputation. Controversy
continues regarding the safety of these
newer treatments. The general public is
also much more aware of this condition
as a result of the publicity surrounding
Terry Fox and his “ Marathon of Hope” .
On page 29, Chowdhury and colleagues
describe a patient who had a late recur
rence following local excision of a telan
giectatic osteosarcoma of the ulna. The
telangiectatic type is one of the rarest
forms of osteogenic sarcoma and is con
sidered by many to be one of the most
lethal varieties. Chowdhury’s article
emphasizes many of the problems in diag
nosing and treating this tumour.
Most osteogenic sarcomas are stage 1IB
lesions at the time of diagnosis (i.e., they
are high-grade extracompartmental sar
comas).1 The best opportunity for local
control is by radical resection or ampu
tation. A local recurrence following

definitive surgery decreases the chance of
survival by half so it is a serious compli
cation indeed. Most limb-salvage opera
tions for osteogenic sarcoma are wideexcision procedures at best and many are
marginal excisions. The risk of local
recurrence following limb-salvage surgery
ranges from 15% to 20%.2 Amputation
with a wide or radical margin of normal
tissue has not always prevented stump
recurrence.3-4 This has been attributed to
the existence of skip lesions, which are
tumour deposits in the affected bone
separated from the primary tumour by
several centimetres of normal bone. Most
local recurrences occur during the first 1
to 2 years after resection and it is very
unusual for an osteogenic sarcoma to
recur almost 6 years later. This is partic
ularly true when the tumour is excised
marginally as in the case Chowdhury and
colleagues describe. In their article they
state that telangiectatic osteosarcoma has
a higher local recurrence rate than clas
sic osteogenic sarcoma. Almost certainly
this is related to the type of resection per
formed. They point out that these lesions
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are often mistaken for aggressive aneurys
mal bone cysts and lesional or marginal
excisions are performed. It is often only
after the tumour recurs that the diagno
sis is made. If this entity is recognized ini
tially and an appropriate excision per
formed, the local recurrence rate should
be the same as for standard osteogenic
sarcoma. It is known that chemotherapy
can delay the appearance o f lung
metastases and local recurrences. This is
unlikely to have caused the late recurrence
in Chowdhury’s patient since the initial
chemotherapy was one of the early adju
vant regimens and considered to be quite
mild by current standards. Many patients
with osteogenic sarcom a die with
widespread lung metastases before a local
recurrence becomes manifest. Since
autopsy is seldom performed in these cir
cumstances, the true local recurrence rate
is unknown and is likely higher than
presently believed. This creates difficul
ties in comparing the safety of limb
sparing procedures to that of am puta
tions.
There has been marked improvement
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in the survival of patients with osteogenic
sarcoma. Before 1972 only 20% of
patients survived 5 years or more.5 Now
the 5-year survival is 60% or greater. The
increase in disease-free survival was
attributed to chemotherapy which was
thought to treat the micrometastases that
are present in 80% of patients at diagno
sis.6 The picture became clouded when
the Mayo Clinic published a review of
their experience with osteogenic sarcoma
treated between 1963 and 1974.7 Survival
during the first few years of the study was
similar to that of other published reports
(i.e., 20%), but by 1972 the 3-year sur
vival of patients treated by surgery alone
had improved to 50%. Their data sug
gested that the natural history of the dis
ease itself had changed and their recent
results were not statistically different
from the results of treatment with adju
vant chemotherapy. The validity of using
historical control data as a comparison to
treatment with adjuvant chemotherapy
was questioned. There was speculation as
to why more patients were surviving when
treated by surgery alone. The most impor
tant factors were believed to be earlier
detection of lung metastases by computed
tomography and aggressive removal of
lung nodules by thoracotomy. It became
apparent that the issue could only be
resolved by a prospective randomized
study comparing patients treated with and
without chemotherapy. This was under
taken by the Pediatric Oncology Group,
which is a multicentre children’s cancer
study group. Patients were randomized
into two groups. In one the patients were
treated immediately after surgery by a
modified Rosen T-7 chemotherapy pro
tocol. The other group received no
chemotherapy after surgery unless the
tum our recurred or metastasized to the

lungs. The study was closed after review
of the initial 36 randomized patients
demonstrated significantly poorer sur
vival of patients who did not receive
immediate chemotherapy.8
The current thrust for adjuvant
chemotherapy in most centres is to give
it preoperatively and m odify the
chemotherapy postoperatively according
to the response of the tumour to the
preoperative agents. The approach was
instigated at the Memorial SloanKettering Cancer Center.9 Patients who
underwent limb-salvage procedures were
waiting up to 12 weeks for their cus
tomized prosthesis to be fabricated. Dur
ing this period they were treated with the
T-7 regimen, which consisted of high-dose
methotrexate, bleomycin, cyclophospha
mide and actinomycin C. The response of
the tumour to the chemotherapy was
graded pathologically and the poor
responders were identified. This informa
tion led to the development of the T-10
protocol where the poor responders were
treated by different agents such as cisplatin postoperatively.10’11 Variations on
this theme have been developed using
intra-arterial injection of doxorubicin or
cisplatin for local tumour perfusion as
well as systemic intravenous chemo
therapy.
For the treatment of osteogenic sar
coma in the future, more studies will be
done with different preoperative
chemotherapy regimens to find more
effective agents. Limb-salvage procedures
appear to be firmly established, and work
is being done to find better solutions for
limb reconstruction with prostheses that
have a greater longevity. As the survival
rate improves, thoughts are being directed
to the patients’ quality of life. The utili
zation of multicentre trials and the shar

ing of information make the future more
promising for patients with osteogenic
sarcoma.
K enneth L.B. B rown ,

m d , frcsc

Department of Orthopedics,
The Montreal Children’s Hospital,
2300 Tupper St.,
Montreal, PQ
H3H 1P3
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The Adrenal Incidentaloma
Before the development of computed
tomography (CT), difficult and often
dangerous procedures such as venography
and arteriography were necessary to
visualize the adrenal glands. These inves
tigations were therefore limited to patients
with clinical and biochemical evidence of
adrenal disease. Now CT scanners visual
ize the normal adrenal glands in 95% of
patients1 and can identify adrenal ade
nomas as small as 1.0 cm in diameter.2
Although this simplifies the investigation
of adrenal disease, it creates a new
problem — what to do with an inciden
tally discovered adrenal mass, the so6

called incidentaloma? About 0.6% of
upper abdominal computed tomograms
reveal these incidentalomas,3 the ma
jority of which are benign and require no
treatment.
Discovery of an incidental adrenal mass
frequently sparks concern about an
adrenocortical carcinoma and leads to
surgical resection, but, as more experience
is gained, a conservative approach is
proving to be more appropriate. Of the
95 cases of adrenal incidentalomas
described in the literature,2'12 71 were
managed surgically, revealing diverse con
ditions — adrenocortical adenomas (30

cases), metastases (17), pheochromocytomas O), cysts (9) and myelolipomas (5).
But no case of adrenocortical carcinoma
presenting as an incidentaloma has been
reported.
Benign, nonfunctioning adrenocortical
adenomas make up the majority of
adrenal incidentalomas. Their natural his
tory is obscure. Adrenocortical adenomas
2 mm or larger in diameter have been
found in 8.7% of autopsies.13 Cortical
adenomas greater than 5 mm (the optimal
resolution of the best CT scanners) were
found in 1.4% of 1495 autopsies.14 The
frequency of adrenocortical carcinoma is
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only 1 in 400 000,15 indicating that
malignant transformation is extremely
rare. The infrequency of clinically impor
tant adrenocortical adenomas further sug
gests that few of these lesions would
progress and thus require surgical
excision.
The second commonest adrenal
incidentaloma reported in the literature
is a metastasis from a known primary
tumour — especially the breast and lung,
and lymphomas. The adrenal glands are
a favoured site for malignant spread, with
as many as 26% of cancer patients hav
ing adrenal metastases at the time of
death.16 These metastases, presenting as
adrenal incidentalomas, may even precede
the detection of the primary tumour.12
About 10% of adrenal incidentalomas
are cystic lesions. Asymptomatic adrenal
cysts are found in 0.06% of autopsies.17
One half of these are true cysts with an
endothelial lining, the others are cystic
degenerated adenomas or pseudocysts,18
which are often the result of hemorrhage
into benign or malignant tumours.19
Pheochromocytomas have fortuitously
been discovered as adrenal incidenta
lomas in several recent reports.2'3'6 The
high frequency of this diagnosis among
incidentalomas is supported by a recent
study demonstrating unsuspected pheo
chromocytomas in 0.3% of autopsies.20
Correct diagnosis of this condition
preoperatively substantially reduces peri
operative morbidity.
The investigation of the adrenal
incidentaloma includes three main steps:
a review of the computed tomogram, a
review of clinical data and results of
investigations, and performance of hor
monal studies (Fig. 1). The information
thus obtained may suggest other diagnos
tic maneuvers.
A review of the computed tomogram
may provide some answers. Lipomas and
myelolipomas have very low attenuation
coefficients due to their high fat con
tent.21 Simple cysts can often be confi
dently identified from their characteris
tic homogeneous water density, round

FIG. 1—Algorithm for investigation of
adrenal incidentaloma.

shape, sharp margins and lack of contrast
enhancement.2 When there is doubt,
needle aspiration may be useful. Aspira
tion of clear fluid strongly supports the
diagnosis of a benign simple cyst,22 but
a bloody aspirate may be found in benign
and malignant lesions. The confident
diagnosis of other kinds of adrenal
incidentalomas is usually not possible by
computed tomography alone, and further
investigation is indicated.
A review of all available clinical and
investigational data is essential at this
point. If a specific endocrine syndrome
such as pheochromocytoma, hyperandrogenic state, Cushing’s or Conn’s syn
drome is suspected, then following the
standard diagnostic protocols for these
conditions is the most efficient approach.
If the clinical setting suggests the presence
of metastatic disease and the primary is
occult, needle biopsy is the best way to
make the diagnosis. Tissue obtained by
percutaneous needle biopsy under com
puted tomographic guidance established
the diagnosis in 94% of adrenal tumours
in a recent study.8 However, it is very
difficult to differentiate adrenocortical
adenoma from carcinoma in these speci
mens. Therefore, needle biopsy is most
valuable when an adrenal metastasis is
suspected.
Screening hormonal studies are neces
sary even when the clinical features of
endocrine syndromes are absent, since
even occult hormonal secretion may exact
a metabolic price from the patient. Subclinical hypercortisolism still leads to
osteoporosis and increased susceptibility
to infections. The clinical effects of
pheochromocytomas are characteristi
cally paroxysmal but are life-threatening.
Adequate screening for excess steroidhormone production includes measure
ment of serum cortisol, dehydroepiandrosterone sulfate and testosterone levels,
as well as a minimum of two 24-hour
urine collections to measure free cortisol.
Urine collections can reliably be obtained
on an outpatient basis with simultaneous
measurement of the urinary creatinine
value to assess the completeness of the
collection. Since adrenocortical tumours
with normal basal steroid excretion may
show lack of dexamethasone suppression
the measurement of steroid hormones
should be repeated during 2 days of dex
amethasone suppression (2.0 mg every 6
hours).
No aldosterone-secreting incidentaloma
has been reported so far in the literature.
However, the presence of hypertension or
hypokalemia with inappropriate kaliuresis is an indication that plasma renin
activity and aldosterone levels should be
measured.
When the three main steps have failed
to produce a diagnosis, the lesion is likely
a benign cortical adenoma. Although

adrenocortical carcinoma is rare, it has
to be kept in mind since early resection
provides the only chance of cure. Further
investigations are rarely helpful. Other
imaging techniques such as ultrasonogra
phy and angiography provide little new
information. The role of radioisotope
scanning with iodocholesterol for
adrenocortical tumours or with iodobenzylguanidine for pheochromocytoma has
not been studied in this clinical setting.
Therefore, with respect to computed
tomography, the question is: Does the
lesion appear sufficiently benign to allow
nonsurgical management? Comparison of
the computed tomographic appearance of
adrenocortical carcinomas and adenomas
has revealed certain characteristic fea
tures. Criteria suggesting an adenoma
include a round or oval shape, diameter
of less than 5 cm and clear delineation
from surrounding structures.10 The
criterion of 5 cm is useful since adenomas
are almost always smaller than this while
more than 90% of carcinomas are
larger.23 Close clinical follow-up and
repeat computed tomography at 3
months, 6 months and 1 year is necessary.
Mitnick and colleagues10 followed up 12
patients who satisfied the above criteria
and found no evidence of progression.
Enlargement of the lesion calls for surgi
cal resection.
The management of the adrenal
incidentaloma presents a new challenge
in medicine. Few lesions investigated
will be clinically important, yet they
will cause patients and their physicians
much anxiety. On the basis of our
review of 95 cases of incidentaloma in the
literature, we recommend a conservative
approach to management of these lesions.
T im J. O ’L e a r y , m d , fr c pc
T.C. Ooi, MB, BS, FRCPC, FRACP

Division of Endocrinology
and Metabolism,
Ottawa Civic Hospital,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
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Contributions to the Correspondence section are welcomed.
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Radiation Exposure
and the Surgeon
To the editors.—Sometimes different sur
geons will look at the same data and come
to opposite conclusions. In their recent
article on Ender’s nailing of hip fractures
(Can J Surg 1985; 28: 25-26), Moreau
and Ashmore stated that “ the radiation
received by the operating team is well
within the acceptable limits” . I disagree
with this statement. In their table of 31
patients (Table I), the radiation dosage
received by the operating team varied
from 0 to 69 mrem per case for the sur
geon, 0 to 14 mrem for the nurse and 0
to 12 mrem for the anesthetist. Since 62
patients received this operation over 18
months, the case and exposure load might
be approximately 40 patients per year for
the institution or approximately 15
patients per surgeon, since the table indi
cated that three surgeons performed the
procedure. Thus, one surgeon might
reasonably average 290 mrem exposure
per year for Ender’s nailing procedures
alone (excluding all other exposures he
might receive from other procedures).
Another surgeon would probably average
180 mrem and the third might average 130
mrem per year. One would need more
information to calculate individual nurse
and anesthetist doses. One assumes that
the criterion for “ acceptable limits” is the
official Canadian government standard
for “ acceptable” radiation exposure: a
Canadian maximum of 500 mrem per
year for an individual in the general popu
lation and 5000 mrem per year for an
individual whose livelihood involves radi
ation risks (e.g., doctors, radiographers,
uranium miners, nuclear power plant
workers).
A threshold below which damage from
radiation does not occur has never been
demonstrated, and many now believe that
a threshold does not exist. What seems
clear is that the greater the exposure to
radiation the more likelihood there is of
incurring serious side effects such as
cancer, cataracts and birth defects. There
is no good scientific evidence to demon

strate that 500 mrem is “ safe” . Many
would argue that the limits of 500 and
5000 mrem are unreasonably high and
should be set lower. While Canadian
authorities use one of the international
standards, some countries, the United
States in particular, use lower exposure
limits. On the other hand, intertrochan
teric fractures will continue to occur and
patients need to be treated properly.
At the relatively small hospital where
I work (fewer than 100 beds), I use
Richards’ sliding compression lag screws.
We do not have an image intensifier for
the operating room and we use a standard
portable x-ray machine that gives us
anteroposterior and lateral views as
required. It is inconvenient having to wait
several minutes to see the films, but our
patients have not suffered because of the
extra anesthetic time required. We gener
ally, but not always, leave the room dur
ing roentgenography. My radiation badge
has not detected any exposure in the 5
years that I have worked at this hospital
and we serve an older population so we
treat fractured hips frequently. In fact,
the radiology equipment at our hospital
is modern enough and the practice of the
radiologist and radiographers diligent
enough that x-ray exposure for all medi
cal purposes in our hospital is at a far
lower level per individual per year than
that incurred by the surgeons in Moreau’s
article. A full-time radiologist with almost
30 years’ service who is diligent about
wearing his exposure badge has less than
700 mrem of life-time exposure which
means that he is being exposed to less
than 25 mrem of additional radiation per
year because of his job. The radi
ographers on our staff have exposures in
the same range. The surgeon’s radiation
badge indicates even lower exposure, and
this includes performance intraoperatively
of roentgenography for many fractures
both closed and open, as well as routine
operative cholangiography during
cholecystectomies.
In Nova Scotia the average background
radiation is 110 mrem per year and this
is of course an irreducible risk in that you

cannot be alive and have no radiation
exposure and thus no risk. The radiation
exposure of health professionals at our
hospital is so small per year that we are
not concerned.
Radiation exposure of patients is not
restricted by government regulation, and
diagnosis and treatment are handled on
an individual risk versus benefit basis for
each case. Most health professionals at
our hospital are reasonably healthy and
require very few diagnostic roentgeno
grams during the year; thus, our medical
diagnostic and treatment radiation levels
are extremely low and these people receive
less total radiation exposure than that
received in the performance of Ender’s
nailings by the surgeons in M oreau’s
paper. Presumably these surgeons have
additional exposure from other proce
dures in addition to background radiation
within their location.
While no one can say how many side
effects, such as cancers and cataracts,
may be incurred by the extra exposure of
M oreau’s surgeons, I believe that it is a
risk a surgeon should not take if there are
alternative ways to treat the patients.
More important, I think that it is unethi
cal for surgeons to subject anesthetists
and nurses to additional exposure. Were
participating nurses in M oreau’s series
advised of the exposure involved? Have
any of them read the current best theo
retical calculations in “ Radiation and
Human Health” ? 1
In conclusion, although patients should
receive the best treatment available, such
treatment should present the minimum
risk to patients and staff alike. The treat
ment studied by Moreau and Ashmore
does not appear to fulfil this criterion.
W . T H U R LO W , MD, FRCSC, FACS

McCleave Medical Centre,
Digby, NS
BOV 1A0
Reference
1. GOFMAM JW: Radiation and Human Health, Sierra Club
Bks, San Francisco, 1981
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Preoperative Embolization
of Supratentorial Meningiomas
To the editors.—Rutka and associates
(Can J Surg 1985; 28: 441-443) are to be
congratulated for their series.
They do not state how long after the
embolization the surgery was performed
except that all patients but one were oper
ated on within 4 days. Our own
experience has been that the reduction of
blood flow is greatest immediately after
embolization or after the occlusion of a
vessel. Almost within minutes, expansion
of visible collaterals can be seen, as for
example during a scalp incision for a
craniotomy when the external carotid
artery is ligated or embolized. We embolize these extremely vascular meningiomas
intraoperatively using serial angiography
to direct catheter placement and subse
quent embolization through the external
carotid artery branches.1In their conclu
sions, Rutka and colleagues point out that
the overall reduction in vascularity
depends on the relative contributions of
the internal and external feeders. Unless
a meningioma arises close to the carotid
artery to which its meningeal branches
have access, virtually none of its supply
comes from the internal carotid. The
reduction in blood supply after emboli
zation, followed immediately by the sur
gical exposure, is dramatic. If the emboli
zation is carried out during the turning
of the flap or afterwards, the field
becomes virtually dry under the surgeon’s
eyes.
We agree that total tumour removal
must be the objective in cases of menin
gioma and almost invariably the best way
to control the bleeding is by total removal
of the tumour, particularly its point of
attachment.
We would suggest to the authors that
they try intraoperative embolization.
They will be delighted by the enormous
reduction in vascularity that will last for
several hours.
D wight P arkinson, md , frcsc, facs
Professor of Neurosurgery,
Health Sciences Centre,
700 William Ave.,
Winnipeg, Man.
R3E 0Z3

Reference
1. P arkinson D, leg a l J, H olloway AF, et al: A new
combined neurosurgical headholder and cassette changer
for intraoperative serial angiography. Technical note. J
Neurosurg 1978; 48: 1038-1041

To the editors.—Dr. Parkinson’s obser
vations that intraoperative embolization
of highly vascular meningiomas results in
a marked reduction in tumour vascular
ity is an extremely important observation.
With one exception all our patients under
10

went operation within 4 days of emboli
zation, but none on the day of emboliza
tion. We demonstrated the computed
tomographic and angiographic changes
that occurred after embolization but
avoided speculating as to the efficacy of
reduction in tumour vascularity. It might
be noted from the results that the amount
of intraoperative blood loss did correlate
with tumour diameter.
Dr. Parkinson’s observation that
intraoperative embolization results in a
visible reduction in tumour vascularity is
a very welcome and important obser
vation.
P aul J. M uller , md , m sc , frcsc
Chief,
Division of Neurosurgery,
St. Michael’s Hospital,
38 Shuter St.,
Toronto, Ont.
M5B 1A6

Simple Stapling Technique
to Fashion
an Intestinal Valve
To the editors.—Recently there has been
a resurgence of interest in recreation of
the ileocecal valve after its resection.
Below, I describe a simple technique I
have devised; by using available stapling
devices, very little extra time is added to
the original operation.
Before handling, segments of the large
and small bowel are isolated with non
crushing clamps about 30 cm from the
divided edges and contents are milked
into sponges, which are immediately dis
carded. An EE A stapler (Auto Suture
Company, Division of US Surgical Corp.,
Norwalk, Conn.), without the anvil, is
inserted through the open end of the
colon (Fig. 1). Alternatively, a distal
colotomy may be used. The centre rod
dents the antimesenteric side about 5 cm
from the cut edge. A small nick with a

Medical Management
of Endometriosis
To the editors.—The interesting report by
Buckspan and associates on endometrio
sis (Can J Surg 1985; 28: 447-449) raised
two issues: the cause of endometriosis and
its management at unusual sites.
It has been well established experimen
tally and clinically that retrograde men
struation does occur in humans and that
the endometrium shed at that time can
grow in ectopic sites. Sampson, espe
cially, spent most of his professional life
demonstrating this phenomenon. The
serosal metaplasia theory dates back to
Rokitansky in 1860 and should perhaps
now be considered a historical curiosity.
With respect to the management of
endometriotic deposits in unusual sites,
the diagnosis is frequently made at
laparotomy (as in the case described by
Buckspan and colleagues), and the temp
tation to remove the lesion is often
irresistible. However, medical treatment,
particularly with Danazol, is often effec
tive in decreasing the size of the
endometriotic deposit and in reducing the
inflammatory process caused by the cycli
cal localized bleeding. In Buckspan’s
case, a histologic diagnosis and the deci
sion concerning management was made
at the time of surgery. Possibly ureteric
catheterization immediately followed by
medical treatment would have been suc
cessful. The point, however, is that this
ubiquitous disease is now frequently
managed successfully and conservatively
by suppressing ovulation.

FIG. 1—Stapler without anvil is passed
through colon.

FIG. 2—Anvil of stapler is inserted into
ileum and purse-string suture around cut end
is tied tight.

P.T. H ewlett , mb, bs, frcsc
Women’s College Hospital,
76 Grenville St.,
Toronto, Ont.
M5S 1B2

FIG. 3—Anastomosis of ileum to colon is
intussuscepted into colon and fixed with
sutures.
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scalpel is made here and the centre rod
is pushed through and the anvil attached.
A purse-string suture is placed around the
cut end of the small intestine, which has
had the distal 4 cm of mesentery removed.
The anvil is inserted into the small gut and
the purse-string tied tight (Fig. 2). The
EEA stapler is closed and fired. Without
opening the instrument, the anastomosis
is now intussuscepted into the colon for
about 3 to 4 cm and fixed in place with
seromuscular sutures around the invagi
nation (Fig. 3). The stapler is now opened
and removed, and the rings obtained are
inspected. Hemostasis of the intus
suscepted anastomosis is confirmed. The
distal colon is closed with a TA-55 stapler.
A ndrus J. Voitk , md , frcsc
178 Mississaga St. W,
Orillia, Ont.
L3V 3B5

Localization of
Occult Breast Tumours
To the editors.—Neither in his letter (Can
J Surg 1985; 28: 300) nor in his original
article on the intraoperative localization
of occult breast tumours (Can J Surg
1985; 28: 329-330) does Mahoney address
the major flaw in his technique, namely
the lack of mammographic evidence
preoperatively to establish the relation

ship of the needle to the lesion. The needle
is your guide even if you replace it with
dye. It is not uncommon for a needle to
be off the mark sufficiently to require
reinsertion and, even with acceptable
placement, it may be a centimetre or so
out in either plane. We make the neces
sary corrections at surgery, based on our
estimate of the distance and direction the
needle may be off the mark. Not know
ing where the needle is in relation to the
lesion makes Mahoney’s procedure rela
tively blind. His very meticulous excision
is being performed without knowing the
exact site of the lesion.
Most patients, in whom we find carci
noma in an occult mammographic lesion,
are treated as Mahoney indicates. When
we stated in our editorial (Can J Surg
1985; 28: 297-298) that these mammo
graphic lesions should be managed
aggressively, we did not refer to the extent
of surgery, but rather the timing. We
believe that biopsy should be performed
early, using a proper localizing technique
rather than waiting a few months and
repeating the mammogram to see if there
is any change.
Mahoney discusses our use of a circumareolar incision. Obviously if the
lesion is well away from the areola, we
do not attempt to excise it through the
areola, but when the areola is fairly large
and the lesion not more than 2 or 3 cm
from its margin, the lesion can be

removed easily through an areolar inci
sion, excising mainly the distal part of the
dye-stained tract, thus giving excellent
cosmesis.
Knowing exactly where the lesion is in
relation to the needle simplifies the oper
ation and allows me to remove much less
tissue than would be necessary if I was
operating “ blind” . Because about 85%
of these lesions are benign, removal of a
minimal amount of tissue is possible and
this maintains better breast form.
Surgeons attem p tin g to follow
Mahoney’s technique, with omission of
the vital preoperative needle-localization
mammogram, are going to miss many
lesions at surgery, in spite o f a wide and
frequently inappropriate excision of nor
mal breast tissue. Although it appears to
work quite well in M ahoney’s hands, I
would not recommend it as an explora
tion technique. You will not get marks for
performing a meticulous wide excision in
the wrong direction. My advice is that you
get acquainted with your radiologist and
take the extra step.
A lan A. Bassett, md , frcsc , facs
Director, Breast Treatment Unit,
Department of Surgery,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont.
M5G 1X5
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SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

OSCE Is Effective, Efficient and Not Too Painful
“ It’s practical and reasonably efficient,
and better-structured than oral exams,”
says Walter Waddell, FRCSC, “ and it
allows us to look at things that are impos
sible to test by other means.”
An exciting new diagnostic technique?
In a way, yes, but the objective-structured
clinical examination (OSCE) is to find out
how well students, rather than patients,
perform. Waddell, who is the coordina
tor of undergraduate education for the
Department of Surgery at the University
of Ottawa, was talking to CJS about the
exam, which is being used for the first
time in the department this academic
year. In July the first batch of 4th-year
students faced OSCE (pronounced like a
nickname for Oscar) as part of the surgi
cal rotation; the second batch completed
the exam in November and early next
month a third will follow suit.
Students move through “ stations” that
test their skills rather than their recall; for
example, the test in November incorpo
rated 21 stations in which, among other
activities, the students examined the back
of one patient and the vascular system of
another, studied x-ray films to come up
with a differential diagnosis and wrote
orders for a patient with acute pancrea
titis.
Says Waddell, “ We also asked them to
close a 5-cm laceration; now this is pig’s
skin, but the history was for a 16-yearold girl who had fallen on the school yard
and sustained a clean, sharp wound on
broken glass. In addition to the prac
tical thing, we asked about tetanus
prophylaxis, choice of suture material,
wound debridement and when to bring
her back to take out the sutures.” Each
station was designed to take 5 minutes,
and the 20 students taking the exam had
completed the test in just 2 hours. As
Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery, PO
Box 8650, Ottawa, Ont. K1G 0G8.

Waddell points out, “ 10 students in halfhour orals would take 300 minutes — 5
hours. The exam takes more preparation
than an ordinary oral but less than a mul
tiple choice test with 100 to 150 ques
tions.”
In fact, as long as the numbers of stu
dents are fewer than 100, OSCE proba
bly takes less time than any other format
now being used extensively, says Ian
H art, FRCPC, the man who introduced
the concept to North America just 6 years
ago. Hart chairs the Department of Medi
cine at the Ottawa Civic Hospital and has
been an active advocate of reforms in
methods of assessing clinical competence.
Says Hart, “ OSCE is a format rather
than a type of examination; it allows
examiners to use many different methods
of testing students but encourages them
to consider exactly what they want to
measure and how best they might do so.
OSCE was developed because no single

exam can measure the skills and
knowledge needed to practise medicine.
“ If you want to measure how well
someone examines a patient’s chest,
there’s no point in asking him or her to
write an essay; you are measuring the per
son’s ability to write clear, lucid English
in an organized fashion. You aren’t meas
uring anything about what the person
does with his or her hands on the patient’s
body. At one time I could write a superb
description about how to remove some
one’s appendix but I wouldn’t under any
circumstances ever let me do an appen
dectomy.
“ If you want to find out how well s ti^
dents write and organize their thoughts,
there’s no reason you can’t ask them to
write a short essay in one station; in the
next station you might ask them to do
something with their hands — examine a
chest, feel for the patient’s liver; at the
next station you might ask them to do a
lumbar puncture in a rubber model; in the
next station you might ask them to sit and
talk to a patient whose daughter has died
of some genetic disease and is worried
about having more children —'a counsel-

Interpreting x-ray films is part of the OSCE that is being used in the Department of Surgery
at the University of Ottawa to test medical students’ skills. Dr. F. Shamji (left) is one of the
department’s examiners.
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ling station; the next station might be one
in which they take some information
from an x-ray film, interpret it and make
a treatment decision.”
In the most recent medical exam, stu
dents were asked to advise an AIDS
patient (simulated) on the changes in life
style demanded by the disease. Says Hart,
“ Counselling is not normally tested, but
we feel it’s important because most phy
sicians spend a majority of their time
advising and counselling patients.”
The patients in the University of
Ottawa surgical OSCE were volunteers
from the Civic Hospital’s day-care pro
gram, and Hart notes that most Canadian
medical schools have little difficulty
recruiting patients to assist in the testing.
“ In the US, patients seem to feel, ‘I pay
doctors; why shouldn’t they pay me?’ ”
How can OSCE be used to judge a stu
dent’s ability to perform an appendec
tomy? T hat’s a good question says Hart
and he doesn’t feel it’s possible or realis
tic to set up a station to assess one’s capa
bility to operate. However, as OSCE
spreads to surgical departments, clearly
H art is correct when he says: “ With
innovative thinking, the potential for test
ing surgical techniques is vast.”
For some reason, however, surgical
departments have been somewhat slower
than others to adopt the approach: of the
16 medical schools in Canada, 12 now
have some form of OSCE, but until this
year the University of Toronto was the
only school whose surgery department
was using the format regularly. Ironically,
the group in Dundee, Scotland, who
pioneered OSCE, published results of its
use for surgery almost immediately.
Says Hart, “ I don’t want to sound as
if the surgeons are behind — they are not
the only group not using OSCE. Word is
just now spreading: when the concept was
new, it mainly appeared in articles for
journals of medical education,” but the
body o f journal articles and conferences
as well as experience with the format is
growing rapidly. H art’s department in
Ottawa hosted an international confer
ence in July 1985; they expected about 60
participants but ended up with more than
200. They are planning a follow-up meet
ing in 1987. Also the most recent annual
meeting of the Royal College of Physi
cians and Surgeons of Canada included
a session about assessing clinical compe
tence and Hart was one of the speakers.
Reflecting the growing interest is an
expanding databank of stations housed
by the University of Ottawa. At present
the databank includes five complete
20-station examinations, available for a
nominal charge to cover handling and
postage. Any medical school can access
or add to the databank.
Students do not have access to the
information, says Hart, mainly because
the databank is incomplete. “ If they have
14

access to what is there now, they may
think that’s all they need to know. When
the bank adequately covers all facets of
medical practice, then I have no problem
with giving students access.” Anyway,
“ they know the stations that have been
used and word gets around” .
Waddell agrees. “ The first group of
students had no idea what to expect, so
they weren’t as happy about the exam as
the next group who had an opportunity
to talk to the first group and were better
prepared. Overall, however, the first
group scored higher than the second.
With this examination, we are able to give
immediate feedback and that helps. If
you provide instant feedback, the exami
nation — if not accepted with pleasure —
is at least not too painful.”

Research Workshop to Be
Regular Event of CAGS

“ Surgeons who spend all their time in
clinical practice seem to feel that surgi
cal investigators or research fellows are
wasting their time,” says Max M. Cohen,
FRCSC, Associate Professor, University
of Toronto.
Combatting this attitude, according to
Cohen, is what 25 general surgeons had
in mind when they met last year at
Chateau Montebello to discuss the
problems peculiar to surgical research.
The group were all actively involved in
research and were anxious to draw into
their midst other members of the Cana
dian Association of General Surgeons.
They decided to convene annually and
have chosen the Rocky Crest Resort in
Muskoka District, Ontario, as the site for
their meeting June 2 and 3 this year.
The group plans to come up with posi
tive steps to remedy the low status, low
pay and shortage of operating funds that
they say combine to limit interest and,
hence, numbers of surgeons doing
research.
Grant applications to the Medical
Research Council seem to support their
claims. According to Lewis Slotin, PhD,
Director of the Council’s Program
Branch, applications from surgeons are
few: “ Although we don’t have exact
statistics, the overall impression is that
applications from surgeons are not that
plentiful. The success rate for surgeons
in the competition was higher in the late
1970s and early 1980s; then there was a
dip; and there seems to be a slight
upswing now.”
Slotin spoke to the CAGS group that
met in Montebello and outlined MRC’s
objectives, review process and priorities.
As the first deadline for applications in
1986 is Feb. 1, he gave CJS a recap.

“ I pointed out that there was no bias
in the Council against clinical research.
In fact, it has a strong interest in en
couraging clinicians to become involved
in research. At present 60% of the funds
we provide for operating grants are held
within clinical departm ents. This
represents a shift from 15 years ago when
80% of funds went to basic science
departments. The milieu in which bio
medical research is going on in this coun
try is changing. There has been an expan
sion of hospital-based research.
However, Slotin admitted that the
Medical Research Council is biased
against poorly written applications.
“ There’s no question that the way an
application is written is important. All
applicants need to interact with people
who have been successful as well as to
interact with people who sit on the review
committees. You need to know a priori
what will be looked for and how to struc
ture the application. Across the country,
there should be grant-preparation days at
which MRC personnel or people from
other grant agencies come and explain
what is useful. The very obvious require
ments are to begin with a single, broad
statement of where you want to be in
knowledge in 20 years or so. Then follow
with specific objectives or milestones
along the route. Do a good, thorough
literature search to pick out those things
that suggest your hypothesis has merit or
that the methods you plan to use will
answer the questions you are posing. If
a portion of the research proposal
requires techniques that you don’t have,
you need letters from collaborators who
attest to the fact they will assist you.”

Appointments and
Changes in Kingston

Dr. Dale Mercer, a general surgeon
with particular interest in managing
problems of the esophagus and upper gas
trointestinal tract, has just joined the staff
of the Hotel Dieu Hospital in Kingston
after 2 years studying in Seattle,
Washington.
Dr. Ronald Pace, a graduate of the
University of Western Ontario, has been
appointed general surgeon on the staff of
the Kingston General Hospital. He is
researching splenic function.
J.R. McCorriston, FACS, FRCSC,
head of the Department of Surgery at
Queen’s University from 1963 to 1978,
retired from active practice June 30, 1985.
During his term as head of the depart
ment, Dr. McCorriston also served on the
editorial board of CJS.
A my C houinard
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B. fragilis, the most prevalent anaerobe in intra-abdominal infections,
was responsible for up to 60% of mortalities in patients with B. fragilis
bacteremia when inappropriate treatment was given1. And recent
North American studies show23 B. fragilis is becoming resistant to
newer antibiotics such as clindamycin or cefoxitin.
A verag e re s is tan c e

B. fragilis

C lin d a m y c in

C e fo x itin

M o x a la cta m

M e tro n id a z o le

4.8%

8.8%

17.9%

0%

No proven resistance to metronidazole
Flagyl 500 Inj. (metronidazole) remains unaffected by B. fragilis
resistance23. Flagyl 500 Inj. is active, regardless of bacterial concentra
tion or growth stage4-5. It has an excellent record of safety, and it is
compatible with most antibiotics6 used for aerobic coverage in intra
abdominal and pelvic surgery.
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Whenever B. fragilis cannot be ruled out

FLAG
metronidazole

a selective anaerobicide
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Whenever B. fragilis cannot
be ruled out
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(metronidazole)

a selective anaerobicide
Therapeutic Classification

Antibacterial-Antiprotozoal
Actions
Flagyl (metronidazole) is bactericidal against
anaerobic bacteria, it exerts trichomonacidal
activity and is also active against Giardia
lamblia and Entamoeba histolytica. Its exact
mechanism of action has not been entirely
determined as yet. It has been proposed that
an intermediate in the reduction of metronidazole,
produced only in anaerobic bacteria and
protozoa is bound to deoxyribonucleic acid
and proteins, and inhibits subsequent nucleic
acid synthesis.

INDICATIONS AND CLINICAL USES
Bacterial infections
The treatment of serious anaerobic abdominal
infections due to susceptible anaerobic bacteria,
such as Bacteroides fragilis (and other species
of Bacteroides), Clostridium, Fusobacterium,
Peptococcus, and Peptostreptococcus species.
Culture and susceptibility studies should be
performed to determine the causative organisms
and their susceptibility to metronidazole.
Based on clinical judgment and anticipated
bacteriological findings, therapy may be
started while awaiting the results of these
tests.
In mixed aerobic and anaerobic infections,
consideration should be given to the con
comitant administration of an antibiotic
appropriate for the treatment of the aerobic
component of the infection. (See Warnings).
Flagyl (metronidazole) has also been used in
the treatment of a small number of cases of
brain or lung infections (some with abscesses)
caused by anaerobic bacteria.

CONTRAINDICATIONS
Flagyl (metronidazole) is contraindicated in
patients with a prior history of hypersensitivity
to metronidazole or other nitroimidazole
derivatives.
Flagyl should not be administered to patients
with active neurological disorders or a history
of blood dyscrasia, hypothyroidism and
hypoadrenalism.

Warnings
Flagyl (metronidazole) has no direct activity
against aerobic or facultative anaerobic bacteria.
In patients with mixed aerobic-anaerobic
infections appropriate concomitant antibiotics
active against the aerobic component should
be considered.
Known or previously unrecognized moniliasis
may present more prominent symptoms after
treatment with Flagyl.
Studies in rats and mice have provided some
evidence that metronidazole may cause tumors
in these species when administered orally for
a long period at high doses. The relevance of
these findings in humans is not known.
Severe neurological disturbances (i.e. convulsive
seizures and peripheral neuropathy) have
been reported in patients treated with Flagyl
(administered orally or intravenously). These
have been observed very infrequently.

Precautions
Patients taking Flagyl (metronidazole) should
be warned against consuming alcohol, because
of a possible disulfiram-like reaction. For the
same reason, patients receiving Flagyl should
not be administered disulfiram concomitantly.
Transient eosinophilia and leukopenia have
been observed during treatment with Flagyl.
Regular total and differential leukocyte counts
are advised if administration for more than

10 days or a second course of therapy is
considered to be necessary.
Metronidazole crosses the placental barrier.
Although Flagyl has been given to pregnant
women without apparent complication, it is
advisable that oral administration be avoided
in pregnant patients and Flagyl be withheld
during the first trimester of pregnancy. In
serious anaerobic infections, if the adminis
tration of Flagyl to pregnant patients is
considered to be necessary, its use requires
that the potential benefits be weighed against
the possible risks to the fetus.
Metronidazole is secreted in breast milk in con
centrations similar to those found in plasma.
Intravenous or oral administration of Flagyl
should be avoided in the nursing mother.
Metronidazole has been reported to potentiate
the anticoagulant effect of warfarin resulting
in a prolongation of prothrombin time. This
possible drug interaction should be con
sidered when Flagyl is prescribed for patients
on this type of anticoagulant therapy.
Clinical experience in children is very limited.
The monitoring of this group of patients is
particularly important. The safety and effec
tiveness of intravenous Flagyl in children has
not been established.
A rare case of reversible but profound
neurological deterioration has been reported
following a single oral dose of Flagyl; it is
therefore advisable that a patient taking
Flagyl for the first time not be left unattended
for a period of two hours. The appearance of
abnormal neurologic signs demands prompt
discontinuation of Flagyl therapy and, when
severe, immediate medical attention. Gastric
lavage may be considered if no more than
two or three hours have elapsed since
administration of the drug.
Treatment with Flagyl should be discontinued
if ataxia or any other symptom of CNS
involvement occurs.
Patients with severe hepatic disease metabolize
metronidazole slowly with resultant
accumulation of metronidazole and its
metabolites in the plasma. Accordingly, for
such patients, doses of Flagyl below those
usually recommended should be
administered and with caution. The
determination of serum glutamic oxaloacetic
transaminase (SGOT) by the Technicon SMA
12/60 system in blood samples from patients
receiving Flagyl may give abnormally low
values. This abnormality is artifactual and
caused by the absorption of metronidazole at
the wavelength where the enzymatic reaction
is monitored spectrophotometrically.

Adverse reactions
Gastrointestinal: diarrhea, nausea, vomiting,
anorexia, epigastric distress, dyspepsia,
constipation.
Mouth: furred tongue, dry mouth, unpleasant
metallic taste.
Hematopoietic: transient eosinophilia or
leukopenia.
Dermatologic: rash and pruritus.
Cardiovascular: palpitation and chest pain.
Central Nervous System: convulsive
seizures, peripheral neuropathy, transient
ataxia, dizziness, drowsiness, confusion,
insomnia and headache.
Peripheral neuropathies have been reported
in a few patients on moderately high to
high-dose prolonged oral treatment with
metronidazole. It would appear that the
occurrence is not directly related to the daily
dosage and that an important predisposing
factor is the continuation of oral and/or I.V.
medication for several weeks or months.

Profound neurological deterioration, within 2
hours after Flagyl administration has been
reported. The occurrence is not directly
related to the dosage level.
Metabolic: An antithyroid effect has been
reported by some investigators but three
different clinical studies failed to confirm this.
Local Reactions: Thrombophlebitis has
occurred with I.V. administration.
Other: Proliferation of Candida albicans in
the vagina, vaginal dryness and burning;
dysuria; occasional flushing and headaches,
especially with concomitant ingestion of
alcohol; altered taste of alcoholic beverages.
Darkening of the urine has been reported.
This is probably due to a metabolite of
metronidazole and seems to have no clinical
significance.
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SYMPTOMS AND TREATMENT OF
OVERDOSAGE
Symptoms
Massive ingestion may produce vomiting and
slight disorientation.

4

Treatment
There is no specific antidote. Early gastric
lavage may remove a large amount of the
drug; otherwise, symptomatic treatment.

DOSAGE AND ADMINISTRATION
Treatment of anaerobic infections
Treatment should be initiated by the I.V.
route. Oral medication may be substituted
when it is feasible and/or practical. Duration
of therapy depends upon clinical and
bacteriological assessment. Treatment for
seven days should be satisfactory for most
patients. However in cases where infection
sites cannot be drained or which are liable to
endogenous recontamination by anaerobic
pathogens, a longer treatment may be
required.

<*
«

I.V. Administration
100 ml_ (500 mg) by intravenous infusion
every 8 hours. The injection should be
infused intravenously at the rate of 5 mL per
minute.
Flagyl Injection is compatible in a volume
ratio of 1:5 with normal saline, dextrosesaline, dextrose 5 per cent w/v or potassium
chloride injections (20 mmol and 40 mmol).
These admixtures will remain stable for a
period of 24 hours when kept in the dark or
in combined daylight and artificial light. Not
to be mixed with sodium lactate injection
5% w/v, or dextrose injection 10% w/v.

V.
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AVAILABILITY
Injection 0.5% w/v Viaflex* plastic bags of
100 mL (500 mg) for i.v. infusion.

*

'Trademark of Baxter Travenol Laboratories Inc.

Complete information available on
request.
1. Tally FP, Gorbach SL. J Inf 1979; (Suppl 1):25-37.
2. Cuchural GJ, Tally FP et al. Antimicrob Agents
Chemother 1984; 26:145-148.
3. Lamothe, F, Bourgault AM et al. Union Med
Can 1984; 113:485-488.
4. Bartlett JG et al. Arch Surg 1983; 118:181-184.
5. Corrodi P, Bush DF et al. In Metronidazole:
Selected Proceedings of the International
Metronidazole Conference. Excerpta Medica 1979;
161-168.
6. Bisaillon S, Sarrazin R.J Parent Sci Tech 1983;
37(4).
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ROYAL COLLEGE SYMPOSIUM
Symposium on Venous Disease
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1. Diagnosis of Thrombophlebitis
*
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There is overwhelming evidence that a
clinical diagnosis of venous thrombosis is
nonspecific and that patients suspected
clinically of having venous thrombosis
From the Department o f Pathology,
McMaster University Medical Centre,
Hamilton, Ont.
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should be investigated by more reliable
objective tests. The reference standard for
the diagnosis of the disease has been
venography. If a venogram is adequate
and the results are negative, then an alter
native diagnosis should be sought and
anticoagulants may safely be omitted. It
should be stressed, however, that before
a venogram can be read as negative, all
of the veins normally seen by ascending
venography (peroneal and posterior tibial
veins and the popliteal, superficial and
common femoral, and external and com
mon iliac veins) should be visualized and
seen to be free of intraluminal filling
defects. In our experience, approximately
15% of all venograms are technically
unacceptable, in which case the procedure
should be repeated.

Clinical studies have shown that veno
graphy can be replaced by less invasive
procedures. Noninvasive tests that have
been evaluated clinically and shown to
be reliable are: the combination of
impedance plethysmography and iodine
125 fibrinogen leg scanning, serial
impedance plethysmography alone, serial
Doppler ultrasonography and other
plethysmographic techniques.
The plethysmographic and Doppler
techniques are sensitive and specific for
proximal vein thrombosis but less sensi
tive for calf vein thrombosis. They can
be used in patients with clinically sus
pected venous thrombosis provided that,
when the result is negative, the test is
repeated serially over the next 7 days to
detect an extending calf vein thrombosis.

J o s e p h G . S l a d e n , m d , f r c sc

2. Complicated Deep Venous Insufficiency:
Conservative Management
An understanding of venous
pathophysiology is helpful in managing
deep venous insufficiency. Examination
of the patient after standing for 10
minutes by searching for perforator
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tenderness and milking away the edema
will reveal incompetent perforators. A
sponge pump improves calf pumping and
reduces local tissue damage from the
systolic peak pressures of walking. It is
an invaluable aid in treatment. The com
bination of high ligation of the superficial
system and compression sclerotherapy
for the perforators gives excellent con
trol. Compression sclerotherapy can be
readily repeated as necessary. Patients
with severe deep venous insufficiency
should always be advised to wear a sur
gical support stocking indefinitely.
Une bonne connaissance de la physiopathologie veineuse est utile au traitement
de I'insuffisance veineuse profonde. La
permgabilite des veines perforantes est

evalude en cherchant chez le patient
laisse en position debout pendant 10
minutes la sensibilite des veines perfo
rantes et en verifiant la resorption de
I'oedeme apres massages. Une pompe a
eponge ameliore le pompage des mollets
et reduit les dommages tissulaires locaux
causes par les pointes de pression systolique a la marche. II s'agit d'une aide
therapeutique considerable. D'excellents
resultats sont obtenus en associant la
ligature haute du systeme superficiel et
la sclerotherapie par compression des
veines perforantes. Au besoin. la sclero
therapie par compression peut etre facilement repetee. On devrait conseiller aux
patients souffrant d'insuffisance veineuse
profonde de toujours porter un bas de
soutien chirurgical.
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I would like to introduce my portion of
this symposium with a description of the
anatomy and pathophysiology of the deep
venous system.
The normal calf pumps blood when we
walk. In the standing position venous
pressure at the ankle is about 120 cm
H20 (120 cm being roughly the distance
between the heart and the ankle). In the
normal limb this pressure drops to about
40 cm H20 on walking but rises to the
resting value when exercise ceases. The
limb with deep venous insufficiency has
an inconsequential drop in pressure with
walking whereas the limb with superficial
venous disease alone has a reduction in
pressure that is about half way between
the two. Anatomically both the superfi
cial and deep systems have valves so
placed that they prevent reflux of blood
from groin to calf. Additionally, there are
one to three valves in each perforator
vein, located deep to the fascia, directing
the blood from the superficial to the deep
venous system. The perforator veins do
not join the saphenous veins directly but
through connecting or communicating
veins.
Mechanically there are two types of
deep venous insufficiency — obstructive
and incompetent. In both cases, the deep
venous pressure rises, perforator valves
become incompetent and blood in the calf
vein stagnates and is directed to the sur
face through the incompetent perforators.
(Dr. Bergan will discuss new approaches
to the surgery of deep venous insuffi
ciency, which are aimed at bypassing
obstructed veins and providing valves in
the incompetent group.)
The deep system may be obstructed by
throm bus that has n o t lysed but
progressed to fibrosis or by tumour.
Patients with obstruction present with
swelling and bursting pain that may
increase to the point of venous claudica
tion on walking as the calf “ loads up”
because of increased inflow and
obstructed outflow. Incompetent veins
can be familial or may be acquired secon
dary to valvular damage associated with
deep phlebitis. These limbs are character
ized by signs of tissue damage that
develop a little later in the disease process
and are secondary to the water-hammer
effect of systole with walking. Pressure
is directed from the deep system through
the perforators to the superficial tissues
and skin, bruising them from within. The
three perforators most often affected are
referred to as Cockett’s perforators. They
are unsupported by muscle, situated
posteriorly at the level of the medial
malleolus and 7 and 12 cm above it.
What is the role of the superficial sys
tem in deep venous insufficiency? Browse
and colleagues stated that if this system
is incompetent, it contributes more than
50% of the pressure, as measured at the
ankle.1 We must be aware of this as
18

more than half of the patients with deep
venous insufficiency have an incompetent
superficial system.
Examination

Before examination patients stand for
10 minutes to load up the venous system
and remain standing during examination.
Saphenofemoral incompetence must be
noted and may be checked easily with a
Doppler. We search for perforators and
control points using the “ sliding finger
technique” , milking away the edema over
perforator sites to display high-pressure
veins, palpating particularly for tender
ness over Cockett’s perforators. Findings
are recorded on an appropriate form.2
The patient is prepared for more defini
tive treatment by fitting a below-knee sur
gical stocking. My own preference is the
Sigvaris (S.H. Camp & Co. of Canada
Ltd., Trenton, Ont.). To gain patient
compliance, we prescribe the 30 to 40 mm
Hg compression and use a “ sponge
pump” over the Cockett perforator area.
The pump is made from 1.25 cm soft
latex foam, about 20 x 8 cm, and
bevelled so that the edges do not indent
the tissue. This pump is wrapped on,
using half of a 10-cm tensor bandage,
applied tightly below by crisscrossing and
easing the pressure proximally. The
patient is directed to walk 3 km daily and
given a handout on deep venous insuffi
ciency and compression sclerotherapy.
Treatment

If the long saphenous vein is incompe
tent, I do high ligation of the vein and its
branches under local or general anesthe
sia on a day-care basis. Although there
may be temporary improvement of
saphenofemoral incompetence after treat
ment of the perforators by compression
sclerotherapy, it has been my experience
that each long saphenous vein that was
incom petent before com pression
sclerotherapy was again incompetent 2 to
3 years later. The expedient treatment is
to tie the vein off initially. Both Douglas
and associates3 and Hobbs4 agree with
the indication for surgery under these cir
cumstances.
We treat the perforators by compres
sion sclerotherapy. This treatment and its

T a b le 1 - P r im a r y C o m p la in t o f 1 0 0 P a t ie n t s W ith
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complications are well described in the
literature but I wish to emphasize a few
points. The vein is needled most readily
when the patient is standing and the vein
is “ loaded up” , but the leg must be
elevated and the vein empty when the
sclerosant is injected. Trapping the
sclerosant by wrapping the leg (i.e., the
compression) and compliance with it are
important despite a report5 that it is not
possible to keep compression on the leg
for more than 6 to 8 hours. Pressure over
the needle puncture site in the vein
reduces the occurrence of “ injection
ulcer” . The bandage is protected by an
old nylon stocking at all times and pres
sure is maintained by applying the Sig
varis stocking over the nylon stocking
whenever the limb is dependent. We keep
the legs wrapped with the initial bandage
and sponge for 3 weeks, tightening the
bandage if it loosens. This is followed by
3 weeks in the surgical stocking supported
by the sponge pump. Incidentally, if the
patient cannot tolerate the sponge pump
during the preparatory period, we do not
carry out compression sclerotherapy. This
eliminates the occasional patient who has
a totally inadequate deep system.
One hundred patients who had
presented initially with complicated deep
venous insufficiency (Table I) were fol
lowed up at an average of 4 years after
compression sclerotherapy. Of these, 95
were pleased with the treatment and
would repeat it. Of 229 incompetent per
forators that had been injected, about
20% were again incompetent. One third
of the patients underwent repeat compres
sion sclerotherapy or were advised to do
so. All patients were advised to continue
wearing a surgical support stocking;
about two thirds complied. Of interest is
that at least one third of these patients
would have been poor candidates for
operation because of age or obesity. Ideal
patients for compression sclerotherapy
are those with the majority of the disease
below the knee. Perforators, very large
veins and stasis ulcers are well treated by
this method which should be part of the
armamentarium of every surgeon treat
ing venous disease.
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3. Current Concepts in the Management of Varicose Veins
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Varicose veins are a very common
problem, affecting women more than
men. The major concern is usually the
unsightly appearance of the veins. Vari
ous options to deal with this problem are
discussed — compression stockings,
compression sclerotherapy and surgery.
For good results and patient satisfaction,
the cause and natural history of varicose
veins must be understood. Depending on
the type of varicose vein, different
modalities of treatment are required and
may need to be combined. "Cosmetic"
varicosities can usually be managed con
servatively with compression stockings.
Sclerotherapy is best used for dilated
superficial or residual varicose veins,
recurrent varicosities or leg perforators.
Operation should be reserved for very
large varicose veins or an incompetent
long or short saphenous vein.
A sound understanding of the
problems and discussion of anticipated
results with the patient will prevent
unrealistic expectations.
Les varices, un probleme courant, affectent davantage les femmes que les hom
ines. La principale inquietude a leur sujet
concerne habituellement leur aspect inesthetique. On commente les diverses
options qui s'offrent pour faire face a ce
probleme: bas de soutien, sclerotherapie
par compression et chirurgie. Pour obtenir de bons resultats a la satisfaction du
malade, la cause et I'histoire naturelle
des veines variqueuses doivent etre bien
comprises. Selon le type de varices,
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diverses modalites de traitement sont
necessaire et doivent parfois etre associees. Les affections variqueuses dites
"cosmetiques" peuvent habituellement
etre traitees de facon conservatrice a
I'aide de bas de soutien. La sclerothera
pie convient davantage aux varices
superficielles dilatees ou residuelles, aux
varices recidivantes ou aux varices des
veines perforantes. L'operation doit etre
reservee pour les varices tres grosses ou
dans les cas d'insuffisance des saphenes
longues ou courtes.
Une solide comprehension des problemes et une bonne discussion des resul
tats escomptes avec les patients permettra d’eviter les attentes irrealistes.

Varicose veins are the commonest vascu
lar condition, affecting 20% of the popu
lation. There is a preponderance of
females and a 20% familial incidence of
varicose veins.
Current management is based on a
sound knowledge of the anatomy,
pathophysiology, treatment alternatives
and cost of therapy.
Pathophysiology
In the ambulatory person, venous
drainage is inward to the deep veins
through the perforating veins.1 Integrity
of the valves in the perforating veins is
essential to prevent high-pressure leaks,
leading to local venous hypertension upon
exercise. There is disagreement on how
much of a pressure rise is necessary before
varicosities will develop.2’3 Even a slight
rise may be sufficient in a susceptible
person.
Primary varicose veins are associated
with defective valves and a congenital
weakness in the vein walls. Congenital
incompetence of perforators is rare.1
Damaged valves in the perforators, per
mitting high-pressure leaks to occur, may
be due to minor episodes of phlebitis or
thrombosis in the deep veins.
An unusual type of varicose veins is
seen on the lateral aspect of the lower
limb. They usually occur in women and
have no obvious communication with the

long or short saphenous veins. Probably
there is a congenital abnormality of the
vein wall and although “ points o f con
trol” may be demarcated, they do not
necessarily correlate with perforators.
History, Physical Examination
and Investigation
The main complaint of women with
varicose veins is of their cosmetic appear
ance, although these women may also
complain of discomfort, tiredness and
heaviness aggravated by menstruation.
Men tend to wait until they have large
varicosities or complications thereof.
Swelling in primary varicosities is unusual
and, if present, should alert the physician
to the possibility of deep venous throm 
bosis. Pigmentation and ulceration indi
cate incompetent perforators and do not
occur in primary varicose veins.
The patient is examined standing and
in good light. The configuration of the
varicose veins is assessed, including their
association with the long or short
saphenous system, their distribution
above or below the knee or atypically on
the lateral aspect of the limb. Incompe
tence at the saphenofemoral junction is
elicited by the cough test. An impulse is
normal, but a thrill indicates incompe
tence and can be verified by a bidirec
tional Doppler.
Perforators can be assessed using tour
niquets or digital compression to deter
mine points of control. Other methods
that are used are photoplethysmography,
bidirectional Doppler, ultrasonography,
venography and invasive pressure meas
urements.4 The bidirectional Doppler is
used to record abnormal flow patterns in
the superficial venous system and to
assess the integrity of the deep venous sys
tem. Venography should be reserved for
patients suspected of having deep venous
thrombosis.
Management of Varicose Veins
Conservative
Many women complain of visible veins
that they find unsightly. It is important
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to reassure them that these are normal
veins and no treatment is required.
Patients with early or primary varicose
veins should be assured of the benign
nature of their condition. Many have a
friend or relative in whom an ulcer has
developed, and they are scared that this
may happen to them.
Low-pressure stockings are of dubious
benefit to patients with minor varicose
veins, but they may be helpful during preg
nancy. With larger varicose veins,
properly fitting elastic stockings (Jobst or
Sigvaris) can control the condition
indefinitely. These stockings are used if
the patient refuses invasive treatment or
is not a suitable candidate for surgery.
Theoretically, the stockings should cover
the varicose veins and points of control;
however, patient compliance is poor with
the high-level stocking or panty-hose.
Below-knee varicosities are the ones most
likely to give problems and may be con
trolled with a below-knee stocking. Men
tolerate the stocking better than women
mainly because it is not visible.
In patients with varicose veins above
and below the knee, below-knee stockings
are advised for two reasons: better patient
compliance and the lower limb varicosi
ties are subjected to higher pressures,
which must be controlled.
The patients with secondary varicose
veins due to post-phlebitic conditions
must wear below-knee elastic stockings
indefinitely. Compression by elastic
stockings reduces peak systolic venous
pressure during exercise in the postphlebitic limb.5 Lateral varicosities on
the thigh should be treated conservatively
whenever possible. These veins have a
very high recurrence rate no matter what
type of treatment is used. If the patient
insists on some form of therapy, then
compression sclerotherapy is recom
mended.
Compression Sclerotherapy
In 1963, Fegan6 was responsible for
renewed interest in sclerotherapy. He
combined injections with compression
and exercise and achieved good results.
The aim of compression sclerotherapy is
to restore normal pressure patterns within
the superficial venous network.7 Current
sclerotherapy uses 3% sodium tedradecyl
sulfate (Thrombovar); 0.5-mL boluses are
injected into points of control that do not
necessarily correlate with perforators.8' 10
Three to 10 injections per leg are made

and up to three visits may be needed to
get a good result. A pad or dental pledgets
are taped in place over the injection site.
A crepe or rubberized bandage is worn
for 2 to 3 weeks and the patient is urged
to walk at least 3 km daily. This relatively
low-risk, low-cost procedure can be
repeated. The most annoying complica
tions of the procedure are pigmentation,
and residual and recurrent varicose veins.
Allergic reaction, arterial injury and deep
venous thrombosis are very rare.
Hobbs8 carried out a prospective trial
of surgery versus sclerotherapy in 1977.
His results after 5 years are summarized
in Table I, which shows that surgery gave
a better result for incompetence of the
greater and lesser saphenous vein system,
while sclerotherapy gave a good result for
dilated superficial varicosities and vari
cose veins due to incompetent perforators
in the leg. Good results have also been
reported by Sladen9 and Douglas and
colleagues11 in Canada, and the proce
dure was shown to be cost effective.9' 11
Some areas of controversy remain.
They include the strength of the scleros
ing solution that should be used and the
length of time that bandaging is neces
sary. Raj and colleagues12 showed that a
crepe bandage had to be reapplied every
8 hours to be effective. Batch and
associates13 did a randomized trial on
bandaging for 3 to 6 weeks with no result
ing difference. Compression sclerother
apy is useful for dilated superficial veins,
the atypical lateral varicosities and for
residual tributaries and recurrent varicos
ities after surgery.
Surgery
With a better understanding of the
pathophysiology, the surgical approach
to varicose veins has undergone change.
An important consideration is the use of
the long saphenous vein in the surgical
treatment of coronary artery disease and
vascular reconstruction. Stripping the
long and short saphenous veins should be
restricted to patients with incompetence
of these veins. Patients with saphenofemoral incompetence must undergo
flush ligation and division of all the tribu
taries of the long saphenous vein in the
groin to prevent recurrence.
Those with incompetent leg perforators
may be treated by compression sclerother
apy. With very large subcutaneous vari
cosities a surgical approach may be indi
cated. The decision will be based on the
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likely final cosmetic and functional
results.
For subcutaneous, residual and recur
rent varicose veins, compression sclero
therapy is the best palliation. Rarely are
multiple ligations required.
With stripping, various methods have
been used to remove subcutaneous vari
cosities. These include large incisions,
small multiple incisions, coagulation
probe,14'15 cautery and subcuticular liga
tion with Dexon.16 The most appropriate
method and one that gives a good cos
metic result is multiple incisions 0.3 to 0.5
mm closed by one or two 5-0 nylon
sutures. Of patients who undergo surgery,
33% to 45% subsequently need injections
for residual or recurrent varicosities.
Thus, a combined approach to these var
icosities (surgery and sclerotherapy) is
successful.8,17
The most annoying complications of
operation are scars, nerve injury, which
occurs in 5% to 20% of patients, and
residual varicose veins.18 To obviate the
possibility of having a good technical
result and an unhappy patient, the vari
ous treatment alternatives should be dis
cussed with the patient, with emphasis on
the advantages, disadvantages and pos
sible complications of operation.
Conclusions

A better understanding of the
pathophysiology of varicose veins, alter
native treatments and improved results
have allowed surgeons to give better
advice to their patients. A frank discus
sion with the patient will prevent unrealis
tic expectations. Varicose veins do not
have a single cause and no one treatment
is better than all others. Good judgement
and a sound knowledge of the problem
are essential for good management.
“ Cosmetic” varicose veins are best dealt
with conservatively and if necessary by
compression sclerotherapy. Varicosities in
many patients can be managed adequately
by compression stockings. Surgery should
be restricted to patients who have an
incompetent long or short saphenous vein
or very large subcutaneous varicose veins.
In patients with dilated superficial vari
cose veins, residual varicose veins, recur
rent varicosities or leg perforators, com
pression sclerotherapy is recommended.
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Direct reconstruction of veins is being
applied to patients with chronic venous
stasis. Crosspubic bypass and
saphenopopliteal bypass have proven
satisfactory, and valve reconstruction
by valvuloplasty, segment transfer and
autotransplantation is being explored.
These procedures add to the surgeon's
armamentarium in dealing with chronic
venous stasis. The results of their appli
cation are summarized.
Des reconstructions veineuses directes
sont effectuees chez les patients souffrant de stase veineuse. Les derivations
pubiennes et sapheno-poplitees se sont
averees satisfaisante et Ton explore
maintenant les reconstructions valvulaires par valvuloplastie, les transferts segmentaires et i'autotransplantation. Ces
operations elargissent les moyens d'intervention du chirurgien dans les cas de
stase veineuse chronique. On resume les
resultats de leur utilisation.

The patient with chronic, intractable,
venous stasis that prevents gainful
employment or the enjoyment of leisure
activities may be a candidate for surgical
therapy. Many of these patients have
incompetent distal deep veins but they
account for less than 15% of patients with
documented proximal, major venous
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thrombosis.1 It remains to be shown
whether thrombolytic therapy or direct
surgical intervention prevents sequelae of
venous stasis. In some patients these
sequelae develop without known previous
occurrence of deep vein thrombosis.
Which Patients Have
Intractable Disease?

While it has been noted that conven
tional interruption of subfascial perfora
tors and varicose-vein stripping both fail
to prevent recurrence of venous ulcera
tion in about 20% of patients, it is also
true that such conventional therapy can
produce healing in the remaining 80%.
Patients who do not respond to treatment
with graded elastic compression, careful
attention to skin hygiene, avoidance of
allergenic medications and removal of
superficial varicosities may be considered
for venous reconstruction. The patient
with intractable disease is one in whom
surgery is unsuccessful, particularly when
removal of superficial varicose veins is
combined with subfascial interruption of
perforating veins and when the pho
toplethysmography tourniquet test or
venography has revealed the presence of
incompetent perforating veins.
Methods of Venous Reconstruction

Palma and Esperon2 described an
ingenious method of venous bypass using
a single venous anastomosis. This tech
nique of decompressing a limb obstructed
by a proximal iliac occlusion was modi
fied by Gruss,3 who added a distal arteri
ovenous fistula. Subsequently, the use of
externally reinforced polytetrafluoroethylene grafts, with or without arteriovenous
fistulas, provided another alternative. In
addition, free venous bypasses as
described by Danza and colleagues4 may
find application in selected cases.
Experimental venous valve autotran
splantation was used in the 1960s, but

reports of follow-up studies have been
contradictory. The most important break
through has been direct venous recon
struction using valvuloplasty, introduced
by Kistner5 in 1968. His operation has
only recently become generally recog
nized. The technique enables surgeons to
evaluate patients for direct venous recon
struction by selecting those who had
failed a course of conservative care and
conventional subfascial interruption of
perforating veins. Investigation of these
patients by ascending and descending
venography gave surgeons the opportu
nity to perform crosspubic bypass (the
Palma operation), saphenopopliteal
bypass or valvuloplasty. Kistner’s contri
bution should also be recognized for the
use of venous-segment transfer, which
enables the venous stream to be redirected
through a competent proximal valve. His
methods produced excellent long-term
results in over 80% of patients and he
noted that “ When interruption of
incompetent perforators was performed
in addition to femoral vein reconstruction
an excellent result was achieved in 12 of
25 cases. In comparison, in 16 cases of
repair of the incompetent deep system
without treatment of incompetent perfo
rators, good results were achieved in 11,
and excellent results in only one.” The
cautionary message from Kistner is that
primary valve repair alone is not suffi
cient in the management of chronic
venous stasis. Moreover, there is an
urgent need for objective evaluation of
venous reconstructive surgery because
clinical results alone do not provide an
acceptable method of assessment. If
direct venous reconstruction is to succeed,
objective scientific data must be provided.
Future Directions

The availability of direct venous recon
struction, and the accuracy of evaluation
by noninvasive techniques and ascending
and descending phlebography have
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resulted in the establishment of surgical
services whose prime interest is the treat
ment o f venous disease. This must be
regarded as a step forward. When such
clinics are established in institutions where
scientific methods o f evaluation are used,
knowledge of venous physiology could be
updated, the natural history of venous
disease processes recorded and the long
term results of direct surgical reconstruc
tion properly evaluated. Only in this way
can rational methods o f modern surgical
treatment be planned. Until such infor
mation becomes available, the best
method o f managing severe venous sta
sis remains the application o f conserva
tive and standard techniques, reserving
more modern direct venous reconstruc
tion for patients who do not respond to
conventional therapy.
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Gastric Carcinoma: 30-Year Review
The records of 1030 patients with gas
tric carcinoma seen between 1941 and
1970 were analysed. A 10-year follow
up was available for 1024. The overall
operability and resectability rates were
80.9% and 53.5% respectively, and in
the two decades 1951 to 1960 and
1961 to 1970, the rates increased sig
nificantly, as did the subtotal gastrec
tomy rate of 46.9% . Subtotal resection
for cure was done in 59.5%, and for pal
liation in 40.5% . Fifty-six patients under
went a total gastrectomy.
There was no significant increase in
consecutive decades in either overall
5-year survival or survival following sub
total gastrectomy. The 5- and 10-year
survival rates of 15.1% and 6.6%. Of
the 5-year survivors, 54% had no lymphnode involvement and 35.2% had nodes
positive for tumour spread.
Gastroesophagectomy was associated
with a high morbidity and extremely low
survival. Of 56 patients having a total
gastrectomy, 37 lived 1 year or more
while only 5 survived 5 or more years.
Linitis plastica occurred with equal fre
quency in men and women. Operability
and resectability rates were lower and
there was a 90.6% 1-year death rate.
On a analyse les dossiers mddicaux de
1030 patients qui ont souffert de cancer
de I'estomac entre 1941 et 1970. Pour
1024 d'entre-eux, on possede un suivi
de 10 ans. Pour I'ensemble, les taux
d'operabilite et de resecabilite ont ete de

80.9% et de 53.5% respectivement et,
aux cours des decennies de 1951 a
1960 et de 1961 & 1970, ces taux ont
augmente de facon importante tout
comme le taux de gastrectomie partielle
de 46.9% . Resection partielle a visee
curative fu t accomplie pour 59.5%, et
pour resection a visee palliative 40.5% .
Cinquante-six patients ont subi une gas
trectomie totale.
Au cours des decennies consecutives,
on n'a observe aucune augmentation
significative de la survie a 5 ans ou de la
survie apres gastrectomie partielle. Aprds
resection a visde curative, les taux de
survie a 5 et 10 ans ont ete de 34% et
20.5%. Les resections a visee palliative
ont donne des taux de survie a 5 et 10
ans de 15.1% et 6.6%. Parmi les survivants a 5 ans, 54% n'avaient pas
d'atteinte des ganglions lymphatiques
alors que 35.2% avaient des signes ganglionnaires d'envahissement tumoral.
Les gastro-oesophagectomies ont £te
reliees a une morbidity elevee et une
survie extremement faible. Des 56
patients qui ont subi une gastrectomie
totale, 37 ont survecu 1 an ou plus,
alors que seulement 5 ont depasse 5
ans. Les epitheliomas squirrheux de
I'estomac ont ete observes aussi fr6quemment chez les hommes que chez
les femmes. Les taux d'operabilite et de
resecabilite etaient faibles et on a cons
tate une mortalite a 1 an de 90.6%.

b

This study reviews the records and follow
up of 1030 patients with gastric carcinoma
admitted to the Royal Victoria Hospital,
Montreal, from 1941 to 1970. A review
of 427 patients admitted between 1941
and 1950 was presented previously.1 The
results of that study are included here to
expand the follow-up and survival data
and to compare the results obtained for
each of the three decades.

the Royal Victoria Hospital. Six patients
were lost to follow-up, leaving a total of
1024 who were followed up for more than
5 years. Significance was tested statisti
cally using the x2 test with Yates’ correc
tion for continuity with a 2 x 2 contin
gency table.

Findings
Figure 1 demonstrates the annual inci
dence of carcinoma of the stomach at the
Royal Victoria Hospital from 1941 to
1983. The numbers of new cases for each
decade between 1941 and 1970 were 427,
363 and 240 respectively.
Thirty-six patients had two primary
tumours and 3 a triple primary. One
patient, in addition to her gastric lesion,
had a right breast carcinoma, a lung car
cinoma and a carcinoma of the bladder.
Fifty-three (5.2%) patients (28 women)
had linitis plastica. The youngest was 26
years old and the oldest 80; only 9 were
over 70 years of age. Weight loss was a
symptom in all but seven of these
patients. Forty (75.5%) were operated
upon, with 18 (34%) having resections.
Subtotal resections were done in 10 and
total gastrectomies in 8. Seventeen had an
exploratory procedure only while 5 had
miscellaneous operations in an attempt to
achieve palliation. Forty-eight (90.6%)
died within 1 year. The survival times and
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the type of operation in the five patients
who lived longer than 1 year are set forth
in Table I.
Sex
Of the 1030 patients, 678 (65.8%) were
men (Fig. 2). In the first and second
decades, the women constituted 34.2%
and 29.2% of the total group. However,
in the third decade, the proportion of
women had risen to 41.3% (p < 0 .0 1 ).
Age
The youngest patient was 21 years of
age and the oldest 90 years. There were
68 patients between the ages of 20 and 39
years (Table II), and 54 between 40 and
44 years of age. The incidence of gastric
carcinoma continued to increase with
advancing age without reaching a plateau,
with 186 cases in the 65 to 69-year age
group. Patients 70 years of age and older
made up 21.8% of the total. Forty-two
patients were 35 years of age or younger
and 35 (83%) of those died within 1 year
of diagnosis.

tumour was located in the prepyloric area
in 74 of these patients, at the cardia in 20
and in the body of the stomach in 1
patient. Three patients had colonic
obstruction due to tumour spread.
Forty-five of the 58 patients admitted
with acute bleeding were operated upon.
Twenty-six (44.8%) had subtotal resec
tion and 5 underwent total gastrectomy.
Fourteen patients survived 1 year, 10
patients 2 years and 4 patients survived
5 years. One patient lived for 12 years.
All of the patients who were not operated
on died within 1 year.
Perforation occurred in 19 (1.8%)
patients. Suture closure was used in 13
and 6 underwent subtotal resection. The
longest survivors were two patients who
had subtotal gastrectomies and who lived
2 years. Twenty-four patients had a
documented history of duodenal ulcer
before the gastric carcinoma developed.
Surgery for peptic ulcer had been per
formed on eight previously. A subtotal
resection had been carried out in four
patients at 3, 6, 7 and 24 years before the
gastric carcinoma was diagnosed.

in 33 (9.1%) of 363 in the following
decade, and in the last decade there were
85 (35.4%) endoscopic examinations in
240 patients. The diagnostic accuracy
increased from 71.4% to 72.7% in the
second decade and 78.8% in the final
decade. Overall, 139 endoscopic exami
nations were carried out with a positive
diagnosis in 106 (76.2%).

Operations
Operability increased significantly
(p < 0.05) during the last two decades
(Table IV), in which there was also a

Diagnostic Investigations
Signs and Symptoms
Signs and symptoms in order of fre
quency are noted in Table III. All but two
patients presented with symptoms of gas
trointestinal disturbance. In one, the dis
ease was discovered during the course of
a “ check-up” . The second patient was
investigated for prostatic obstruction and
found to have an epigastric mass. Sym
ptoms were present for 3 months or less
in 339 patients, while 122 had symptoms
for 2 or more years. Of the 120 patients
who survived 5 years or more, 29 (24.2%)
had had symptoms for 3 months or less,
while 37 (30.8%) had a symptomduration time of 2 or more years. Weight
loss was present in 688 (67%) patients. Of
these, 141 (20.5%) underwent subtotal
resection for cure. They made up over
half of the 244 patients who underwent
resection for cure. An epigastric mass was
present in 73 (8.4%) of the 874 patients
who were operated upon and 28 of these
underwent a subtotal resection for cure,
with 18 patients surviving 5 years or
longer.
Nausea and vomiting as a symptom of
obstruction occurred in 98 (9.5%). The

Type of operation
Exploratory only
Subtotal resection
Laparotomy only
Hemigastrectomy
Subtotal resection
26

One hundred and fourteen patients
(44.2%) of 258 whose blood group was
recorded were of blood group A. Eightyseven (33.7%) were of blood group O.
Gastric analysis, done in 494 instances,
revealed 332 (67.2%) who were achlor
hydric. The blood protein level was re
corded in 170 patients; in 65 (38.2%), the
albumin-globulin ratio was reversed, in 49
(28.8%), the serum albumin level was
below 30 g/L and in 56 (32.9%) it was
normal. Pernicious anemia was present in
10 (1.7%) of 603 patients whose records
included sufficient data to establish the
diagnosis.
The findings of an upper gastrointes
tinal barium examination were recorded
in 843 patients. The examination was
unsatisfactory or incomplete in four
patients (0.5%). The malignant lesion
was diagnosed in 762 (90.4%); no lesion
was seen in 51 (6.0%). In 26 patients
(3.1%) the findings, although not con
clusive, indicated that operation was
necessary, during which the diagnosis
of gastric carcinoma was made.
In the decade 1941 to 1950, endoscopy
was done in 21 (4.9%) of the 427 patients,

Table I—Data on Five Patients With Linitis Plastica
Who Survived Longer Than 1 Year
Nodal
involvement
Negative
Negative
No gross involvement
Positive
Negative

Duration of
survival, yr
1
1.1
2.8
3.5
8

Table II—Age Distribution
of the 1030 Patients
Age
group, yr
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
> 70

No.
2
11
17
38
54
82
106
151
158
186
225

%
0.2
1.1
1.7
3.7
5.2
8.0
10.3
14.7
15.3
18.1
21.8

Table Ill-Signs and Symptoms in Order of
Frequency of Occurrence
Sign/symptom

No.

Weight loss
688
Abdominal pain
650
Weight loss and abdominal pain 422
Nausea and vomiting
412
Anorexia
335
Abdominal tenderness
293
Weakness
272
Abdominal fullness
171
Pallor
166
Epigastric mass
165
Cachexia
129
Constipation
119
Nausea (without vomiting)
115
Gaseous eructations
68
Acute bleeding
58
Dysphagia
56
Ascites
11

%
67
63
41
40
33
28
26
17
16
16
13
12
11
7
5.5
5
1
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small, but significant (p < 0.05), increase
in the resectability rate (Table IV). The
rate for all decades was 53.3% of patients
operated on or 45.2% of all patients in
the series. Exploration only was done in
238 (27.2%) of the 874 patients. The inci
dence of exploration without resection fell
significantly (p < 0.001), from 34.7% in
the first decade to 29.4% in the second
decade to 11.2% in the third. Subtotal
gastrectomy was performed on 410
(46.9%) of the patients operated upon
(Table V), 39.8% of the total series. The
increase in the last two decades was sig
nificant (p < 0.05).
Subtotal resection was carried out for
cure in 244 (59.5%) patients operated
upon and for palliation in 166 (40.5%)
(Table V). This relationship did not
change significantly during the three
decades, relative to either the number of
patients operated upon or the total popu
lation of the series (Table V). Gastroen
terostomy was done in 90 (10.3%) of 874
instances. In the years 1941 to 1950, the
rate was 12.9%. In the following two
decades, it was 8.1% and 9.3% respec
tively. These differences were not statisti
cally significant.

was not significant. Of the patients who
underw ent subtotal resection, 108
(26.3%) survived for 5 years or longer,
and 61 (14.9%) were alive at 10 years
(Table VII). There was no significant
difference between decades. Of the 244
patients who had subtotal resection for
cure, 93 (38.1%) survived 5 years, and
50 (20.5%) lived for 10 years or longer.
The operating surgeon described the
resection as palliative in 166 of the 410
resections and 25 (15.1%) of these
patients lived for 5 years or longer, while
11 (6.6%) survived for more than 10
years. The operative death rate for
patients who underwent subtotal resection
was 8.8% (36 patients). A proximal sub
total gastrectomy with distal esophagec
tomy was performed in 34 patients, with
an operative death rate of 23.5% (8
patients). Only two patients survived
longer than 5 years; one for 7 years and
the other for 9 years.
Of 56 patients (6.4% of those operated
on) who underwent total gastrectomy, 37
died within 1 year, 5 lived 5 or more years
and 3 lived 19 years. Four of the patients
living longer than 5 years had positive
nodes.

Survival

Pathological Features

The overall 5-year survival rate was
11.7%. Although it increased in the con
secutive decades (Table VI), the increase

Thirty-eight (35.2%) of the 5-year sur
vivors following subtotal resection had
positive nodes. In 59 (54.6%) patients,

Table IV--Operability and Resectability by Decade
Operability
Years
1941-50
1951-60
1961-70

No.
349
320
205

Resectability
%*
81.7
88.2
85.4

1941-70
874
84.9
•Percentage of total series.
tPercentage of patients operated on in the respective decade.

Years
1941-50
1951-60
1961-70
1941-70

Years
1941-50
1951-60
1961-70
1941-70

No.
163
170
133

%t
46.7
53.1
64.9

466

53.3

Table V-Number of Subtotal Gastrectomies Performed by Decade
Cure
Palliation
Total
%
%
%
of total
of total
% of
of total
% of
% of
No. operations
series
No. operations series
series
No. operations
44.9
81
55.1
19.0
66
147
42.1
34.5
15.5
92
62.2
25.3
56
37.8
15.4
46.2
40.7
148
71
61.7
44
47.9
29.6
38.3
18.3
115
56.1
244
59.5
23.7
166
40.5
16.1
410
46.9
39.8

Table VII—End Results After Subtotal Resection
Alive 5 yr
No.
No.
%
147
39
26.5
148
39
26.4
115
30
26.1
410
108
26.3

Alive 10 yr
No.
26
18
17
61

there was no lymph-node involvement.
There was no record of nodal disease
in 11 patients.
Table VIII describes the gross patho
logical features of the lesions in 701
patients. A papillary lesion was present
in 46.2% and these tumours usually
showed some degree of ulceration. There
was a primarily ulcerative tum our in
33.1%.
The peripheral nodes were occasionally
involved. Fourteen patients had a Vir
chow’s node, and 14 had positive neck
nodes. The axillary nodes were the site of
metastases in eight. One patient had a
positive right supraclavicular node.
Discussion

For unknown reasons, the incidence of
gastric carcinoma in the United States
began to decrease in the early 1930s.2
That this decrease has continued has been
well documented.3,4 Except for a slight
increase between 1941 and 1949, and
between 1975 and 1980, there was a
downward trend in our series. There was
a preponderance of men except in the
decade from 1961 to 1970, although the
relative number of women in the last two
decades of the study has increased signifi
cantly.
Gastric cancer is primarily a disease of
the elderly, but a sufficient number of
cases occur in young people to make one
wary o f symptoms of gastrointestinal
tract disease. The 83.3% death rate at 1
year in those 35 years old or younger,
which corresponds exactly with the figure
of Bloss and associates,5 makes for a
particularly discouraging outlook in this
age group.
Special emphasis should be given to
weight loss as a symptom. It is frequently
a late occurrence in other malignant con
ditions, indicating an advanced stage of
disease. In gastric lesions, however, it is
often among the initial complaints or
findings. Constipation is another symp-

Table VI—Overall 5-Year Survival
Patients
available for
follow-up
Years
No.
%
427
44
1941-50
10.3
360
1951-60
44
11.6
237
1961-70
32
13.5
1024
1941-70
120
11.7

Table VIII—Gross Pathological Features
%
17.6
12.2
14.7
14.9

Type

No.

%

Papillary
Ulcerative
Local infiltration
Linitis plastica

324
232
92
53

46.2
33.1
13.1
7.6
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tom deserving emphasis since it was the
chief complaint of 12% of the patients in
our series. A finding of interest is that an
epigastric mass did not always preclude
resectability. Eighteen 5-year survivors
had a palpable abdominal tumour.
The number of patients in blood group
A so closely approximates the usual num
ber in that blood group in the general
population that it was of no prognostic
importance, in keeping with the findings
of Hartmann and Stavem.6
Some7'9 believe that there is a risk fac
tor for “ stump carcinoma” following
remote subtotal resection for duodenal or
gastric peptic ulcer. Recently, however,
Fischer and associates10 concluded that
individuals previously subjected to Bill
roth II resection for duodenal ulcer were
at no higher risk for gastric carcinoma
than the general population. Also,
Schafer and colleagues11 found that their
group of patients who had surgical treat
ment for benign peptic ulcer disease had
no evidence of gastric cancer during the
subsequent 5 years. Only four patients in
our series had had subtotal resection for
duodenal ulcer previously. Although the
development as a carcinoma usually
occurs after a 15-year interval, in three
cases it occurred within 8 years.
Nicholls9 in his large series, however,
encountered cancers that appeared as
early as 3 years later. A rather surprising
finding was the well-documented history
o f duodenal ulcer in 24 patients.
When the duration of symptoms was
correlated with 5-year survival, it was
found that 24.2% of patients who under
went subtotal resection had had their
symptoms for 3 months or less, while
30.8% had a symptom-duration time of
2 or more years. This is not surprising
since it has been demonstrated by
others12' 14 that patients with gastric car
cinoma — including those who do not
undergo resection — who had the longest
duration of symptoms had the longest
survival.
Although gastric cancers may occur in
patients who have normal acid produc
tio n ,15 the finding of achlorhydria must
certainly raise the possibility of carcinoma
— more than half of the patients tested
in our series had no free acid.
Diagnostic accuracy by barium contrast
roentgenography remained in the vicin
ity of 92%, while that of the endoscopy
was 76%. The increased accuracy for the
latter procedure as well as an increase in
its use is probably due to the introduction
and more frequent use of fiberoptic
endoscopic instruments and biopsy.
Although there was a small significant
increase in operability and resectability in
the second and third decades of this
study, there was no significant change in
the survival rates following subtotal gas
trectomy. The long-term survival at
present attained after resection is due
28

mainly to subtotal gastrectomy, either
proximal or distal, depending on the site
of the lesion. This routinely includes
resection, in continuity, of the greater
omentum and adjacent lymph nodes. A
30% 5-year survival rate for patients
operated on for cure correlates well with
the operator’s assessment at the time of
resection.
An important correlation exists with
node involvement. Following subtotal
resection, the 5-year survival was 54% for
those without involved nodes and 35.2%
for those with involved nodes.
When the operation was described as
palliative by the operating surgeon, 15%
of the patients were alive 5 years later and
6.6% 10 years later. Palliative resection
is worthwhile because it provides better
palliation than a bypass operation for a
potentially bleeding or obstructive lesion.
Also, nodes originally thought to be
metastatic may, in fact, not be.
Gastroesophagectomy for lesions of the
cardia invading the esophagus results in
a disappointingly low survival rate, as
Dupont and colleagues16 found. The real
value of the resection of the tumours may
well be the palliation it provides. This was
the conclusion reached by Ellis and
G ibb,17 and is supported by the findings
in our series. In addition, debulking of
the tumour mass may be of value should
chemotherapy be used.
Total gastrectomy is still associated
with poor survival. Only 18 of our 56
patients survived 1 year, and only 5 lived
5 years or longer. This procedure should
be used selectively and only when there
is a reasonable chance of resecting all dis
eased tissue. Because of its high morbidity
and risk of early mortality, it has little
place as a palliative procedure.
Linitis plastica, an uncommon type of
diffuse infiltrating tumour, had some fea
tures that differ from the more usual
types of adenocarcinomatous lesions. It
occurred with almost equal frequency in
men and women. Weight loss was the
chief symptom in a high percentage (86%)
of the patients. Operability and resecta
bility rates were lower and the 90.6%
death rate at 1 year was particularly dis
couraging.
The overall survival rate for patients
with gastric adenocarcinoma in North
America has changed little for many
years. The results from subtotal gastrec
tomy have also reached a plateau as is
shown in this and other series.18'21
Whether future improvement will depend
on the use of chemotherapy, radiother
apy or a combination of these, remains
to be seen.

I am indebted to Dr. H.M. Shizgal for sig
nificance testing, and to Drs. H.M. Shizgal and
J.L. Meakins for reviewing the manuscript.
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Telangiectatic Osteosarcoma: Unusual Behaviour
The telangiectatic variant of osteogenic
sarcoma is rare. Its biologic behaviour,
treatment and prognosis are controver
sial. The case of a 15-year-old girl with
this tumour is described. Both the loca
tion and clinical behaviour of the tumour
were unusual. The tumour, which in
volved the distal ulna, was initially
treated by a limited resection of the dis
tal 8 cm of ulna. Sixty-nine months later
the tumour recurred locally; there was
no evidence of metastases. The forearm
was amputated and the patient was then
treated aggressively by chemotherapy.
She was well 42 months later.
This case illustrates the tendency for
telangiectatic osteosarcoma to recur
locally if it is not radically excised.

Le sarcome osteogene de type telangiectasique est rare. Son comportement biologique, son traitement et son pronostic
font I'objet de controverse. On en decrit
un cas chez une fille de 15 ans. La loca
lisation et le comportement Clinique de la
tumeur furent inhabituels. La tumeur
affectant la partie distale du cubitus fut
tout d'abord traitee par resection limitee
de 8 cm du cubitus distal. Une recidive
locale apparut 69 mois plus tard; il n'y
avait pas de signes de metastase.
L'avant-bras fut ampute et on ajouta une
chimiotherapie agressive. Quarante-deux
mois plus tard, la patiente demeurait en
bonne sante.
Ce cas illustre la tendance que montre
I'osteosarcome telangiectasique de recidiver localement s'il n'est pas excise
completement.

Despite the early recognition of the telan
giectatic variant of osteogenic sarcoma by
Paget in 1854* and its subsequent clas-

From the *Department o f Surgery and
t Department o f Pathology, Plains Health
Centre, Regina, Sask.
Accepted fo r publication July 22, 1985
Reprint requests to: Dr. E.C. Alport,
Department o f Pathology, Plains Health
Centre, 4500 Wascana Parkway, Regina,
Sask. S4S 5W9

sification as a variant o f osteogenic sar
coma by Ewing in 1922,2 there is still dis
agreement regarding the incidence,
clinical behaviour, optimal treatment and
prognosis o f this entity.3-10 We report a
case o f telangiectatic osteosarcoma in
which the site o f the lesion and clinical
course were unusual. The tumour deve
loped in the ulna and the patient’s course
was complicated by local recurrence. This
case has therapeutic implications concern
ing the use o f limited resection for the
treatment o f this condition.

Case Report
A previously healthy 15-year-old girl was
admitted to hospital with a 3-month history of
progressive pain in the right wrist. Movement
was so limited that she could no longer type
or play the piano. Initial roentgenograms rev
ealed a lytic, 5.0-cm expansile defect involv
ing the distal epiphysis and metaphysis of the
right ulna. The cortical margin was irregular
and there was an associated pathologic frac
ture (Fig. 1). Diagnostic possibilities included
an aneurysmal bone cyst with fracture, a
benign or malignant giant cell tumour and
osteogenic sarcoma. Biopsy showed cystic
blood-filled spaces separated by trabeculae of
cellular tissue containing polygonal and
spindle-shaped cells with anaplastic nuclear fea
tures (Fig. 2, a and b). There were many mitotic
figures (Fig. 2c). Scant, lacy osteoid was
present in a few areas (Fig. 2d). Benign giant
cells and hemosiderin containing histiocytes
were also noted. Outside consultation (D.C.
Dahlin) confirmed the diagnosis of telangiec
tatic osteosarcoma. Results of investigation for
metastatic involvement were negative.
A limited resection of the distal 8 cm of ulna
was performed. This decision was based in part
on the family’s wishes and in part on the con
flicting information available in the literature
at the time (1976) — one group indicating a
uniformly grave prognosis and recommending
radical excision8 and the other group indicat
ing that results of local resection combined with
systemic chemotherapy paralleled those of
am putation.11 Examination of the operative
specimen revealed a soft, hemorrhagic mass
(5.0 x 2.5 x 2.0 cm) replacing the distal ulna
and extending to the articular surface of the
wrist. The proximal surgical margin of exci
sion was free of tumour. Postoperatively, Adriamycin (30 mg/m2 for 3 consecutive days
every 4 weeks) was given over a period of 6
months.
The patient remained well for 69 months,

when pain developed at the previous resec
tion site. Roentgenograms showed bone resorp
tion of the distal end o f the ulnar stump (Fig.
3) and bone scans revealed increased activity
in the same region. There was no evidence of
metastatic disease. Biopsy and subsequent dis
articulation through the elbow confirmed
recurrence of the tumour. The tum our mass
(3.0 x 2.5 x 2.5 cm) involved the distal ulnar
stump and surrounding soft tissue and
extended into the medullary cavity of the ulna
for 6.5 cm (Fig. 4). No skip lesions were
present.
Postoperatively, a modified Rosen regimen
(high-dose methotrexate and vincristine with
citrovorum factor recovery)11'12 was followed
at 6 weeks by a protocol comprising bleomy
cin, cyclophosphamide and actinomycin D. At
9, 10, 14 and 15 weeks she received methotrex
ate with citrovorum factor recovery, then, at
20 weeks, two cycles of cisplatinum followed
by another course of bleomycin, cyclophospha
mide and actinomycin D. To date, 42 months
after her second operation, there is no evidence
of recurrence and her biochemical findings are
normal. Clinically, she is doing well and has
been fitted with a myoelectric prosthesis.

Discussion
The clinical features o f telangiectatic
osteosarcoma have been well defined. As
with the standard form, the tumour is
more common in men (60%), but the
telangiectatic form occurs in a slightly
younger person (mean age 20 years). With

FIG. 1—Primary tumour showing lytic
destructive lesion involving distal end of ulna.
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the exception of the proximal femur and
tibia, which are less frequently involved,
the distribution of this neoplasm is gener
ally similar to that of standard osteogenic
sarcoma: most tumours involve the
metaphysis of major tubular bones.7-9
Symptoms are nonspecific, consisting of
local pain and swelling. Roentgenographic findings show a large, lytic lesion
with cortical erosion and an occasional
“ blown-out” appearance. A permeative
pattern of destruction may also be
seen.13 Extension to the epiphysis and
pathologic fracture occur more frequently
with telangiectatic osteosarcoma than
with the standard type.8 To establish the
diagnosis, some authorities require that
the lesion be purely lytic throughout, but
others accept a predominantly lytic lesion
with minimal sclerosis.9 The roentgenographic picture is frequently less specific
than that of standard osteogenic sarcoma.
The differential diagnosis includes
aneurysmal bone cyst and benign or
malignant giant cell tumour.
The tumour in our case fulfilled the
diagnostic criteria used by Dahlin:13-14

radiologically, the tumour appears to be
a lytic destructive lesion with no apprecia
ble areas of sclerosis; grossly, the tumour
forms a cavity with little solid tumour tis
sue and no apparent sclerosis; and, histo
logically, the tumour consists of single or
multiple cystic cavities containing blood
and necrotic tumour, often traversed by
septae composed of anaplastic cells.
Our case is unusual in several respects.
First, telangiectatic osteosarcoma of the
ulna has seldom been reported. In a ser
ies of 124 cases,7 2 involved the distal
forearm, but whether these primarily
involved the radius or ulna is not clear.
In other series, involvement of the ulna
has not been reported. Second, this
patient’s clinical course was unusual in
that it was characterized by late local
recurrence and prolonged survival (9
years). Local recurrence is an infrequent
finding in standard osteogenic sarcoma
but has been noted in approximately 20%
of cases of telangiectatic osteosarcoma,
usually as a terminal event.8 Had disar
ticulation, rather than limited resection of
the distal ulna, been carried out initially,
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local recurrence might have been
prevented. The initial decision favouring
local resection over disarticulation was
based on the family’s wishes and conflict
ing information in the literature at the
time. The distal location of the tumour
suggested that it would be possible to
excise tissue proximal to the lesion and
eradicate the tumour by local resection as
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FIG. 2—(a) Cystic filled spaces separated by trabeculae of cellular tissue (hematoxylin and
eosin, original magnification x 25). (b) Cellular area composed of polygonal and spindle-shaped
cells with frequent mitotic figures (hematoxylin and eosin, original magnification x 100). (c)
Higher magnification showing pleomorphic cellular features with high mitotic rate (hematoxy
lin and eosin, original magnification x 400). (d) Neoplastic cells separated by scant lace-like
osteoid (hematoxylin and eosin, original magnification X 400).
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FIG. 3—(a) Appearance immediately
postoperatively. Border of ulna is sharply
defined at resection line, (b) With local recur
rence there is resorption of distal ulna.

FIG. 4—Surgical specimen showing locally
recurrent tumour involving ulna. Hemorrhagic
mass is present at previous resection line and
extends proximally within medullary canal for
6.5 cm.
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effectively as by amputation. The clini
cal course, however, confirmed the previ
ously reported tendency for this tumour
to recur locally and illustrates the poten
tial danger of performing limited re
section.
The clinical importance and prognosis
of telangiectatic osteosarcoma are con
troversial. In the Memorial Hospital ser
ies,7 in which focal minimal sclerosis was
accepted in an otherwise lytic lesion, 124
(11%) of 1129 osteogenic sarcomas
were classified as telangiectatic and these
were associated with a similar or even bet
ter prognosis than that for conventional
osteogenic sarcoma. In the same study,
when only 43 purely lytic tumours were
analysed, the survival was the same as
that of standard osteogenic sarcoma. By
contrast, in other series8 in which the
criteria outlined in our case were used, the
relative incidence was lower (2.5%) and
was associated with a much worse prog
nosis, 23 of 25 patients dying of the dis
ease with a mean survival of 16 months.
In other reports,10,15 the relative inci
dence of telangiectatic osteosarcoma to
standard osteogenic sarcoma ranged from
0.4% (1 out of 242 cases) to 12% (21 out
of 170 cases).
Although it is a rare entity and ques

tions still remain about the precise criteria
for diagnosis, incidence relative to stan
dard osteogenic sarcoma and prognosis,
the telangiectatic variant has sufficiently
distinctive clinical and histologic features
to warrant recognition as a separate
clinicopathologic entity. The radiologic
and pathological findings are notorious
for mimicking benign bone tumours, par
ticularly aneurysmal bone cyst.1618 Com
pared with standard osteogenic sarcoma,
the telangiectatic variety more frequently
involves the epiphysis, has a higher inci
dence of pathologic fracture and tends to
recur locally more often. Our case illus
trates this last feature and emphasizes the
potential risk of performing limited resec
tions of high-grade osteosarcomas.
We acknowledge the assistance of Dr. D.C.
Dahlin in reviewing both the original and recur
rent tumours. We also thank Dr. D .A .E .
Shephard for editorial assistance.
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Loop Ileostomy for Anorectal Crohn’s Disease
The treatment of symptomatic Crohn's
disease of the anorectum can be
challenging. Medical therapy may fail and
local surgery may be complicated by
delayed healing or incontinence. The
authors report the clinical course of 12
patients with this condition treated by
fecal diversion with a loop ileostomy.
Seven patients had a rectovaginal
fistula. At the time of review, one of
them had restored intestinal continuity
following successful fistula repair, three
had minimal or no symptoms, one had
an active perianal fistula after closure of
the ileostomy and two had undergone a
proctocolectomy for recurrent symp
toms. Five patients with Crohn's procti
tis or anorectal sepsis were treated by
loop ileostomy. One was asymptomatic,
one had recurrent symptoms and three
underwent a proctocolectomy.
From their experience the authors con
clude that construction of a loop
ileostomy will temporarily improve the
symptoms of anorectal Crohn's disease.
Fecal diversion does not appear to alter
the long-term course of the disease, and
successful restoration of intestinal con
tinuity is uncommon.
Le traitement de la maladie de Crohn
symptomatique avec atteinte de I'anus et
du rectum represente tout un defi. Le
traitement medical peut echouer et la
chirurgie locale peut se compliquer d'un
retard de guerison ou d'incontinence. Les
auteurs decrivent revolution clinique de
12 patients souffrant de cette maladie
qui ont ete traites par detournement de
I'evacuation fecale a I'aide d'une boucle
d'ileostomie.
Sept patientes souffraient d'une fistule
rectovaginale. Au moment de preparer ce
rapport, une d'entre-elles avait eu un
retablissement de la continuite intestinale
apres reparation reussie d'une fistule,
trois presentaient peu ou pas de sympto-
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mes, une avait une fistule perianale
active apres fermeture de I'ileostomie et
deux avaient subi une proctocolectomie
apres r6cidive des symptomes. Cinq
patients prdsentant une rectite de Crohn
ou une infection anorectale ont ete trai
tes par boucle d'ileostomie. Un etait
asymptomatique, un montrait des signes
de rechute et trois avaient subi une proc
tocolectomie.
Suite a leur etude, les auteurs concluent que la construction d'une boucle
d'ileostomie ameliore temporairement les
symptomes de la maladie de Crohn ano
rectale. La derivation de I'ecoulement
fecal ne semble pas modifier revolution
a long terme de la maladie et le retablis
sement de la continuite intestinale reussit rarement.

Crohn’s disease involving the anorectum
may present with a variety of lesions
including hemorrhoids, edematous skin
tags, anal fissures and simple or complex
fistulas. The treatment of symptomatic
patients can be challenging. Medical ther
apy may be unsuccessful, and surgery
may be complicated by delayed healing
or incontinence,1 prompting surgeons to
consider alternative methods of treat
ment. External diversion of the fecal
stream by means of a split or loop
ileostomy appears theoretically to offer
several advantages: to relieve the symp
toms of diarrhea and anal discomfort, to
reduce anorectal sepsis and to prevent or
delay proctocolectomy.
In 1965, Truelove and associates2
reported on five patients with Crohn’s
colitis treated by split ileostomy. Subse
quent papers have suggested that up to
90% of patients with Crohn’s colitis are
temporarily improved after external fecal
diversion.3-5 The effect of an ileostomy
on the long-term course of anorectal
Crohn’s disease is less clear. Although
Harper and colleagues6 found initial
improvement in 72% of patients with
perianal Crohn’s disease treated by a split
ileostomy, intestinal continuity was
restored in only 20%.
We undertook the present review to
analyse our own experience with loop
ileostomy in patients with anorectal
Crohn’s disease.

Patients (Table I)
Twelve patients (3 men, 9 women) with
anorectal Crohn’s disease were treated by
loop ileostomy. They ranged in age from
21 to 46 years. The clinical diagnosis
was confirmed by a combination of
endoscopic, radiologic and histopatho
logic examinations. The average duration
of C rohn’s disease until the loop
ileostomy was done was 6 years.
Seven women (group 1) had rectovagi
nal fistulas associated with Crohn’s dis
ease. All complained of the passage of
stool or flatus through the vagina. Two
had perineal pain and four had abdomi
nal pain, diarrhea or anorexia. Rectovagi
nal fistulas were associated with Crohn’s
disease of the small intestine in two
patients, the colon in one and both the
small intestine and colon in four. The rec
tum was uninvolved macroscopically or
was minimally diseased in all the women.
All had received prednisone or sulfasala
zine and five had completed at least one
course o f m etronidazole w ithout
improvement. In three women, the loop
ileostomy was combined with small-bowel
resection.
Three patients (group 2) had anorectal
sepsis due to complex fistulas. Symptoms
in these patients included crampy
abdominal pain, severe perianal pain and
diarrhea. All had colonic disease, which
was associated with small-bowel disease
in two. In addition to prednisone or sul
fasalazine, two had previously been
treated with metronidazole with only
minimal improvement.
The remaining two patients had severe
proctitis (group 3). Both had crampy
pain, diarrhea, tenesmus and weight loss.
Radiologic and endoscopic investigations
revealed severe Crohn’s disease confined
to the colon and rectum. In addition to
sulfasalazine and prednisone, one patient
was treated with metronidazole without
improvement.
Surgical Technique
Preoperatively, the site of the proposed
ileostomy is marked appropriately in the
right lower quadrant. Under general
anesthesia, a laparotomy is performed
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and the small bowel examined. A loop of
normal bowel closest to the ileocecal valve
is chosen for the ileostomy. A stomal
aperture is made that will admit two
fingers. The ileum is delivered through the
abdominal wall and secured over a small
plastic ileostomy rod to prevent retraction
of the stoma (Fig. 1). After the abdomi
nal incision has been closed, an eccentric
opening is made in the distal portion of
the ileal loop (Fig. 1). The stoma is
matured by everting the distal end
towards the proximal end and suturing
the ileum to the skin with interrupted
absorbable sutures as described by Turnbull and Weakley7 (Fig. 2). An ileostomy
appliance is placed, although the
ileostomy usually does not begin to func
tion for several days postoperatively. The
ileostomy rod is removed 5 to 7 days after
operation. The stoma functions as if it
were an end ileostomy and patients use
standard ileostomy appliances.

due to mucous discharge from the distal
limb of the loop ileostomy. This problem
was eventually solved by converting the
loop to a split ileostomy. The other
patient had a bowel obstruction caused
by a loop of small intestine that became
twisted about the undersurface of the
ileostomy site. She required laparotomy,
at which time the loop ileostomy was
closed.
Only one group 1 patient had the loop
ileostomy successfully closed. Three still
have the loop ileostomies but have
minimal or no symptoms from the rec
tovaginal fistula. One patient is sympto
matic with a perineal fistula that deve
loped after the loop ileostomy was closed.

Two patients required proctocolectomy.
One month after loop ileostomy, the
three group 2 patients had reduced their
medications and were free of perineal
pain. On examination, however, the
fistulas rem ained un h ealed and
endoscopy showed active rectal disease.
At the time of review only one patient in
this group is asymptomatic, 30 months
postoperatively. One patient required a
proctocolectomy 4 months after construc
tion of the ileostomy because of recurrent
perianal infection, frequent bowel move
ments and crampy abdominal pain. The
third patient had similar complaints 21
months after- construction o f the loop
ileostomy. He remains symptomatic but

Results

Complications
The mean hospital stay after loop
ileostomy was 14 days (range from 10 to
25 days). Five patients had complications
postoperatively that responded to medi
cal management; they included incom
plete small-bowel obstruction in two and
high ileostomy output in three. One
patient had wound dehiscence requiring
reoperation.
Two patients suffered late complica
tions. One had peristomal skin irritation

FIG. 1—Loop of distal small bowel is
brought through stomal aperture in right lower
quadrant. It is maintained in position by plas
tic ileostomy rod. Enterotomy is made in dis
tal portion of this loop of bowel. Stoma is
matured by everting distal end toward prox
imal end.

FIG. 2—At completion, proximal limb of
ileum forms protruding stoma while distal limb
is flush with skin.

Table I—Patient Data and Clinical Course After Treatment of Anorectal Crohn's Disease by Loop Ileostomy
Subsequent surgery
Age,
Site of
(mo after loop
Current status (mo
Group
Sex
disease
Previous treatment
ileostomy)
after loop ileostomy)
yr
1 - rectovaginal
F
34
SB
Metronidazole, small-bowel
Repair RVF (10)
Asymptomatic (13)
fistula
resection
Closure loop ileostomy
(13)
F
26
SB/LB
Sulfasalazine, prednisone,
Repair RVF (12)
small-bowel resection
Repair loop ileostomy
(X 2)
(16)
Repair RVF (18)
Proctocolectomy (26)
—
F
LB
46
Sulfasalazine, prednisone,
Asymptomatic (29)
metronidazole
F
23
SBILB
Prednisone, metronidazole
Proctocolectomy (6)
F
26
SB
Sulfasalazine, prednisone,
Ileostomy revision
Asymptomatic (20)
small-bowel resection
(18)
F
37
SB/LB
Metronidazole, small-bowel
Asymptomatic (14)
resection (X 2)
F
27
SB/LB
Metronidazole, small-bowel
Closure loop ileostomy
Active anorectal disease
resection
(22)
(fistula) (25)
—
2 - anorectal
F
27
LB
Prednisone
Asymptomatic (30)
—
sepsis
M
27
SB/LB
Sulfasalazine, prednisone,
Active anorectal disease
metronidazole, small-bowel
(fistula) (21)
resection
M
28
SB/LB
Prednisone, metronidazole
Proctocolectomy (4)
M
21
LB
3 - severe
Sulfasalazine, prednisone
Proctocolectomy (6)
proctitis
F
19
LB
Sulfasalazine, prednisone,
Proctocolectomy (181
metronidazole
SB - small bowel, LB = large bowel, RVF - rectovaginal fistula.
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has so far refused a proctocolectomy.
The two patients in group 3 had less
pain and were able to reduce their medi
cations 1 month after operation. Sig
moidoscopy still showed active disease.
At 6 and 18 months, they required a proc
tocolectomy for recurrent abdominal
pain, frequent bowel movements and
tenesmus despite the fecal diversion.
Discussion
The anorectal m anifestations of
Crohn’s disease include edematous skin
tags, fissures, abscesses, fistulas, stric
tures and proctitis. Large painless anal
ulcers, multiple fistulas and edematous
indurated perianal skin with a dusky
colour are typical perianal findings in
these patients.8
Anorectal involvement is common in
C ro h n ’s disease. Fielding9 reported
abscesses, sinuses, fistulas, tags and fis
sures in 109 of 156 patients with Crohn’s
disease. These lesions were found in 76%
of patients with small-bowel disease, 94%
of patients with large-bowel disease, but
in only 38% of a control population.
Others, however, have found a lower rate
of involvement. O f patients in the
National Crohn’s Cooperative Disease
Study, only 36% gave a history of peri
anal complications at the time of entry.10
Marks and colleagues11 reported that
anal fistula occurred in 112 of 329
patients followed at St. M ark’s Hospital
during a 10-year period. Similarly, Heuman and associates12 reported that 40%
of their patients suffered from perianal
manifestations during a 6-year follow-up.
These differences are likely owing to the
variable criteria used to diagnose perianal
Crohn’s disease. Most authors do agree,
however, that the prevalence of perianal
disease is higher in patients with colonic
and rectal involvement.9'10
No treatment is required if the anorec
tal disease is asymptomatic. The initial
management of symptoms should include
a full assessment of proximal disease and
institution of appropriate medical or sur
gical therapy. If this is effective, the
anorectal disease may resolve spontane
ously.13
Brandt and colleagues14 found that
metronidazole was effective in 26 patients
with persistent anorectal Crohn’s disease
that failed to respond to conventional
medical or surgical therapy. The only
major side effect was paresthesia that
developed in 50% of the patients, and this
resolved when the dose was reduced.
However, when the drug was discon
tinued, the disease recurred in 72%.
Metronidazole has been reported to be a
carcinogen in animals,15 so prolonged
use by humans may be hazardous. This
risk should be considered when prescrib
ing the drug in large doses and for
long periods. Eight of our patients
34

had been treated with metronidazole in
doses ranging from 750 mg to 1000 mg
daily for at least 1 month, including five
patients with rectovaginal fistulas, two
patients with complex fistulas and one
with severe proctitis. All failed to improve
and one patient had to discontinue the
medication because of paresthesia.
The surgical treatment of symptomatic
anorectal Crohn’s disease that has not
responded to medical therapy is challeng
ing. Wound healing may be delayed and
radical local surgical treatment may cause
fecal incontinence. Thus, experienced
surgeons9,13 have advocated a conserva
tive approach. Two principles guide the
surgical m anagem ent of anorectal
Crohn’s disease — sepsis should be con
trolled by incision and drainage of
abscesses, and division of a large portion
of sphincter muscle should be avoided.16
Fistulas with internal openings low in the
anal canal can safely be laid open. Com
plex fistulas with internal openings near
the top of the anorectal ring should be
treated by laying open the external parts
of the fistula to establish drainage, curet
ting the tract to remove granulation tis
sue and perhaps instituting catheter
drainage. This approach may relieve
symptoms and minimize the risk of incon
tinence as a complication of surgical
drainage.
External diversion of the fecal stream
by means of an ileostomy is an alterna
tive surgical treatment for Crohn’s dis
ease.2-5 Unfortunately, relapse after loop
ileostomy is common, and it is difficult
to restore intestinal continuity. Burman
and associates,17 Zelas and Jagelman,3
and Mcllrath4 found that colitis recurred
in one third to one half of patients after
construction of a loop ileostomy and that
intestinal continuity was restored in less
than one third. Six of 22 patients in the
series o f Zelas and Jagelman3 who
underwent loop ileostomy for anorectal
disease remained well for 3 to 5 years.
Harper and colleagues5 reported that 21
(72%) of 29 patients with anorectal
Crohn’s disease treated by split ileostomy
had early improvement. However, only
6 patients had intestinal continuity
restored, 8 had undergone a proctocolec
tomy and 15 remained defunctioned.
Our results following the treatment of
anorectal Crohn’s disease with a loop
ileostomy have been disappointing. One
quarter of the patients had early or late
complications requiring reoperation.
Although all initially improved after fecal
diversion, this was often a transient
response. At the time of review (average
follow-up of 17 months), intestinal con
tinuity has been successfully restored in
only one patient and five are asympto
matic following construction of a loop
ileostomy. Five patients have subse
quently required proctocolectomy.

In patients with proctitis or anorectal
sepsis, loop ileostomy should be viewed
as a temporary measure since it does not
appear to alter the course of the disease.
Nevertheless, there may be some merit in
constructing a loop ileostomy. Perianal
sepsis may become quiescent, at least tem
porarily, so proctectomy is easier to per
form. Consequently, perineal wound
complications may be reduced. In this ser
ies, three of five patients had primary
wound healing after proctectom y.
Although this is a small group, satisfac
tory results were achieved in these highrisk patients. The second benefit is that
it may allow patients to adjust psycholog
ically to an ileostomy. Some patients will
agree to a temporary ileostomy whereas
they would be reluctant to undergo a
definitive procedure initially.
Rectovaginal fistulas due to Crohn’s
disease can be extremely difficult to
manage. Although patients are usually
distressed by their symptoms, few will
readily agree to proctocolectomy and
ileostomy or proctectomy and colostomy.
Again, construction of a loop ileostomy
may temporarily alleviate symptoms and
enable the patient to adjust to life with
an ileostomy. However, patients should
be advised that successful restoration of
intestinal continuity is uncommon. In our
experience, spontaneous healing of the
fistula is rare and symptoms usually recur
once continuity is restored. Most patients
with rectovaginal fistulas have associated
rectal involvement, making local repair of
the fistula possible in only a few selected
p atien ts. Local repair should be
attempted only when the disease is in
remission, the rectum is apparently
healthy and meticulous surgical technique
is used.18,19 The addition of a loop
ileostomy to divert stool may improve
healing and the outcome after surgery.
Conclusions
Our experience with a loop ileostomy
to manage anorectal Crohn’s disease sug
gests that this procedure will provide tem
porary relief of symptoms. Fecal diver
sion does not appear to alter the
long-term course of the disease and suc
cessful restoration of intestinal continuity
is uncommon.
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NOTICES
Sir Mortimer B. Davis-Jewish General
Hospital, 3755 Cote Ste-Catherine, Mon
treal, PQ H3T 1E2, tel. (514) 342-3111.

Laser Surgery in
Gynecology and Dermatology
This postgraduate course will be held Feb.
20-22, 1986, at the Hyatt Lake Tahoe,
Lake Tahoe, Calif. It will provide a com
prehensive review of the biophysical basis
for carbon dioxide laser surgery in gyne
cology, and for argon, neodymium-YAG
and carbon dioxide laser surgery in der
matology. The course is designed for phy
sicians and nurses and will offer separate
programs for each specialty. The range
of applications and surgical techniques
will be detailed. The course will consist
of lectures, video demonstrations and
hands-on training sessions with the sur
gical lasers under faculty supervision.
There will be an extensive commercial
exhibition in conjunction with the course.
For further information on the scien
tific program and registration contact the
course directors: Dr. V.C. Wright,
Department of Obstetrics and Gynecol
ogy, The University of Western Ontario,
887 Richmond St., London, Ont. N6A
3J1, tel. (519) 438-1411; or Dr. Alex
Ferenczy, Department of Pathology, The

Neurovascular Surgery
The 3rd annual meeting of the Neurovas
cular Society of North America and the
Society for Neurovascular Surgery will be
held in Chicago, 111., Apr. 17-19, 1986.
General sessions will strive to identify
problems affecting the heart, blood ves
sels and brain, pathologic mechanisms,
and methods of diagnosis and manage
ment. Special sessions will address in
detail such topics as vertebral artery sur
gery, ultrasonography, headaches, nerve
repair and anticoagulation. The meeting
will be open to all diagnostic, medical and
surgical specialties.
For further information write the
Executive Director, Neurovascular Soci
ety of North America/Society for Neu
rovascular Surgery, PO Box 679, Oak
Park, IL 60302; or call (312) 482-3950.
continued on page 53

M PRESCRIBING INFORMATION ►
mt

Agarol'Capsules
Danthron - Dioctyl Sodium Sulfosuccinate
Peristaltic Stimulant - Stool Softener
INDICATIONS
The management of chronic and acute functional
constipation in geriatric or inactive patients, in
prenatal and postpartum patients and in
postoperative patients.
CONTRAINDICATIONS
Do not use when abdominal pain, nausea,
vomiting or appendicitis are present.
PRECAUTIONS
Appropriate investigation should bo undertaken to
exclude the possibility of more serious conditions.
Frequent or prolonged use may result in
dependence on laxatives. Avoid concomitant use
with mineral oil, dioctyl sodium sulfosuccinate
may enhance absorption of the oil.
ADVERSE EFFECTS
May produce a harmless pink or orange colour in
alkaline urine. Prolonged Agarol administration
may produce brownish discolouration of the rectal
mucosa; this disappears after the drug is
discontinued. Danthron is excreted in breast milk
and should not be given to lactating mothers.
DOSAGE
For symptomatic control of non-specific
constipation: Adults and children over 12 years;
one or two capsules at bedtime for a maximum
of 2 or 3 days or as directed by physician.
SUPPLIED
Each capsule contains 50 mg of danthron and 60
mg of dioctyl sodium sulfosuccinate. Package of
10 capsules.

P A R K E -D A V IS
Parke-Davis Canada Inc., Scarborough, Ontario
PAAB
CCPP

*Reg. T.M. of Warner-Lambert C o m p a n y ______
Parke-Davis Canada Inc. auth. user
1 PM* C ]

NIGHT
SHIFT

For overnight
relief of
occasional
constipation

Danthron 50 mg

Dioctyl Sodium Sulfosuccinate 60 mg

New Agarol* capsules combine a stimulant and
stool softener for dependable overnight relief.
Recommend new Agarol* capsules or regular
Agarol* liquid for the short-term management of
constipation.

P A R K E -D A V IS
Parke-Davis Canada Inc . Scarborough O ntario
•Reg 1M ol Warner-Lambert Canada Inc . Parke-Davis Canada Inc auth user

VOLUME 29, NO. 1, JA N U A R Y 1986 / THE CANADIAN JOURNAL OF SURGERY

35

Introducing new ENRICH,complete
An easy way to give your patients

k

Enrich is a new liquid
source of fibre

*

Enrich gives your patients more than good
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need. Six cans (1410 mL) of Enrich provide
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amount found in the average diet12 - to
regulate bowel function as a normal diet
does.3
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patients on soft diets, by mouth or by tube. 4
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Tube Cecostomy Revisited
A retrospective review of 59 tube
cecostomies, performed between 1971
and 1981, was undertaken to evaluate
current operative indications, outcome
and associated morbidity. Tube
cecostomy was performed as a com
plementary procedure in 81 .4% of
cases; in the other 18.6% , it represented
either the only operative intervention or
the initial stage of a two-stage proce
dure. Complications included local infec
tion in 32% of cases, peri-catheter leak
in 25% , skin excoriation in 24% and
pain in 12% . Catheters remained in place
an average of 14 days, but function was
adequate in only 40% of cases. Cecal
drainage persisted from 24 hours to 90
days after the tube was removed. Two
additional procedures were required to
close persistent cecal fistulas. The
authors conclude that the high morbidity
associated with this procedure militates
against its routine use. Decompression
by cecostomy may be inadequate for
treating acute colonic obstruction.

Une etude retrospective de 59 caecostomies tubaires effectuees entre 1971 et
1981 a ete entreprise dans le but d'evaluer les indications operatoires courantes,
les resultats et la morbidite relies a cette
operation. La caecostomie tubaire avait
ete pratiquee en tant qu'intervention
secondaire dans 81 ,4% des cas; dans
les autres 18,6% , il s'agissait soit d'une
operation unique, soit de la premiere
etape d'une operation en deux temps.
Parmi les complications, on compte 32%
d'infections locales, 25% de fuites pericatheters, 24% d'excoriation cutanee et
de la douleur dans 12% des cas. Le
catheter est demeur6 en place pendant
une moyenne de 14 jours mais il n'a
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fonctionne adequatement que dans 40%
des cas. Un drainage caecal a persiste de
24 heures a 90 jours aprds le retrait du
catheter. Deux operations additionnelles
ont et6 necessaires pour refermer des
fistules caecales persistantes. Les
auteurs jugent que le haut taux de mor
bidite reli£ a cette intervention milite
contre son emploi systematique. Une
decompression par caecostomie peut
s'averee insuffisante dans le traitement
de I'obstruction aigue du colon.

A Malecot catheter was most fre
quently used for the tube. Five procedures
were performed as appendicostomies dur
ing elective surgery. In each case, opera
tion included placing two purse-string
sutures in the wall of the cecum, secur
ing the cecum to the peritoneum, and fix
ing the tube to the skin. Drainage through
the catheter was by gravity into a collec
tion bag.

Pillore of Rouen in 1776 performed the
first recorded cecostomy to relieve colonic
obstruction.1 Once widely practised and
accepted, tube cecostomy is less fre
quently performed as indications for its
use have narrowed. Even when its prac
tice was widespread, the procedure had
its detractors.
Since the turn of the century, tube
cecostomy has been advocated mainly as
a decompression procedure for acute
colonic obstruction2'5 and as a safety
valve for colonic resection.4’6,7 It has also
been suggested for perforation or
impending perforation of the cecum,8,9
for cecal volvulus,8 adynamic ileus of the
colon10 and toxic dilatation in inflamma
tory bowel disease.11 Because of the con
troversy concerning tube cecostomy, we
undertook to evaluate retrospectively the
current operative indications, operative
outcome and associated morbidity in rela
tion to tube cecostomy in order to deter
mine the place of the procedure in
modern surgery.

Indications for the operation are listed
in Table I. In 48 patients (81.4%) the
cecostomy was performed as a com
plementary procedure. Therapeutic
cecostomy was carried out in 11 patients
(18.6%); these represented the only oper
ative intervention or the first step of a
multistage procedure.
Three patients died at 2, 11 and 48 days
postoperatively. All deaths were related
to cardiac arrest in poor-risk patients with
cardiovascular disease.
There was no routine regarding type of
anesthesia, skin closure or antibiotics
given.
The tube remained in place an average
of 14 days. By the end of the third
postoperative week 87% of the catheters
had been removed and all were out within
4 weeks of operation.
Tube drainage was adequate in only 24

Patients and Methods

We reviewed 59 tube cecostomies per
formed between 1971 and 1981 at the Sir
Mortimer B. Davis-Jewish General
Hospital in Montreal. There were 36
women and 23 men, ranging in age from
18 to 91 years (average 68 years).
The decision to perform a tube
cecostomy was made for either of two
reasons: to provide a safety vent, as a
complementary procedure, performed
with another operation or to provide ther
apeutic decompression for colonic
obstruction or dilatation.

Results

Table 1—Indications for Tube Cecostomy
No. of
patients
Disease
Therapeutic
7
Carcinoma
1
Diverticulitis
2
Cecal volvulus
1
Adhesions
Complementary
22
Carcinoma
8
Diverticulitis
1
Ischemic colitis
1
Sigmoid volvulus
1
Hirschsprung's disease
8
Colotomy and polypectomy
2
Adhesions
2
Ogilvie's syndrome
2
Colovaginal fistula
1
Crohn's disease
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patients; in the other 35, there was either
scant or no catheter drainage. For
patients who had a complementary
cecostomy it was impossible to determine
if there was beneficial siphoning off of
intestinal gas. In two patients a therapeu
tic cecostomy did not relieve abdominal
distension, but the distal obstruction
cleared, and when bowel movements
began the distension resolved. There was
no record of whether bowel preparation
for subsequent operations was adequate
or effective.
Catheter care appeared to be a decision
of the individual surgeon. Some catheters
were not irrigated, but others were
irrigated when necessary or once per shift.
Mineral oil (30 mL) was most often used
for irrigation. Catheter function appeared
unrelated to the type of catheter care, the
underlying disease or the surgical
procedure.
Complications
Wound infection was the most frequent
complication (Table II), occurring in 14
of 48 complementary procedures and in
5 of 11 therapeutic procedures. Appendicostomy was associated with a higher
infection rate than simple tube cecostomy
(40% versus 31%).
Persistent cecal fistula (lasting 2 weeks
or more after catheter removal) occurred
in five patients. The time between tube
Table II—Complications Associated With
Tube Cecostomy
No. of
patients (%)

Complication
Infection
Leakage around tube
Skin excoriation
Fistula ( > 2 wk)
Pain
Premature dislodgement

Series

No. of
patients

19(32)
15(25]
14 (24)
5(8)
7(12)
2(3)

Infection

removal and cecostomy closure ranged
from 24 hours to 90 days. Two persistent
fistulas required reoperation to achieve
closure.
Peri-catheter leak, in 15 patients, was
not related to the manner in which the
cecostomy was fashioned. Skin excoria
tion, in most instances, was related to
peri-catheter leakage.
Comment
A protective diversionary cecostomy or
transverse colostomy is now rarely war
ranted for left-sided colon procedures
since these can be safely performed
without diversion as a recent review12
from our institution has shown. Not only
are complementary vents unnecessary but
they add the possibility of sepsis and
many other complications.
The relative value of various diverting
procedures for obstructing lesions of the
left side of the colon has been debatable.
Study of the pertinent surgical literature
does not resolve this issue. The virtues of
tube cecostomy, as cited by its propo
nents, are as follows: it is easy to perform
and can be carried out under local
anesthesia, the cecum is the portion of
colon most likely to perforate, it does not
interfere with subsequent resection of the
left side of the colon and it may eventu
ally close spontaneously. In cases of
extreme obesity of the abdominal wall
and when gross distension of the bowel
has “ used up” the leaves of the transverse
mesocolon, transverse colostomy may be
impossible. Under these circumstances
cecostomy may be the only method of
relieving obstruction.13
The use of cecostomy has frequently
been criticized and has lost favour with
many surgeons.1315 Detractors point out
that it provides less-effective decompres
sion than does a transverse colostomy and
does not allow complete diversion. Clark

and Hubay16 reported that of 37 patients
with acute large-bowel obstruction, two
distal perforations occurred after prox
imal decompression by a cecostomy. Balslev and colleagues17 reported that three
patients died of perforation because
cecostomy did not adequately relieve dis
tension. Aseptic decompression of a dis
tended cecum can be difficult, and perito
nitis after a cecostomy has been reported
as the cause of death.18 Welch and
Donaldson18 reported that the operative
death rate after preliminary cecostomy
was 10 times that after transverse
colostomy for lesions of the left side of
the colon. Balslev and associates17
attributed 22% of the deaths in their ser
ies to cecostomy. W angensteen19
deplored the use of cecostomy and stated:
“ A second year surgical house officer can
relieve an obstructed colon by an aseptic
transverse colostomy with less risk to the
patient than can an experienced surgeon
who favors performance of cecostomy.”
Yet surgeons still cling to its use.3,5'8'16
Tube cecostomy fails to decompress the
bowel adequately in as many as 50% of
cases.20,21 Albers and Smith20 and H unt15
found tube cecostomy an inadequate
emergency decompression procedure and
suggested that transverse colostomy re
sulted in fewer deaths, more effective
decompression, less metabolic disruption
and earlier and better preparation of the
colon (i.e., irrigation) for definitive sur
gery. Most importantly, poor tube func
tion has been shown8,17,22,23 to be respon
sible for a substantial number of deaths
(Table HU,5,8,16,17,24,25)
A growing number of surgeons advo
cate primary resection for an obstructing
carcinoma lying in the proximal or trans
verse colon or even the splenic flexure.
This obviates the need for decompres
sion.13,23,26,27 If there is a perforation
associated with a left-sided carcinoma, a
cecostomy is inadequate.

Table III—Cecostomy Related Morbidity____________________________________
No. of
perioperative
deaths (cecostomy
Premature
Hematoma/
Intraperitoneal
No
bleeding
Fistula
related)
leak
function
dislodgement

King and associates,
1
22
14(5)
1
153
5
1966s
Jackson and Baird,
_
_
10(4)
1
102
3*
5
196724
Westdahl and
_
_
_
20 (0)
0
1
93
7
Russell, 19695
Balslev and
_
_
_
5(5)
8
2
associates, 197017
76
10
Clark and Hubay,
_
_
16
5(1)
1
3
161
6
197216
Stainback and
_
5(2)
1
1
3
2
2
associates, 19734
235
Hoffmann and
_
1
1
8(1)
57
0
0
18
Jensen, 198425
3(0)
2
1
0
5
0
59
19
Present series
•All died.
1 16 of 48 with tube cecostomy required secondary closure. Patients with mucosa-to-skin suturing required secondary closure.
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Secondary
closure
17
5
411
20
6
0
11
2
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In our study, catheter plugging with
stool, despite irrigation, was a constant
problem. Reports addressing the issue of
tube patency vary widely. Some report
successful decompression,22,28 but failure
rates as high as 20%24 and 50%20'21 have
been reported. It is not surprising that
such tubes do not function well. Their
inefficiency can perhaps be explained
partly by the principles governing the flow
o f fluid through cylindrical tubes.
Poiseuille’s law relates flow directly to the
fourth power of the radius and inversely
to both tube length and viscosity of the
fluid. Conversely, resistance to flow is
directly related to fluid viscosity and tube
length and inversely proportional to the
fourth power of the tube radius. Malecot
catheters were used in our study but they
varied in diameter. In some cases it could
be argued that a catheter of inadequate
size was used. However, it must be
remembered that the effluent is a nonhomogeneous fluid of low viscosity and
there is usually a large non-fluid compo
nent. Poiseuiile’s law is operable only
under special conditions and should be
applied to the steady, laminar flow of a
homogeneous fluid. All of these consider
ations could be eliminated by suturing
cecal mucosa to skin primarily, but this
would require another operation for
closure.29'31
Morbidity associated with cecostomy,
exclusive of tube function, has been
extensively described in the literature
(Table III). These reports cannot be com
pared, as some are a series of complemen
tary cecostomies and others are thera
peutic cecostomies perform ed for
obstruction; some are tube cecostomies
while others are mucosa-to-skin suturing
and some are combinations of the two.
Nevertheless, the reports clearly point out
the serious morbidity associated with
cecostomy.
Inadequate function of the tube can be
fatal.17>22'24 Death has been attributed
directly to the cecostomy in up to 40%
of patients who died perioperatively.24
In comparing cecostomy and transverse
colostomy to treat obstruction of the left
side of the colon by carcinoma, Goligher
and Smiddy32 declared that cecostomy
was a much more dangerous operation,
the respective death rates being 50%
versus 17%. Moreover, analysis of the
causes of death after the two operations
revealed that of 36 deaths after
cecostomy, 22 were due to septic compli
cations; none of the 8 deaths after trans
verse colostomy were attributable to
infection. This constitutes a grave indict
ment of the former operation.
In addition to the complications listed
in Table III, many other problems have
been reported. These include severe skin
excoriation,5'25 wound dehiscence requir
ing resuturing under general anesthe
40

sia,25 recurrence of a fistula after closure
o f the cecostom y,5'25 subcutaneous
emphysema,4 prolapse of omentum,17
stitch granulom a,25 evisceration,5
retraction5 and hernia formation at the
cecostomy site.8'25
Infection was the commonest compli
cation in our study. Inflammation and
skin excoriation often occurred in the
region of the cecostomy after the tube had
been in place for a number of days but
these problems were not considered as
infection. King and colleagues8 stated
that almost all their patients suffered
minor wound infections along the tube
tract. These problems have also been
addressed by others (Table III). Rates for
secondary closure are reported to vary
from 0% to 20%. It is notable that these
secondary surgical procedures also carry
an attendant morbidity and mortality.
Other indications for which cecostomy
has been advocated include perforated
cecum,8,9 toxic dilatation associated with
ulcerative colitis11 and cecal volvulus.8
Even for cecal volvulus some33 advocate
a right hemicolectomy rather than
cecostom y. Patients with pseudo
obstruction of the colon may have
tremendous dilatation of the colon and
require decom pression. A lthough
cecostomy has been recommended in the
p a st, recent reports suggest th at
colonoscopic decompression should be
the first line of therapy.34'36 Failing this,
cecostomy may be considered.
From this study we conclude that the
high morbidity rate related to tube
cecostomy militates against its routine
use. Furthermore, decompression of the
colon by cecostomy is generally inade
quate for acute obstruction and with our
present understanding of preoperative
bowel preparation, complementary
cecostomy is rarely warranted. A compar
ison between tube cecostomy and trans
verse loop colostomy as the initial decom
pressive procedure for patients with
obstructing lesions of the left colon is
difficult since we are unaware of any con
trolled prospective trials comparing the two.
A review of the contemporary literature
suggests that reasonable current indica
tions for tube cecostomy include cecal
volvulus, pseudo-obstruction (if an
attempt at colonoscopic decompression
has failed), cecal perforation in associa
tion with an obstructed left-sided lesion,
and to relieve obstruction in morbidly
obese patients when transverse colostomy
is technically impossible.
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Nosocomial Gram-Negative Parotitis
Nosocomial parotitis is an uncommon
postoperative complication, usually
affecting elderly, debilitated, dehydrated
patients. The preponderance of gram
positive pathogens has been emphasized.
The authors present two cases of gram
negative parotitis and review the litera
ture on this condition. Because the
organisms producing nosocomial infec
tion in patients receiving intensive care
are commonly gram-negative bacilli,
treatment should be based on the find
ings of Gram's staining of the pus
obtained from Stensen's duct, altered
when necessary by the final culture
results.
La parotidite nosocomiale est une com
plication postoperatoire peu frequente
qui touche habituellement les personnes
agees, fragilisees et deshydratees. On a
souligne la preponderance des organismes gram-positifs comme pathogenes.
Les auteurs decrivent deux cas de paroti
dites a gram-negatifs et passent en revue
les publications sur le sujet. Comme les
micro-organismes responsables des infec
tions nosocomiales chez les patients soumis a des soins intensifs sont souvent
des bacilles gram-negatifs, le traitement
devrait etre oriente en fonctions des
resultats de la coloration Gram sur le pus
preleve du canal parotidien, quitte a le
modifier ensuite, si ngcessaire, selon les
resultats des cultures finales.

C ase R eports

intravenously. Gram’s staining of the purulent
exudate revealed abundant polymorphonuclear
leukocytes and gram-negative rods. Final cul
tures grew Escherichia coli sensitive to ampicillin and gentamicin. Antibiotic therapy was
changed to ampicillin. The parotitis resolved,
but the diarrhea persisted. When Clostridium
difficile cytotoxin was identified in the stool,
the ampicillin was withdrawn and replaced by
gentam icin. The colitis resolved a fter
metronidazole was prescribed.

Case I

Case 2

the results of definitive cultures are
known. Recent reports have noted the
presence of a widening range of patho
gens, including gram-negative rods and
anaerobes. We report two cases of
nosocomial gram-negative parotitis that
emphasize the increasing importance of
these organisms.

A 46-year-old hypertensive man experienced
the sudden onset of chest pain. Angiography
demonstrated an ascending aortic dissection
(type A). The ascending aorta was replaced
with a Dacron graft at an emergency opera
tion. As prophylaxis the patient received
cephalothin intravenously, followed by
cephalexin orally after he was extubated. Five
days postoperatively, while he was still taking
cephalexin, diarrhea developed. By day 7 he
had pain, swelling and tenderness over the left
parotid gland, a fever and leukocytosis. Exami
nation of the mouth showed dry mucosa and
creamy pus exuding from Stensen’s duct. The
cephalexin was stopped and cloxacillin begun

D iscu ssio n

Acute parotitis, an uncommon disorder,
usually affects the elderly, debilitated,
dehydrated patient. Historically, the
predominance of Staphylococcus aureus
as the infecting organism has been
emphasized, and the empirical treatment
has been antistaphylococcal agents, until
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Accepted fo r publication Sept. 6, 1985
Reprint requests to: Dr. R. Saginur,
Department o f Medicine, Ottawa Civic
Hospital, 1053 Carling A ve., Ottawa, Ont.
K 1Y 4E9

A 50-year-old woman with chronic renal
failure underwent renal transplantation.
Immunosuppressive therapy consisted of
cyclosporine and prednisone. Postoperatively
she became hypotensive and acute tubular
necrosis developed, which required hemodial
ysis. A bleeding diathesis developed 4 days
after operation and she was started on cefoxi
tin for presumed sepsis. On day 11, swelling
of the left parotid gland was noted and she had
a fever and leukocytosis (Fig. 1). Thick creamy
pus was seen draining from Stensen’s duct and
Gram ’s staining demonstrated abundant poly
morphonuclear leukocytes but no bacteria.
Cloxacillin and gentamicin were started
intravenously. Cultures of the pus grew Pseu
domonas aeruginosa and E. coli, sensitive to
gentamicin. Blood cultures grew P. aeruginosa.
The cloxacillin was stopped and the gentam i
cin was given for 10 days. The parotitis
resolved.

FIG. 1—Case 2 showing marked swelling of
left parotid gland.

Inflammation in early parotitis is con
fined to an accumulation of cells within
the larger ducts. The parenchyma and
smaller ducts are spared until the
epithelium of the larger ducts is des
troyed, allowing the inflammatory
process to invade the remainder of the
gland. Once penetration of the paren
chyma has occurred, multiple abscesses
may form and coalesce. If the process is
allowed to continue, pus may penetrate
the capsule and invade the surrounding
tissue, extending into the neck, the exter
nal auditory canal or the skin of the face.
Acute suppurative parotitis is often a
nosocomial infection. It may develop a
few hours or many weeks after surgery.
Crile and Manning1 first observed that
poor oral hygiene and lack of oral intake
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predispose to retrograde invasion o f the
parotid duct by virulent oral flora. Krippaehne and associates2 emphasized that
dehydration, malnutrition, advanced age,
debilitation and the use of anticholiner
gic medication were predisposing factors.
Petersdorf and colleagues,3 in their
review o f seven cases of staphylococcal
parotitis, stressed the importance o f S.
aureus as the primary pathogen. In
Spratt’s4 comprehensive review o f 92
cases at one institution, all but 2 were due
to gram-positive organisms. Similarly,
Krippaehne and colleagues2 found that
64 o f 66 cultures grew staphylococci.
However, the data for these three series
were collected during the period when
gram-positive cocci were the major
nosocomial pathogens. Since the middle
1960s there has been an increasing
proportion o f gram-negative infections
with a relative decrease in gram-positive
infections.5 Thus, more recent reports
have implicated gram-negative rods as the
infecting bacteria in acute parotitis.6'9
Although gram-negative bacilli are found
infrequently in the normal orpharynx,
colonization occurs in patients treated
with antibiotics in direct relation to the
severity o f the underlying illness.10,11
Initial treatment of acute parotitis
should be directed against the
staphylococci and any other organism
identified on Gram’s staining of the pus
from Stensen’s duct. In the very ill this
treatment should include an aminoglyco
side. Antibiotic therapy may be altered by
the final culture results. Meticulous
cleansing of the teeth and gums and main
taining moist oral membranes can
minimize the complication. Finally, if the
parotitis progresses despite adequate
antibiotic therapy, surgical drainage is
indicated.
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Inguinal Neuralgia: a Review of 50 Patients
Inguinal neuralgia, an uncommon condi
tion, can readily be diagnosed if the
anatomy of the sensory nerves of the
lumbar plexus is understood. The authors
review 50 patients with this condition,
pointing out the importance of injury to
these nerves, not only on the anterior
abdominal wall but also in the
retroperitoneal space on the posterior
abdominal wall.
Successful treatment is achieved by
surgical section of the nerves. First the
inguinal region is explored; if this does
not result in cure the authors recom
mend retroperitoneal section of the
nerve.

La nevralgie inguinale, une affection rare,
peut etre diagnostiqude rapidement
quand on comprend bien I'anatomie des
nerfs sensitifs du plexus solaire. Les
auteurs ont etudie les cas de 50 patients
souffrant de cette maladie. Ils soulignent
I'importance d’une lesion de ces nerfs,
non seulement sur la paroi abdominale
anterieure mais aussi dans I'espace retro
peritoneal, sur la paroi abdominale postdrieure.
La guerison suit la section chirurgicale
des nerfs. On doit s'attaquer en premier
lieu a la region inguinale et s'il n 'y a pas
de soulagement, les auteurs recommandent une section rdtroperitoneale du nerf.

communication among these nerves. The
pain may be sharp, aching or burning in
nature. Sharp pain characteristically
arises along the inguinal canal and is felt
in the scrotum or labium, or in the upper
medial thigh. Rarely it may be referred
to the sacroiliac joint or the hip area. The
deep aching pain has a similar distribu
tion. Sometimes there is a dull, hot, burn
ing sensation in association with numb
ness. All types of pain are aggravated by
hip extension, walking, exercise or pres
sure over the inguinal region. Often the
pain is severely debilitating and results in
drug dependency.
Injury to the inguinal nerves on either
the anterior abdominal wall or posterior
abdominal wall in the retroperitoneal
space is often the cause of inguinal neu
ralgia. Anterior wall injury may occur
during herniorrhaphy or appendectomy
or may be associated with the irritation
of inguinal hernias. Posterior wall injury
may follow appendiceal abscesses and
pelvic surgery.
An awareness of the existence of ingui

nal neuralgia and an understanding of the
anatomy of the ilioinguinal and genito
femoral nerves will lead to its diagnosis
and treatment.
Anatomy (Fig. 1)
The cutaneous branches of the lumbar
plexus give rise to the iliohypogastric,
ilioinguinal and genitofemoral nerves and
the lateral cutaneous nerve of the thigh.
Iliohypogastric Nerve
This sensory and motor nerve is a
branch of the T12 or LI nerves. It
emerges behind the psoas muscle just
above the ilioinguinal nerve and pierces
the transversus abdominis above the iliac
crest. Its anterior branch runs forward
between the oblique internal and external
muscles and pierces the aponeurosis of the
external oblique muscle to supply the skin
above the pubis. Its posterior branch sup
plies an area of the buttock just posterior
to the iliac crest.

Inguinal neuralgia is an uncommon syn
drome of chronic pain and paresthesia in
the area served by each of the sensory
nerves in the inguinal region. Typically
the ilioinguinal, iliohypogastric or
genitofemoral nerve is involved. The sen
sory findings vary because of overlap and
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Halifax, N S
Accepted fo r publication M ay 21, 1985
Reprint requests to: Dr. J.K. Purves,
Department o f Surgery, Victoria General
Hospital, Halifax, N S B3H 2 Y9

Fig. la

Fig. lb

FIG. 1—(a) Lumbar plexus and anatomic relations, (b) Genitofemoral nerve and its rela
tions. 1. = iliohypogastric nerve. 2. = ilioinguinal nerve. 3. = genitofemoral nerve. 4. = lateral
cutaneous nerve of thigh.
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Ilioinguinal Nerve

femoral artery, providing sensation to the
upper anterior thigh.

The ilioinguinal nerve, a branch of the
lumbar plexus, L I, emerges from behind
the psoas muscle just below the ilio
hypogastric nerve. It passes obliquely
across the quadratus lumborum and iliacus muscles and perforates the transversalis near the anterior superior iliac spine.
The nerve then pierces the internal
oblique muscle and accompanies the sper
matic cord within the inguinal canal; it
emerges through the external ring. It pro
vides sensation to the upper medial aspect
of the thigh and the scrotum or labium.
Genitofemoral Nerve
This nerve arises from the LI and L2
nerves. It travels obliquely through and
over the psoas muscle, emerging in the
vicinity of L4 in the retroperitoneal space.
It divides into the genital and femoral
branches, which then travel separately
across the base of the broad ligament.
The genital branch passes through the
internal inguinal ring, descends in associ
ation with the spermatic cord or round
ligament, supplying sensation to the scro
tal or labial skin and medial upper thigh;
it also supplies motor fibres to the
cremasteric muscle. The femoral branches
travel beside the external iliac artery and
enter the femoral sheath lateral to the
Table 1—Etiology of Neuralgia (54 Operations)
No. of
operations

Cause
Inguinal canal disease
Indirect hernia
Lipoma of cord
Leiomyoma
Endometrioma
Entrapment on anterior
abdominal wall
Scar
Tented
Previous pelvic surgery
Suspected anterior
abdominal wall injury
Suspected retroperitoneal
injury
Unknown

19
9
8
1
1
9
7
2
16
10
6
10

Lateral Cutaneous Nerve o f Thigh
This arises from the posterior roots of
L2 and L3. It leaves the lateral border of
the psoas muscle, traverses the iliacus
muscle and emerges at or below the junc
tion of the anterior superior iliac spine
and the inguinal ligament. Sensation is
provided to the lateral aspect of the thigh
to a point just above the knee.
Meralgia paresthetica, entrapment of
the lateral femoral cutaneous nerve of the
thigh, is often the result of a congenitally
aberrant path of this nerve around the
anterior superior iliac spine through the
fasciculi of the inguinal ligament. In con
trast, inguinal neuralgia is often related
to hernias or nerve injury secondary to
previous surgery.
Surgery

Historically, the management of ingui
nal neuralgia has been either to identify
the nerve at the site of entrapment or
injury and to free it or to locate the
genitofemoral nerve in the retroperitoneum overlying the psoas muscle and to
transect it there. Because of the high
proportion of inguinal lesions (entrap
ment, hernias) we advocate exploration
of every groin. If the pain is not relieved,
we later explore the retroperitoneum and
divide the nerve through a separate flank
incision. Surgery may therefore be done
in two stages.
A standard groin incision is made
superior and medial to the inguinal liga
ment. The external oblique muscle is
incised at the external inguinal ring. The
superficial branch of the ilioinguinal
nerve is identified and followed through
out its course and is often divided. The
spermatic cord is mobilized, and a search
is undertaken for one or two branches of
the genitofemoral nerve that accompany
the cord.
In women the round ligament is divided
at the internal ring. This ensures section
of the genitofemoral nerve at this level.

In an effort to preserve cord structures
from injury in men, the exploration and
division is often incomplete. For this
reason treatment by exploration of the
inguinal canal alone in men is often
unsuccessful. We therefore advocate a
retroperitoneal approach and section of
the genitofemoral nerve on the psoas fas
cia to assure division of the nerves.
Report of Cases

We reviewed 50 cases of inguinal neu
ralgia. The patients (42 women, 8 men)
were seen by one surgeon between 1970
and 1984. The mean age of the patients
was 41.4 years. Two patients had a
bilateral procedure and two underwent a
second operation for recurrent pain, giv
ing a total of 54 operations. Follow-up
was effected by clinic examination or
mailed questionnaire. The mean follow
up was 3.9 years (range from 4 months
to 14 years).
The 42 women had 46 operations; 38
considered they were either cured (36) or
improved (2) and only 4 felt that the oper
ation had failed. This represents an over
all success rate of 90%. Eight men under
went eight operative explorations. Early
in our series we limited the exploration
to the inguinal canal alone. There were
four failures in this group. Of the other
four men, three have been cured of their
disease and the condition of one has been
improved by retroperitoneal division of
the genitofemoral nerve. This represents
an overall success rate in men of 50%.
Lipomas and small hernial sacs less
than 3 cm in depth appeared to be the
only causative factors in 17 patients. One
leiomyoma and one endometrioma were
found in the inguinal canal of two other
patients. True entrapment was visualized
in only 9 of 50 patients. Ten others had
previously undergone surgery on the
related lower quadrant, but this did not
appear to involve the affected nerve.
In all, 16 women had previously under
gone pelvic surgery that included tubal
ligation, hysterectomy, cesarian section
and appendectomy. Ten of the 16 had
had anterior abdominal wall surgery that

Table II—Lumbar Cutaneous Entrapment Syndrome
Nerve
Feature
Injury site

Pain distribution
Point of maximum
tenderness
Treatment

44

Iliohypogastric
Above inguinal canal

Ilioinguinal
Posterior to anterior superior
iliac spine
Inguinal canal
Femoral region
Above pubis
Groin, scrotum, back
Point of entrapment or where Medial to anterior superior
nerve emerges through
iliac spine or inguinal canal
external oblique muscle
Neurolysis, neurectomy
Nerve block, neurolysis,
neurectomy

Genitofemoral
Posterior abdominal wall

Lateral cutaneous
of thigh

Inguinal region

Junction of inguinal ligament
and anterior superior iliac
spine

Groin, scrotum, upper thigh
Internal inguinal ring

Lateral anterior upper thigh
Anterior superior iliac spine

Excision of portion of main
trunk of nerve

Nerve block, excision of
ligament and nerve
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could not be ruled out as the source of
their nerve pain. In 6 of the 16 the only
underlying cause of inguinal pain was
previous pelvic surgery. We believe
strongly that injury to the genitofemoral
nerve could have occurred at the base of
the broad ligament or behind the cecum
at the time of their operations. The cause
of inguinal neuralgia was undetermined
in 10 patients (Table I).
Discussion
Although lumbar plexus neuralgias
were identified by E.J. Smith in Osier’s
Modern Medicine,1 in 1910, it was not
until 1942 when Magee2 presented his
paper to the “ Gallie Club” in Toronto
that these neuropathies were recognized
as being surgically correctable. Three
years later Lyon,3 another Canadian,
supported Magee’s findings by reporting
three more patients who were successfully
treated by operation. Both authors
divided the genitofemoral nerve in the
retroperitoneum on the psoas fascia
through a transperitoneal approach.
Since that time little has appeared in the

surgical journals4'7 regarding this con
dition.
Inguinal neuralgia is a poorly recog
nized and infrequently diagnosed entity.
D ifferen tiating ilioinguinal from
genitofemoral neuralgia is often difficult
(Table II). An understanding of the anat
omy of these nerves is essential for a cor
rect diagnosis. Many who suffer from this
problem are inadequately treated in pain
clinics or by family physicians.
Many patients in our series had a small
undiagnosed inguinal hernia. We were
impressed that many women who had no
demonstrable inguinal condition had
previously undergone pelvic surgery, such
as tubal ligation, hysterectomy or cesar
ian section. We believe that injury to the
genitofemoral nerve had occurred at the
base of the broad ligament as a result of
pelvic surgery. This syndrome was rarely
associated with true entrapment. Only a
small proportion of our patients had
obvious entrapment within the anterior
abdominal wall.
Treatment of this condition is mainly
surgical. We recommend first an explo
ration of the inguinal canal and resection

of both the genitofemoral and ilioingui
nal nerves. This is usually successful. If
pain persists then we recommend retro
peritoneal section of the genitofemoral
nerve.
We are indebted to James McD. Corston,
FRCOG, Department of Gynecology, Victoria
General Hospital, Halifax, NS, for his ongo
ing interest and support in this study. We thank
Belinda Johnson and Heather Butler for
secretarial help.
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Erosive Silicone Synovitis
Although erosive silicone synovitis is an
unusual complication of implant
arthroplasty, its recognition is important.
The authors describe three patients in
whom this complication occurred after
Silastic replacements of the carpal
scaphoid and trapezium bones. Intercarpal arthrodesis is suggested as a form of
stress shielding for the implants. Regular,
long-term follow-up of patients with
these Silastic implants is recommended.

apres remplacement par implants de
Silastic d'os trapezoide, scaphoide ou du
carpe. On recommande une arthrodese
intercarpienne afin de proteger les

implants du stress. On suggere egalement une surveillance reguliere au long
cours des patients qui ont recu ces
implants de Silastic.

Bien que la synovite erosive causee par
le silicone soit une complication rare des
arthroplasties par implants, il est impor
tant de savoir la reconnattre. Les auteurs
decrivent trois cas de cette complication
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In the past 20 years, several hundred
thousand Silastic joint prostheses have
been implanted in the upper extremity.
These have included interphalangeal,
metacarpophalangeal and wrist joints as
well as the trapezium, scaphoid and
lunate, and radial and ulnar heads. Their
use in the treatment o f rheumatoid arthri
tis, osteoarthritis and osteonecrosis has
been very successful in relieving pain and
improving joint function.
Complications o f these joint replace
ments are fracture or dislocation o f the
prostheses, lymphadenopathy,1'2 infec
tion (less than 1%)3,4 and detritic syno
vitis.5-8 During the past 10 years, approx
imately 15 cases o f foreign-body, giant
cell reactive synovitis have been report
ed. They have been associated with
the trapezium,7 metacarpophalangeal
jo in t,1’2’5,6 trapezoid,7 lunate,9 radial
head7’8 and great toe.7 In only three of
these cases was there a destructive arthritis
secondary to silicone and all were with
lunate replacements. To date there have
been no reports o f problems with the
scaphoid prosthesis or o f erosions o f the
distal radius. This report deals with three
cases o f erosive silicone synovitis. The
first involved a scaphoid replacement.
The other two patients had undergone
trapezial replacement.
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Case Reports
Case 1
A 35-year-old right-handed engineer who
had nonunion of his left scaphoid (Fig. 1)
presented with wrist pain, unresponsive to
nonoperative measures. He underwent a Silas
tic scaphoid replacement (Fig. 2). Five months
later he began to have pain and swelling in the
region of his radiocarpal joint. Synovitis was
evident but there was no indication o f sepsis.
Within 9 months of replacement a large sub
cortical cyst was present in the distal radius
(Fig. 3) and there was an increase in the syno
vitis. The pain and swelling continued. The cyst
was biopsied a year later. The synovial tissue
was hyperplastic with multinucleated giant
cells. Silastic particles were recovered from the
cyst and identified by energy dispersive x-ray
analysis and oil red O staining (Fig. 4). These
studies were done at the Armed Forces Insti
tute of Pathology in Washington, DC.
The prosthesis was not removed nor was the
cyst bone grafted. The patient’s symptoms con
tinued (Fig. 5) for another 16 months when he
underwent wrist arthrodesis. The prosthesis
was removed and further synovial biopsies were
obtained. There was considerable wear of the
prosthesis particularly on its proximal surface.
Once again foreign-body granulomas and syn
ovial reaction to a foreign body were seen.
Polarizing light examination failed to show any
foreign material that polarized light.

Case 2
A 62-year-old right-handed housewife with
osteoarthritis in the carpometacarpal joints of
both thumbs underwent a right trapezial Silas46

r
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FIG. 3—Case 1. Large cyst in distal radius 11 months after scaphoid replacement.
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FIG. 4—Case 1. Biopsy from cyst in distal radius. Note silicone particulate matter (hematox
ylin and eosin, original magnification x 200).
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tic arthroplasty. There was no history of infec
tion but approximately 1 year after replace
ment, she experienced swelling and pain in the
carpometacarpal joint. Follow-up films showed
wear of the prosthesis on its ulnar side and ero
sion of the adjacent carpal bones (Fig. 6). The
prosthesis was removed 3 years postoperatively
and the resulting excision arthroplasty relieved
the patient’s pain.
Considerable wear was noted on the volar
surface of the excised implant and there were
several loose bodies in the joint. There was
moderate synovitis on the volar aspect of the
joint and the stem of the prosthesis was frac
tured. Bacteriologic cultures were negative.
Specimens obtained from the joint and from

the metacarpal shaft both showed fibrous con
nective tissue with abundant foreign-body
material. This did not polarize light and was
interpreted as consistent with silicone particles.

Case 3
A 58-year-old woman underwent a right
trapezial Silastic replacement because of pain
ful osteoarthritis of the carpometacarpal joint.
Forty months later she was seen because of
pain and swelling in the region of the car
pometacarpal joint of her right thumb. There
was no suggestion o f infection but roentgeno
grams showed cystic changes in the adjacent
carpal bones (scaphoid and trapezoid) (Fig. 7).

FIG. 5—Case 1. Three years after scaphoid replacement there is deterioration of radial
cyst, changes in trapezium and thinning of prosthesis.

To date she has declined further surgery.
This woman also had a left trapezial replace
ment in January 1980 but to date has had no
problems associated with it.

Discussion

The exact etiology of the erosive
changes in these cases is not fully under
stood. It may represent an idiosyncratic
response in susceptible individuals. On
the other hand, it may be the end result
produced when the Silastic prosthesis
articulates with degenerated, incongruous
joint surfaces, giving rise to microscopic
particles of silicone elastomer. The
amount of wear seen in the two removed
prostheses would support the latter the
ory. Fibrillation of the implants is likely
due also to the prolonged intermittent
compression they receive with across-thewrist load. It is our belief that some stress
shielding is necessary to protect the
prosthesis; intercarpal arthrodesis is
recommended (e.g., triscaphium fusion
with lunate replacements and capitolunate
with scaphoid replacements).10,11
As experience is gained with any
implantable prosthesis, so will potential
complications be identified. Wear of and
local reactions to prostheses are inevita
ble as long as man-made materials are
used. We do not wish this report to be a
condemnation of implant arthroplasty,
using Silastic, as immeasurable good has
resulted from the use of such implants.
We do believe, however, that it is impor
tant for patients and surgeons to be aware
of the potential complications of a
prosthetic device and that further surgery
may be necessary should a complication
occur. It is suggested that Silastic carpal
bone replacements be reassessed clinically
and radiologically every year.
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Fracture of a Polyethylene Acetabular Cup: a Case Report
Fracture of a polyethylene acetabular cup
is rare. Current theories of its cause
emphasize wear of the component.
The case reported illustrates the
presence of a loosening membrane in
association with cup fracture. Histologic
study of the loosening membrane indi
cated a foreign-body reaction to poly
ethylene and acrylic wear particles. The
authors propose a theory relating micro
motion of the acetabular component to
the production of particles of wear with
a subsequent foreign-body reaction fol
lowed by further loosening. The erosion
of bony support leads to the concentra
tion of stress at the junction of the sup
ported and unsupported segments. This
may ultimately result in fracture of the
cup.
Les fractures des acetabules de
polyethylene sont rares. Les theories
actuelles sur leur cause insistent sur
I'usure de la piece.
Le cas que I'on decrit ici montre la pre
sence d'une membrane de decollement
en association avec la fracture de I'acetabule de polyethylene. L'examen histologique de cette membrane de decollement
suggere une reaction contre un corps
etranger, en I'occurrence des particules
d'erosion de polyethylene et d'acrylique.
Les auteurs suggerent une theorie reliant
une microdislocation de la prothese acetabulaire a la production de particules
d'erosion qui provoquent subsequemment une reaction tissulaire responsable
d'un relachement plus important. L’erosion du support osseux mene a une con-
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centration du stress sur la jonction des
segments soutenus et non soutenus. A
la limite, ceci entralne la fracture de la
prosthese acetabulaire.

Fracture o f the ultra high-density poly
ethylene acetabular cup after total hip
replacement is a rare clinical occurrence.
C urrent theory emphasizes that wear of
the com ponent is the main cause of its
failure.1'2 We present a case to illustrate
the presence o f a loosening membrane
and osteolysis as a consequence of
foreign-body reaction to wear particles,
and we propose a theory relating aseptic
loosening to the cup fracture.

medial wall of the acetabulum extending distally into the ischium. Because of superior and
posterior acetabular bone loss the acetabulum
was reconstructed using a Muller reinforcement
ring and an autogenous bone graft. The
femoral component was found to be stable.

Case Report
A 58-year-old white man underwent a right
Charnley-Muller total hip replacement in
March 1973 and a similar procedure on the left
side in March 1977 for degenerative arthritis
secondary to alcohol-induced avascular necro
sis. The intra- and postoperative courses were
uncomplicated.
In November 1984 the patient was seen with
severe left hip pain caused by a fall while intox
icated 1 week earlier. He could not bear weight
on the affected leg. He admitted that he had
experienced some left groin discomfort on
initiating ambulation for several months before
the fall but he had not attended a clinic for
review since 1977.
The patient weighed 109 kg and was 1.70 m
tall. He had an antalgic gait with restricted
range of motion of the left hip due to pain.
Roentgenograms of the left hip showed a
grossly displaced acetabular cup with discon
tinuity of the metal ring (Fig. 1), confirmed by
push-pull and abduction-adduction films.
Lucent lines wider than 2 mm were noted at
the cement-bone interface surrounding the cup
in zones I, II and III as well as in the ischium.3
The femoral component did not appear to be
loose.
Through a Smith-Peterson anterior
approach to the hip the acetabular cup was
found to be fractured, with a large free
posterolateral fragment adjacent to a fracture
of the posterior acetabular rim. The
superomedial portion of the cup was stable and
firmly cemented. The cement mantle was
excised, and inspection of the cup revealed
severe eccentric wear (Fig. 2). The fracture had
occurred through the thinned wall of the cup.
An area of osteolysis associated with abundant
loosening membrane was noted deep to the
fractured portion of the cup and along the

FIG. 1—Anteroposterior roentgenogram
showing acetabular cup loosening and fracture
with femoral subluxation.

FIG. 2—Fracture of 50 mm outside diameter
32 mm inside diameter acetabular cup. Arrow
indicates area of eccentric wear.
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Results
Aspirated joint fluid was examined
under polarized light microscopy reveal
ing many birefringent wear particles
previously identified as polyethylene frag
ments (Schatzker J, Goodman SB,
Sumner-Smith G: Unpublished data,
1983).
Histologic sections of the loosening
membrane revealed large numbers of
histiocytes and multinucleated giant cells
in fibrous tissue. Examination under
polarized light showed many needle-like

birefringent particles located within the
cells (Fig. 3). Sections through specimens
of synovium showed a similar cellular
reaction around particles of cement and
polyethylene (Fig. 4).
The findings were interpreted as
demonstrating evidence of a foreign-body
reaction to polyethylene and cement
debris produced as a result of wear.
Discussion
Reports in the literature discussing the
cause of polyethylene fracture have

FIG. 3—Polarized light microscopy of loosening membrane with giant cells (light arrow)
and histiocytes surrounding polyethylene particles of wear (dark arrow) (hematoxylin and eosin,
original magnification x 400).

emphasized component thinning due to
w ear.1'2 Salvati and colleagues1 reported
two cases of fractured acetabular cups.
They noted that poor cementing tech
nique may allow increased motion of the
acetabular cup and a greater tendency to
fracture through the superior grooves.
Weightman and associates2 reported a
case in which a polyethylene tibial com
ponent of ultra high molecular weight
fractured. They suggested that the lack of
bony support led to increased bending of
the component and eventual fracture due
to tensile failure.
Histologic examination of the cementbone interface in clinically loose total hip
replacements has demonstrated the exis
tence of a foreign-body membrane com
posed of histiocytes and giant cells con
taining acrylic and polyethylene debris.4-7
Experimental evidence in dogs has related
the degree of membrane formation to
poor cement-bone interlock and micro
m otion.8
Our observations lend credence to the
following theory: micromotion o f the
deformable acetabular cup results in
cement and polyethylene debris secondary
to shear stresses at the cement-bone inter
face. The acrylic and polyethylene parti
cles stimulate a foreign-body membrane.
This membrane is capable of osteolysis,6
leading to further abnormal motion of the
component due to undermining of the
bony support. This produces more acrylic
and polyethylene debris, initiating a cycle
that leads to clinical loosening of the
prosthesis.
We have noted that a portion of the
cup can be well cemented and stable while
the adjacent segment can be loose and
subject to increased bending and shear
ing forces. Stress concentration at the
junction of these segments may predi
spose to polyethylene cup fracture.
We thank Dr. J. Delaney for his assistance
in the histologic studies.
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Inflammatory Abdominal Aortic Aneurysm
The inflammatory abdominal aortic
aneurysm has received little attention in
the literature. To date only four reports
have addressed the subject specifically.
Controversy remains as to whether this
is a variant of the usual atherosclerotic
aneurysm or a separate entity. The oper
ative reports of 24 patients with inflam
matory abdominal aortic aneurysms are
reviewed; 21 were intact and 3 ruptured.
Intact aneurysms ranged in diameter
from 5 to 12 cm and the ruptured ones
from 5 to 10 cm. Nine patients with
intact aneurysms had symptoms of
abdominal or back pain. Of 13 patients
who underwent excretory pyelography
before operation, only 3 had evidence of
obstruction. Nine patients had tube
grafts placed, 10 had aortoiliac grafts
and 5 aortofemoral grafts. There was
one intraoperative duodenal injury and in
another patient it was necessary to
divide the left renal vein for proximal
exposure. No attempt was made to
expose the ureters at operation. All
patients were discharged from hospital.
The authors believe that the inflamma
tory aneurysm is a variant of the
abdominal aortic arteriosclerotic
aneurysm. Intraoperative complications
can be avoided by the recognition of the
pathological features.

d'une variante de I'an6vrisme atherosclerotique habituelle ou d'une entite distincte. On etudie ici les resultats operatoires chez 24 patients presentant un
anevrisme inflammatoire de I'aorte abdo
minale; 21 6taient intacts et 3 etaient
ruptures. Le diametre des anevrismes
intacts variait entre 5 et 12 cm et celui
des anevrismes ruptures, entre 5 et 10
cm. Neuf patients porteurs d'anevrismes
intacts se plaignaient de douleur abdomi
nale ou lombaire. Des 13 patients qui
ont subi une pyelographie descendante
avant I'operation, seulement 3 montraient des signes d'obstruction. Neuf
patients ont repu une greffe tubaire, 10
une greffe aorto-iliaque et 5 une greffe
aorto-femorale. On a enregistre une
lesion duodenale operatoire et, chez un
autre patient, il a ete necessaire de separer la veine renale gauche afin d'exposer
la partie proximale. Aucun essai
d'exposer les ureteres fut tentg en cours
de chirurgie. Tous les patients ont recu
leur conge de I'hopital.
Les auteurs croient que I'anevrisme
inflammatoire est une variante de I'anevrisme arteriosclerotique de I'aorte abdo
minale. Quand on reconnatt ceci, des
complications opgratoires peuvent etre
evitees par reconnaissance des traits
pathologiques.

L'an&vrisme inflammatoire de I'aorte
abdominale occupe peu de place dans la
presse medicale. A ce jour, seulement
quatre articles ont touche spgcifiquement
ce sujet. On discute toujours s'il s’agit

In 1972 Walker and associates1described
the inflammatory abdominal aortic
aneurysm and suggested that it was a
different clinical entity from the
atherosclerotic variety. Recently, Baskerville and colleagues2 used the term perianeurysmal fibrosis to describe the lesion.
Inflammatory abdominal aortic aneur
ysms constitute 2.5% to 10% of all
infrarenal abdominal aortic aneur
ysms.13'5 The diagnosis is often not sus
pected preoperatively, and intraoperative
complications have led to increased mor
bidity and death. The etiology, diagnosis
and appropriate surgical management,
particularly in relation to the aneurysm
repair and associated ureteric obstruction,
are controversial. Our experience with
this complicated aneurysm forms the
basis of this report.
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Patient Material
Retrospectively, we reviewed the charts
of all 255 patients who underwent repair
of abdominal aortic aneurysms at the
Health Sciences Centre in Winnipeg
between 1977 and 1983. In 21 (9%)
patients (19 men, 2 women) the aneurysm
was considered inflammatory. Of 197
intact aneurysms, 18 were inflammatory,
as were 3 of 58 ruptured aneurysms.
Patients ranged in age from 52 to 82 years
(average 67 years).
The diagnosis was made by the gross
appearance of the lesion and biopsy
examination of the aneurysm wall. About
one half of the patients had tissue
removed at operation and the typical
microscopic findings of fibrosis and
chronic inflammation were present. Three
patients with intact inflam m atory
aneurysms treated before 1977 are
included in this report, giving a total of
24 patients with inflammatory aneurysms.
Clinical and Laboratory Findings
Of the 21 patients with intact inflam
m atory aneurysm s, 9 com plained
preoperatively of abdominal or back
pain, which is commoner than in nonin
flammatory aneurysms. The size of the
aneurysm was assessed preoperatively by
clinical examination, abdominal roent
genography or ultrasonography or was
measured at operation. Aneurysms varied
in size from 5 cm to 12.5 cm in diameter
(average 7.5 cm). The smallest aneurysm
was one that had ruptured. Thirteen of
21 patients with intact aneurysms under
went excretory pyelography preopera
tively. Ureteral obstruction was present
in three patients. Bilateral ureteric
involvement, probably secondary to
prostatic hypertrophy, was present in one.
In the remainder the pyelograms were
reported as normal. Only 2 of 10 patients
with an abnormal serum creatinine value
preoperatively had ureteric obstruction.
Fifteen of 21 patients with intact inflam
matory aneurysms had erythrocyte
sedimentation rates measured preopera
tively. The values ranged from normal to
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very high (Table I). Although sympto
matic patients with extensive perianeurysmal inflammation tended to have the
highest sedimentation rates, there was no
reliable correlation.
Pathological Features

operation is the most important thing for
the surgeon to recognize. The characteris
tic features are the dense, white, fibrotic
tissue and adherent duodenum (Fig. 1).
All our patients had gross findings of
perianeurysmal fibrosis, and adjacent
structures were involved to varying
degrees. The fibrosis extended from the

The gross pathological appearance at
T a b le 1 - E r y t h r o c y t e S e d im e n t a t io n

left renal vein to the common iliac bifur
cations in some instances. Biopsies of the
aortic wall revealed extensive periadventitial fibrosis and destruction of the inter
nal elastic lamina and most of the media
(Fig. 2). There were foci of lymphocytes,
plasma cells and eosinophils. Lymph fol
licles and giant cells were sometimes
present. The histologic appearance can
resemble that of syphilis.
Operative Management and Results

R a te in 1 5 P a t ie n t s W it h In f la m m a t o r y
A b d o m in a l A o r t ic A n e u r y s m
N o . of
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4

>

2

60

FIG. 3—Incision of aorta to allow adherent
duodenum to retract.

Fig. lb
FIG. 1—(a) Inflammatory aneurysm with
adherent duodenum (arrow). Note white mass
with overlying vascularity, (b) Aneurysm
opened. Note thick anterior wall.

It is most important for the surgeon to
be aware of the gross appearance of the
inflammatory aneurysm so that adjacent
structures will not be injured inadver
tently. Most serious complications result
from injuries to the duodenum or adja
cent veins during ill-advised dissection of
these structures.1,3'6 It is essential to
avoid the adherent duodenum by first
obtaining proximal control of the aorta.
Division of the left renal vein may give
better proximal exposure. It may be
preferable to gain temporary control of
the aorta at the level of the diaphragm,
especially when the aneurysm has rup
tured, as suggested by Crawford and
associates.5 With proximal control the
aneurysm is opened, allowing the duode
num to retract to the right with the wall
of the aneurysm (Fig. 3). If the inflam
matory process involves the iliac arteries,
no attempt should be made to dissect or
clamp them. It is preferable to obtain
intraluminal balloon control of the ves
sels through the open aneurysm (Fig. 4).
The iliac arteries are oversewn from inside
the sac and the limbs of the graft
anastomosed to the external iliac or com
mon femoral arteries. Likewise, the prox
imal anastomosis is made inside the sac.
The aneurysm wall is then approximated
over the prosthesis. A knitted Dacron
graft is used for elective reconstruction
and a w oven g ra ft fo r ru p tu re d
aneurysms (Table II). By these tech
niques, it was possible to repair all inflam
matory aneurysms in this series with
minimal morbidity and no deaths. One
duodenal perforation occurred but it was
repaired successfully, and the patient’s
recovery was uneventful following graft
replacement.
Discussion

FIG. 4—Intraluminal control of iliac
arteries.
T a b le I I - - T y p e o f G r a f t R e p a ir
No. of
G ra ft
T u b e g ra ft

FIG. 2—Photomicrograph showing, on left,
normal aortic wall and on right greatly thick
ened wall with marked inflammation (original
magnification x 1).

A o r t o ilia c
A o rto fe m o ra l
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24

The etiology of the perianeurysmal
fibrosis and inflammation, which is
associated with up to 10% of abdominal
aortic atherosclerotic aneurysms, remains
obscure. An attractive hypothesis and one
we support is that of an autoimmune
reaction with protein breakdown in the
aortic wall. Although unproven, the
histologic features and response to steroid
therapy as reported by Baskerville and
associates,2 lend support to this hypothe
sis. Rose and Dent6 have demonstrated
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that the inflammatory process is present
in most atherosclerotic abdominal aortic
aneurysms but varies in extent. The 12%
incidence associated with extensive fibro
sis in their series is in keeping with that
reported by others.‘-3-4 Further studies
may confirm these pathological findings.
Although Walker and colleagues1 sug
gested that this entity differs from the
standard atherosclerotic aneurysm, the
majority support the concept that it is an
exaggerated inflammatory process that
accompanies atherosclerosis.3-5’6 Undue
back pain, weight loss and a markedly
elevated erythrocyte sedimentation rate
are suggestive of an inflammatory
aneurysm. Excretory intravenous pyelo
graphy should be done in all patients who
undergo abdominal aortic surgery, to
delineate the anatomy of the kidneys and
ureters. When involved, the ureter charac
teristically is displaced medially by the
fibrosis at the level of the pelvis (Fig. 5).
However, ureteric displacement or
obstruction neither confirms nor excludes
the existence of perianeurysmal fibrosis.
Aortography is of no benefit in the diag
nosis of the inflammatory component.
Ultrasonography7 of the aorta may show
a thickened wall, but recent reports indi
cate that enhanced computed tomography
may be the most reliable method of
assessment.2-5-7-8 Since this perianeurys
mal fibrosis may be present in the absence
of any unusual clinical features, the sur
geon must be familiar with the gross
pathological features so that the poten
tial dangers of standard repair are rec
ognized at operation and modified
appropriately. M anagem ent of an
obstructed ureter remains controver
sial.9"11 The urologic literature favours
ureterolysis9 and Darke and colleagues10
have suggested simultaneous aneurysm
repair and ureterolysis as their treatment
of choice. If normal drainage is demon
strated preoperatively, no attempt should
be made to mobilize the ureters since there

is no evidence that obstruction occurs
later. When unilateral ureteral obstruc
tion is present preoperatively, the surgeon
will have to decide whether to perform
ureterolysis. In one patient in this series,
spontaneous resolution of ureteric
obstruction occurred 6 months after
repair of the aneurysm (Fig. 6). Since ure
terolysis may complicate the aneurysm
repair, it would seem preferable to await
spontaneous resolution and perform
follow-up excretory pyelography. It has
been demonstrated that with steroid ther
apy the fibrosis and ureteral obstruction
may resolve without aneurysm resection.
Delayed ureterolysis is advisable when
conservative measures fail.

Fig. 6b
FIG. 5—Excretory pyelogram demonstrates
medial deviation o f ureter (arrow) due to
inflammatory aneurysm.
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Summary
Twenty-four patients with inflamma
tory abdominal aortic aneurysms were
reviewed; 21 were intact and 3 ruptured.
The erythrocyte sedimentation rate was
elevated in a number of patients and three
had ureteric obstruction. The diagnosis
was rarely made preoperatively, although
it was occasionally suspected because of
pain, elevated sedimentation rate and ure
teric involvem ent. The operative
approach must be modified to avoid
injury to the duodenum. All aneurysms
were successfully replaced with a prosthe
sis and there were no operative deaths.
The management of associated ureteric

Fig. 6d

FIG. 6—(a) Preoperative excretory pyelo; ;ram showing left hydronephrosis, (b) Preoperative retrograde pyelogram showing medial devial ion of ureter (arrow) which is patent, (c) Excretory
pyelogram 3 months after repair of aneurysn i without ureterolysis. (d) Excretory pyelogram
6 months after operation showing resolution of hydronephrosis.
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involvement remains controversial but
our present approach is to repair the
aneurysm, then follow-up the ureteric
obstruction and perform ureterolysis later
if necessary.

Prescribing Information

References

1

*

%
*r

->

* - *■

Z A N TA C ® IN JE CTIO N (ranitidine hydrochloride)

1. W alker DI, Bloor K, W illiams G, et al: Inflamma
tory aneurysms of the abdominal aorta. Br J Surg 1972;
59: 609-614
2. Baskerville PA, Blakeney CG, Yo u n g AE, et al:
The diagnosis and treatment of peri-aortic fibrosis
(inflammatory aneurysms). Br J Surg 1983; 70: 381-385
3. GOLDSTONE J, M alone JM, M oore WS: Inflamma
tory aneurysms of the abdominal aorta. Surgery 1978;
83: 425-430
4. OLCOTT C IV, HOLCROFT JW, STONEY RJ, et al:
Unusual problems of abdominal aortic aneurysms. Am
J Surg 1978; 135: 426-431
5. CRAWFORD JL, Stow e CL, Safi H J, et al: Inflamma
tory aneurysms of the aorta. J Vase Surg 1985; 2: 113-124
6. ROSE AG, den t DM: Inflammatory variant of abdomi
nal atherosclerotic aneurysm. Arch Pathol Lab Med 1981;
105: 409-413
7. AIELLO MR, COHEN WN: Inflammatory aneurysm of
the abdominal aorta. J Comput Assist Tomogr 1980; 4:
265-267
8. Vint VC, U sselman JA, Warm ath MA, et al: Aor
tic perianeurysmal fibrosis: CT density enhancement and
ureteral obstruction. A JR 1980; 134: 577-580
9. A bbott d l , Skinner DG, Yalow itz p a , et al:
Retroperitoneal fibrosis associated with abdominal aor
tic aneurysms: approach to management. J Urol 1973;
109: 987-989
10. DARKE SG, G lass RE, Eadie DA: Abdominal aortic
aneurysm: perianeurysmal fibrosis and ureteric obstruc
tion and deviation. Br J Surg 1977; 64: 649-651
11. Bainbridge ET, Woodw ard DA: Inflammatory
aneurysms of the abdominal aorta with associated ure
teric obstruction or medial deviation. J Cardiovasc Surg
1982; 23: 365-370

NOTICES
continued from page 35

Surgery at Wimbledon
A course on various surgical topics will
be held in London, England, from June
28 to July 5, 1986. Topics to be discussed
include what’ s new in liver surgery, gas
tric inlet obstructions, vascular surgical
emergencies, inflammatory bowel disease,
thyroid surgery and progress in the treat
ment o f burn injury.
For further information contact Dr.
Paul Ross, 490 Old Dock Rd., Kiawah
Island, SC 29455; (803) 768-1033.

Otolaryngology

4

■ ^4

The University o f California School o f
Medicine at San Francisco will be present
ing a symposium on otolaryngology to be
held Feb. 1-9, 1986 in Grindelwald, Swit
zerland. Designed for otolaryngologists,
otologists, head and neck surgeons, and
plastic and reconstructive surgeons, this
symposium will evaluate recent develop
ments and future directions in related
areas.
F or m ore in fo rm a tio n contact
Extended Programs in Medical Educa
tion, The University o f California School
o f Medicine, Rm. 569-U, San Francisco,
C A 94143; or call (415) 666-4251.
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Mediastinitis After Whiplash Injury
The authors describe a rare complication
of whiplash injury. Diffuse mediastinitis
resulted from extension of a whiplashinduced retropharyngeal abscess into the
thorax. Early diagnosis of the cervical
infection was masked by the simultane
ous presence of infectious mononucleo
sis. Aggressive surgical management
including bilateral thoracotomy was
required to resolve the septic course.
A review of the literature discusses
the pathogenesis of this complication
including the route of extension into the
mediastinum and supports the use of
aggressive surgical therapy to reduce the
associated mortality.
Les auteurs decrivent une complication
rare des lesions traumatiques de la
colonne vertebrale: une mediastinite dif
fuse qui a resulte de I'extension dans le
thorax d'un abces retropharynge consecutif a un coup de fouet cervical. Le dia
gnostic precoce d'infection cervicale a
ete masque par la presence surimposge
d'une mononucleose infectieuse. Un traitement chirurgical agressif avec thoracotomie bilaterale a ete necessaire pour
venir a bout de la sepsie.
Une revue de la litterature permet
d'elaborer sur la pathogenese de cette
complication, dont la voie d’extension
dans le mediastin. Elle soutient le recours
6 un traitement chirurgical agressif
comme moyen de reduire la mortality qui
y est rattachee.

Acute mediastinitis caused by extension
o f infection from the cervical region is
extremely rare. It is usually a complica
tion o f an odontogenic infection or
esophageal perforation during instrumen
tation.1'3 We report a case of acute medi
astinitis that occurred after a whiplash
injury sustained in a minor motor vehi
cle accident.
From the Division o f Surgical Infectious
Diseases, Department o f Surgery and the
Section o f Infectious Diseases, Department
o f Medicine, University o f Minnesota, Min
neapolis, Minn.
*Feltow, Medical Research Council o f
Canada
Accepted fo r publication July 17, 1985
Reprint requests to: Dr. O.D. Rotstein,
Ste. 404, 25 Leonard Ave., Toronto, Ont.
M 5T2R2
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Case Report

A 19-year-old man sustained a whiplash
injury in a minor motor vehicle accident. At
the local hospital’s emergency department he
complained of minor neck and back pain.
Neck films were normal and he was discharged.
Five days later, a sore throat and fever de
veloped. The patient’s family physician pres
cribed amoxicillin. Over the next 5 days he
experienced fatigue, increasing fever, chills,
jaundice and a tender swollen neck due to lymphadenopathy. The monospot test was posi
tive and he was admitted to hospital with a
diagnosis of infectious mononucleosis compli
cated by hepatitis. After 2 days of intravenous
fluid and prednisone therapy he was discharged
but was readmitted 2 days later with a sore
throat, dysphagia, an elevated temperature
(39.4°C), weakness, dyspnea, a diffuse
erythematous rash and increased neck swell
ing. Repeat neck roentgenograms were normal.
The leukocyte count was 20.0 x 109/L . Over
the next 24 hours, pleuritic chest pain and
diffuse abdominal pain with tenderness deve
loped. At a laparotomy for presumed ruptured
spleen no abnormalities were found. Postoperatively he became hypoxemic and had bilateral
pleural effusions (Fig. 1); 800 mL of purulent
fluid drained from the left pleural cavity. Stain
ing of the fluid revealed gram-positive
diplococci and gram-negative rods. The patient
was transferred to the university hospital 17
days after injury.
On admission, he complained of fever, dysp
nea, chest discomfort and left-sided abdomi
nal pain. A diffuse erythematous maculopapular rash was seen. The blood pressure was
160/50 mm Hg, heart rate 132 beats/min,
respiratory rate 32/min and his oral tempera
ture 38.3°C. The pharynx was mildly
erythematous with no exudate. There was
diffuse, tender, cervical lymphadenopathy,
particularly in the left supraclavicular fossa.
Chest examination revealed reduced breath
sounds in the left base with bilateral basilar
rales. Heart sounds were normal and the find
ings on abdominal examination were un
remarkable except for a well-healed incision.
Roentgenograms of the neck revealed air in
the subcutaneous tissues and slight swelling of
soft tissues (Fig. 2). The leukocyte count was
11.3 x 109/L (53% neutrophils, 18% band
forms, 18% lymphocytes). No atypical lym
phocytes were noted. Total serum bilirubin
level was 34.2 jimol/L with a normal alkaline
phosphatase level and mildly elevated serum
asp artate am in o tran sferase level. An
echocardiogram showed a small posterior
pericardial effusion, and the roentgenogram
after a Gastrografin swallow was normal. A
left chest tube was inserted and drained puru
lent material.

A diagnosis o f high esophageal perforation
was made. Cefamandole, clindamycin and
amikacin sulfate therapy was started. At oper
ation examination of the pharynx revealed mul
tiple punctate holes and a small laceration in
the left posterior hypopharynx just above the
laryngeal inlet. Purulent material could be
expressed by pressure on the posterior pharyn
geal wall. The neck was explored through an
incision along the anterior border of the left
sternomastoid muscle. Purulent material was
found in the retroesophageal space and was
drained with Penrose drains. A right
thoracostomy tube was placed to drain the
right-sided empyema and the pericardial cavity
was drained through a transxiphoid approach.
Three substernal mediastinal drains were

FIG. 1—Diffuse widening of mediastinum
and bilateral pleural effusions.

FIG. 2—Lateral neck roentgenogram shows
air in subcutaneous tissues (arrow), loss of cer
vical lordosis and mild soft-tissue swelling.
These are findings compatible with retro
pharyngeal abscess.
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inserted through a subxiphoid incision and
advanced to the base of the neck. Culture of
the pleural fluid grew Eikenella corrodens,
Streptococcus intermedius and Peptococcus
magnus. Cefoxitin replaced cefamandole in the
antibiotic regimen to cover the E. corrodens.
Postoperatively, the patient remained sep
tic with fever, tachycardia, an increased cardiac
output and reduced systemic vascular
resistance. On postoperative day 6, a swelling
in the right supraclavicular region was incised
and drained 30 mL of purulent material that
cultured S. intermedius and Propionibacterium
acnes. Repeat computed tomography revealed
a widened mediastinum, an appearance con
sistent with the presence of undrained pus (Fig.
3). Eight days after the first operation, the
patient underwent a left thoracotomy with
decortication of the left lung, replacement of
the substernal drainage system and bilateral
neck explorations. The mediastinum was
entered through an incision anterior to the aor
tic arch and a small amount of purulent
material was drained. Cultures again grew E.
corrodens and S. intermedius. The patient
became afebrile for several days but sepsis
again developed. Right pleural decortication
was undertaken and the mediastinum was
opened both anteriorly and posteriorly and
drained with chest tubes. There was no large
collection of pus. The mediastinal fluid grew
m ethicillin-resistant coagulase-negative
staphylococci.
The patient remained febrile with leukocy
tosis but the fever gradually resolved over 3
weeks. He was treated with vancomycin, clin
damycin and gentamicin for 2 weeks, then with
vancom ycin alone for an o th e r week.
Amphotericin B (0.5 mg/kg daily) was added
empirically 6 days after operation for 21 days
because of his persistent febrile state. His
recovery was somewhat delayed by nausea,
abdominal discomfort and food intolerance but
this resolved and he was discharged home 36
days postoperatively.

Discussion
It has been reported1,4 that 22% of

mediastinal infections originate in the
neck. Three major routes of communica
tion allow spread of infection from the
cervical region into the mediastinum:5
the retropharyngeal space, the perivascu
lar space and the pretracheal space.
Pearse1 reported that the retropharyn
geal space was involved in 71 % o f cases
of mediastinitis that occurred after cer
vical suppuration while spread by way of
the pretracheal and perivascular spaces
was found in 8% and 21% of instances
respectively. Most of the cases in the liter
ature are due to spread of an odontogenic
infection or extension of a retropharyn
geal abscess caused by traumatic perfo
ration of the oropharynx.
Our patient represents one of the rare
cases of mediastinitis following cervical
flexion-hyperextension injury.4,6-10 These
injuries may cause perforation o f the
pharynx or cervical esophagus by one of
the following three m echanism s:6' 8
pinching of the posterior wall between
adjacent vertebral bodies as they snap
back during the flexion phase; breakdown
of the posterior pharyngeal tissues con
tused during hyperextension; and direct
injury by being impaled on a cervical
osteophyte or fracture dislocation. Our
patient likely bruised the posterior
pharynx and sustained a small mucosal
laceration during hyperextension. The
resulting inflammation progressed to a
retropharyngeal abscess and subsequently
extended by way of the retroesophageal
space into the mediastinum. Although it
is possible that the posterior pharynx was
injured during endotracheal intubation,
this is unlikely since our patient’s symp
toms began before his laparotomy and
the attending anesthetist noted that intu
bation was uncomplicated. Although two
groups4,8 have warned that the onset of

FIG. 3—Computerized tomogram of upper chest revealing markedly abnormal mediasti
num and bilateral pleural effusions.

fever and neck swelling after a whiplash
injury should alert the physician to the
possibility of this complication, the diag
nosis in our patient was masked by the
simultaneous presence of infectious
mononucleosis. This was diagnosed ini
tially by monospot test and confirmed by
viral serology.
The bacteriologic features of the medi
astinitis and neck abscess were consistent
with an oropharyngeal source for this
infection.11 Eikenella corrodens, S. inter
medius and P. magnus are all components
of the normal oral flora of man. Eikenella
corrodens has previously been reported
only once in mediastinitis,12 probably
because its frequency in m outh flora is
low and because it is a fastidious microor
ganism that may be overlooked with rou
tine culture methods.13 The E. corrodens
isolated in our case was resistant to clin
damycin and aminoglycosides and sensi
tive to cefoxitin. This is the typical pat
tern for this microorganism14 and was
the basis for adding cefoxitin to the
antibiotic regimen. An aminoglycoside
was continued through most of the
patient’s stay in the intensive care unit,
even though a sensitive facultative gram
negative bacillus was never isolated. Its
use was probably unnecessary but it was
continued because of the prolonged
manifestations of sepsis.
Mediastinitis after cervical suppuration
is associated with a high death rate. Stan
dard therapy consists of antibiotics, sup
portive hemodynamic and nutritional care
and surgical drainage. Death almost
always occurs when the surgeon attempts
to drain a diffuse mediastinal infection
originating in the neck by a cervical inci
sion. Although the posterior mediastinum
can be exposed through the neck down
to the level of T4-6, this approach is
clearly inadequate when diffuse mediasti
nitis is present. Our case demonstrates
this point. After a failed attempt to drain
the mediastinum by neck exploration and
substernal irrigation tubes, a right thora
cotomy with anterior and posterior medi
astinal drainage reversed our patient’s
persistent septic course. The literature
also supports this contention. Thirty case
reports1,4-10,12,15-24 in which mediastinitis
followed cervical infection were available
for review. Death occurred in 40% (12)
of these cases and was due to sepsis in all.
Eleven of the 12 patients were treated by
cervical exploration alone without thora
cotomy. Among the 18 survivors, 9 had
thoracotomies for drainage, usually after
a neck exploration failed to improve the
patient’s status. The other nine survived
with neck exploration and transcervical
drainage of the superior mediastinum.
Interestingly these patients usually had
well-loculated collections as defined by
computed tomography, roentgenography
with contrast or operation. This differen
tiation between a well-defined “ mediasti-
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nal abscess” and a more diffuse “ phleg
monous mediastinitis” has been
previously made by Neuhof.2 As a
general approach to these patients, we
believe that if a well-defined superior
mediastinal collection is found by com
puted tomography or contrast radio
graphy, transcervical drainage of this col
lection at the time of neck exploration
may be attempted. Failure of the patient’s
sepsis to resolve, or progressive mediasti
nal involvement demonstrated radiologically, indicates the need for thoracotomy
and open mediastinal drainage. Diffuse
mediastinal involvement when the patient
presents initially is an indication for early
thoracotomy.
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Impact on Surgery of Preoperative Localization
of Parathyroid Lesions
With Dual Radionuclide Subtraction Scanning
from the combined thyroid and para
thyroid thallium image.
In this paper, we describe our scanning
technique and the results obtained in
patients who underwent surgery for
hyperparathyroidism. The impact on the
surgical procedure of the correct preoper
ative localization of parathyroid ade
nomas is also discussed.
Methods
The study comprised 20 patients with
a clinical diagnosis of hyperpara
thyroidism who were subjected to surgery
after parathyroid scanning. Preopera
tively, the condition was considered to be
primary hyperparathyroidism in 13
patients and secondary in 7. Only one
patient did not have hypercalcemia, but
primary hyperparathyroidism was sus
There are usually four parathyroid glands pected because of recurrent renal calculi
in humans, located close to or within the and hypercalciuria.
The scanning procedure used in the
thyroid gland. However, the number and
location can vary. It may be difficult to first four cases was similar to that de
recognize parathyroid from other tissue scribed by Young and associates.2 Only
and a normal from an abnormal gland by the neck was scanned in these patients.
Dans une tentative pour localiser des
gross inspection during operation. Subsequent patients were imaged by a
lesions parathyroi’diennes en preoperaIntraoperatively, sampling of tissues for modified technique currently in use. After
toire, une scintigraphie au thallium et au
histologic proof is frequently required. It the intravenous administration of 80
technetium radioactifs a 6t6 pratiquee
is not surprising, therefore, that surgery to 100 MBq of sodium pertechnetate
chez 20 patients prgsentant des signes
for hyperparathyroidism can be very tedi Tc 99m, 20 minutes are allowed for the
cliniques d'hyperparathyroi'die. Sur 11
ous, sometimes requiring considerable radionuclide to accumulate in the thyroid
patients chez qui la chirurgie a revele un
cervical dissection and mediastinal explo gland. The patient then lies supine under
adenome parathyroidien unique, la scinti
ration.
the pin-hole collimator of the scintillation
graphie avait correctement localise la
Preoperative localization of parathy camera and 100 to 120 MBq of thallous
lesion dans 10 cas; chez le dernier
roid lesions would greatly simplify the chloride T1 201 is given intravenously.
patient, la lesion se trouvait dans le
surgical management. Recently, a new Immediately afterwards, alternate
m£diastin non examine par scintigraphie.
dual radionuclide imaging procedure that 1-minute thallium and technetium images
uses radioactive thallium and technetium are obtained for the neck to a total of 20
has been described and reported to be suc minutes. Subsequently, images of the
From the *Department of Nuclear Medi
cessful in localizing parathyroid lesions, upper mediastinum are obtained in a simi
cine, j Department o f Surgery and
XDepartment of Pathology, Health Sciences particularly adenomas.1'3
lar manner. All images are recorded dig
Centre, Memorial University of Newfound
Intravenously administered radioactive itally by computer using 64 x 64 matrix
land, St. John’s, Nfld.
thallium is taken up by both the thyroid frames. During the procedure, the patient
gland and the parathyroid lesion, hence must remain perfectly still. For the neck,
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In an effort to localize parathyroid lesions
preoperatively, scanning with radioactive
thallium and technetium was performed
in 20 patients considered clinically to
have hyperparathyroidism. In the 11
found at surgery to have single
parathyroid adenomas, scanning cor
rectly localized the lesion in 10; in the
other patient the lesion was in the
unscanned mediastinum. Preoperative
scanning was not as rewarding in the
seven patients with parathyroid hyperpla
sia. A thyroid lesion was the source of
an abnormality seen on the parathyroid
scan in one patient, while neck scanning
and surgical exploration were negative in
another. Comparison of the patients who
had parathyroid adenomas localized in
the neck with a control group of similar
patients who did not undergo preopera
tive scanning showed that the average
surgical time was reduced by 50% with
preoperative localization and there was a
decrease in the number of non
parathyroid tissue biopsies.

Dans les sept cas d'hyperplasie parathyroidienne la scintigraphie preop£ratoire
n'a pas connu des r£sultats aussi satisfaisants. Chez un patient, une lesion
thyroidienne 6tait a I'origine de I'anomalie observee a la scintigraphie parathyroTdienne alors que dans un autre cas, la
scintigraphie et I'exploration chirurgicale
du cou se sont averees negatives. La
comparaison des patients qui souffraient
des adenomes parathyroidiens localises
dans le cou avec un groupe t^moin com
pose de patients similaires mais qui n'ont
pas eu de scintigraphie preop£ratoire a
revele que le temps moyen de chirurgie a
ete reduit de 50% grace a la localisation
pr6operatoire. On a constat^ egalement
une diminution du nombre des biopsies
de tissu non parathyroidien.

Correction for technetium comptom scat
ter is unnecessary as the contribution of
compton to the thallium image with these
amounts of radioactivity is small. The
mediastinal images are subsequently
processed in the same manner. Focal
residual activity on the subtracted image
is interpreted as a parathyroid lesion.
For proper subtraction, there should be
perfect alignment of the thyroid gland on
the thallium and technetium images, as
motion creates artefacts. Gross motion
can be corrected by computer reposition
ing of the images if necessary. By adopt
ing the alternate imaging technique, we
strive to obtain a perfect anatomical
alignment on the two sets of images.
One patient had negative neck and
mediastinal scans and a negative surgical
exploration of the neck. Before mediasti
nal exploration was attempted, repeat
mediastinal scanning was performed
using thallium alone, because a substernal thyroid gland was not present and
subtraction of thyroid activity would not
have been necessary.
The effect of correct localization on the
surgical procedure was evaluated. The
operative time and the number of
intraoperative nonparathyroid tissue
biopsies perform ed were obtained
retrospectively from the clinical records.
The findings in the patients who had
preoperativ e scan lo calizatio n of
parathyroid adenomas in the neck were
compared with those in a control group
of nine consecutive patients in whom
similar surgery was performed before
scanning was available.
Results
Primary Hyperparathyroidism
The correlation between the scans and
surgical findings in 13 patients who were
considered preoperatively to have primary
hyperparathyroidism are summarized in
Table I. At surgery, single parathyroid
adenomas were found in the neck in nine
patients and in the thymus in two. In one
patient a follicular adenoma of the

thyroid with an occult sclerosing papillary
adenocarcinoma was discovered, and in
another no neck lesion was detected.
The scans correctly localized all nine
single parathyroid adenomas in the neck
(Fig. 1).
In one patient with a parathyroid ade
noma located in the thymus, the initial
scans of the neck and mediastinum were
negative. Surgical exploration of the neck
was also negative. A repeat mediastinal
scan with thallium alone showed a focal
area of uptake, 5 cm below the supraster
nal notch, immediately to the right of the
midline (Fig. 2). The focal uptake had
almost completely disappeared 25 to 30
minutes after thallium administration (the
initial mediastinal scan was started after
the neck scan was completed but the
repeat scan was started immediately after
the intravenous administration of the
201T1). At operation the parathyroid ade
noma was resected from the thymus, at
the site identified on the scan.
In the second p atien t with a
parathyroid adenoma located in the thy
mus, the neck scan was negative and
mediastinal scanning was not done. At
surgery, neck exploration in itself was
negative but the parathyroid adenoma
was found and resected from the thymus
through the neck incision.
The neck scan showed a large focal
abnormality in the lower part of the right
thyroid lobe of one patient. The lesion
was cold on the 99mTc thyroid scan, but
it accumulated thallium. Because of its
large size and the lack of hypercalcemia,
a thyroid lesion was suggested, although
the possibility of a parathyroid adenoma
could not be ruled out. The patient was
under investigation for recurrent renal
calculi and hypercalciuria. At surgery, a
thyroid adenoma with an occult scleros
ing papillary adenocarcinom a was
resected, but no parathyroid lesion was
found.
Both neck scan and surgical explora
tion were negative in one patient. The
mediastinum was neither scanned nor sur
gically explored. Here, as in the two
patients with parathyroid adenomas in the

thymus, neck exploration verified the nor
mal scan results obtained for the neck.
Secondary Hyperparathyroidism
In seven patients who were thought
preoperatively to have secondary hyper
parathyroidism, the scan results were not
as helpful. Parathyroid hyperplasia was
found at neck surgery and no patient had
mediastinal exploration.
A scan correctly localized all four
hyperplastic parathyroid glands in one
patient (Fig. 3). In another in whom three
glands and part of the fourth had previ
ously been resected, the remaining seg
ment was localized on the scan (in
retrospect). In a third patient, a scan
localized two of four hyperplastic glands.
In another, one of three hyperplastic

FIG. 1—Images obtained in patient with
parathyroid adenoma in neck. Upper left is
summed thallium image (TL201), upper right
is summed technetium image (TC99M) and
lower left is difference between them. Sub
tracted image shows parathyroid adenoma
located in region of left thyroid lobe, medially
above level of isthmus.

Table 1-Scan Correlation With Surgical Findings
Surgical results

No.

Scan results

Single parathyroid adenomas
In neck
In thymus

11
9
1
1

Correct localization in all cases
Correct localization*
Mediastinum not scanned!

Follicular adenoma of thyroid with occult sclerosing
papillary adenocarcinoma
Negative neck exploration

1
1

False positive
Negative neck scan!

‘ Initial neck and mediastinal scans were negative. Subsequent surgical exploration of neck was also
negative. Repeat mediastinal scan with thallium only was positive.
tNeck scanning was negative. Mediastinum was not scanned. Surgical exploration of neck area was
negative but parathyroid adenoma was resected from thymus through neck incision.
^Mediastinum was neither scanned nor explored.
58

FIG. 2—Summed thallium image of upper
mediastinum showing area of focal uptake,
located 5 cm below suprasternal notch and
immediately to right of midline; at surgery,
parathyroid adenoma was readily identified in
thymus in exactly that position.
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glands was identified but the fourth gland
was not found in the neck during surgery.
In a fifth patient, one of three hyperplas
tic parathyroid glands was localized; the
fourth was histologically normal. A sixth
patient had only one of four hyperplas
tic glands identified and in the last patient
no glands were localized.
Length o f Operation
The operative times in the nine patients
with parathyroid adenomas in the neck,
localized preoperatively, ranged from 40
minutes to 120 minutes (mean 61
minutes). In the control group the oper
ative time ranged from 70 minutes to 220
minutes (mean 122 minutes).
The number of nonparathyroid sam
ples examined by frozen section in each
of the nine patients with parathyroid ade
nomas in the neck, localized by scanning,
did not exceed one. In the control group
the number ranged from zero to nine per
patient.
Discussion
The results of parathyroid scanning
with subtraction radionuclide imaging are
excellent in patients with primary hyper
parathyroidism, but not as rewarding, in
our hands, in those with secondary hyper

parathyroidism. Our results are in agree
ment with those reported elsewhere.2
Normal parathyroid glands are not visual
ized by the method described.
When a diagnosis of primary hyper
parathyroidism is made clinically, it is
now possible to localize the parathyroid
adenomas before surgery. In our patients
whose parathyroid neck adenomas were
localized preoperatively, the average time
of surgical exploration of the neck was
half that in a control group of patients
whose neck adenomas were not localized.
During exploration, the surgeon
usually biopsies tissue suspected o f being
parathyroid for examination by frozen
section. The process is repeated until posi
tive identification is achieved — quite a
difficult task by gross inspection of the
tissues during surgery. In our patients
with parathyroid adenomas in the neck
and preoperative localization, the ade
nomas were identified immediately at sur
gery. Nonparathyroid tissue was biopsied
in some cases in an attempt to locate other
parathyroid glands that were not involved
and hence not localized on the scan. The
present approach is to explore only the
side on which the adenoma has been
located preoperatively and not to biopsy
normal glands. With preoperative locali
zation, the task of the surgeon and
pathologist is greatly simplified.

When primary hyperparathyroidism is
diagnosed, negative neck scanning with
a reliable imaging technique should be
considered important. Neck exploration
was negative in three of our patients with
negative neck scans, although in one a
parathyroid adenoma was found and
resected from the thymus through the
neck incision.
After neck scanning is completed,
mediastinal scanning is usually performed
at the same sitting. When the parathyroid
adenoma is in the mediastinum, a false
negative scan could result because of
delayed imaging if the washout of thal
lium from the lesion is fast. This fast
washout occurred in one of our patients.
Therefore, when routine neck and medi
astinal imaging are negative, our present
approach is to repeat the mediastinal
scan, starting immediately after thallium
adm inistration. W hen a substernal
thyroid is not present, the administration
of sodium pertechnetate Tc 99m can be
omitted, since subtraction o f the thyroid
from the image would not be necessary.
Cold thyroid nodules and vascular
lesions can give false results because they
can accumulate thallium but not tech
netium. Careful palpation of the thyroid
gland and restriction of the scanning
procedure to patients in whom a diagno
sis of hyperparathyroidism is well estab
lished clinically would limit the incidence
of false-positive results.
Why parathyroid lesions take up radio
active thallium is not clear. The thallous
ion is an analogue of the potassium ion,
and, like potassium, is extracted by cells
upon perfusion. The high cellularity and
vascularity present in parathyroid ade
nomas may be contributing factors.2
These factors are nonspecific and could
lead to uptake in nonparathyroid lesions.
The failure to demonstrate some hyper
plastic parathyroid glands is not under
stood.
Conclusions
The dual radionuclide technique with
subtraction imaging is a reliable method
of detecting parathyroid adenomas. The
preoperative localization o f parathyroid
adenomas is beneficial in shortening the
operative time and in reducing dissection
and the number of frozen sections
required.
References
1. FERLIN O, Borsato N, P e r elli R, et al: Technetiumthallium subtraction scan: a new method in the preopera
tive localization o f parathyroid enlargement (abstr). Eur
J N ucl M ed 1981; 6: 54
2.

FIG. 3—Upper row shows summed thallium and technetium images. Lower row shows
subtracted images with and without outline of thyroid gland. Four hyperplastic parathyroid
glands are demonstrated on subtracted images as areas of increased thallium uptake.

y o u n g AE, G a u nt JI, c r o f t DN, et al: Location of
p a rath y ro id adenom as by th allium -201
and
technetium-99m subtraction scanning. Br M ed J [Clin Res]
1983; 286: 1384-1386

3. F erlin G, Borsato N, C a m era n i M, et al: New per
spectives in localizing enlarged parathyroids by technetiumthallium subtraction scan. J N ucl M ed 1983; 24: 438-441

VOLUME 29, NO. 1, JA N U A R Y 1986 / THE CANADIAN JOURNAL OF SURGERY

59

P e t e r A. Sa lm o n , m d , p h d , f r c s c , f a c s
A

Failure of Gastroplasty Pouch and Stoma Size
to Correlate With Postoperative Weight Loss
At the University of Alberta hospitals
patients who underwent gastroplasty —
horizontal, vertical with multistranded
nylon banding of the stomas and vertical
banded with Teflon reinforced stomas —
have been followed up for over 2 years.
Pouch volume ranged from 25 to 30 mL.
Pouch volume and stoma size were
measured radiologically 2 years after
operation and correlated with the percen
tage excess weight loss. Any patient fail
ing to lose at least 40% of the excess
weight was considered a failure.
There was no consistent correlation
between pouch or stoma size and per
centage excess weight loss for any of
the three procedures studied. The failure
rate for patients included in the study
group was 33.3% for horizontal, 32.4%
for vertical and 32.8% for vertical
banded gastroplasty.
The probable reason for the lack of
correlation is that some patients change
their diets so as to subvert the restric
tion imposed by the gastroplasty.
Les patients des hopitaux affilies a I'Universite d'Alberta qui ont subi une gastroplastie (horizontale, verticale avec ban
dage du stoma 6 I'aide de multifilaments
de nylon, ou verticale avec bandage du
stoma h I'aide de Teflon) on fait I'objet
d'examens de surveillance sur une
periode de 2 ans. Le volume du sac
variait de 25 h 30 mL. Le volume du sac
et la taille du stoma ont ete mesures & la
radiographie 2 ans aprds I'operation et
6taient proportionnels au pourcentage de
perte de poids excedentaire. Tous les
patients qui n'ont pas reussi a perdre au
moins 4 0 % d'excgs de poids ont ete
consid ers comme un echec.
On n'a constate aucune correlation
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constante entre la taille du sac ou du
stoma et le pourcentage de perte de
poids excedentaire pour aucune des trois
interventions etudiees. Les taux d'echecs
ont 6te de 33.3% pour les patients trai
l s par gastroplastie horizontale, 32.4%
dans les cas de gastroplastie verticale et
32.8% pour les gastroplasties verticales
avec bandage.
La raison probable du manque de cor
relation est que certains patients changent
leur regime, renversant les restrictions
telles qu'imposees par la gastroplastie.

Gastroplasty, a method of inducing
weight loss by limiting ingestion of food,
is said to achieve its effect through the
creation of a small pouch at the cardia of
the stomach, emptying through a restrict
ing stoma into the distal stomach. In our
hands the operation, whether horizontal,
vertical or vertical banded, has been suc
cessful initially. However, during the
second postoperative year failures have
become more frequent and a number of
patients have regained a substantial
amount of the lost weight. Surgeons who
have measured pouch and stoma sizes in
the postoperative period have noted an
increase in both, especially after horizon
tal gastroplasty and vertical gastroplasty,
although the increase was less marked in
the latter. Failure to lose weight has often
been attributed to these changes. The ten
dency, therefore, has been to reduce gas
troplasty pouch and stoma size, the pouch
being constructed on the minimally dis
tensible lesser curvature and the stoma
reinforced and lengthened.

Gastroplasty
procedure
Horizontal
Vertical
Vertical banded

It has been my observation that in
horizontal gastroplasty pouches with
nylon-reinforced stomas ranging in
volume from 25 to 60 mL and followed
up for 3 to 6 years, the initial pouch size
did not correlate with initial weight loss
or subsequent failure ra te .1 Some
patients with larger stomas and pouches
achieved satisfactory weight loss that was
maintained, but others with a small pouch
and stoma, although achieving initial
weight loss, subsequently regained
weight. The question is, What is the role
of pouch and stoma size in the results
achieved after restrictive operations for
weight loss?

+■
A 4

Patients and Methods
Both women and men were included in
this survey, in a ratio of 8:1.
There were three separate groups: 54
patients who underwent horizontal gas
troplasty, 61 patients who had a vertical
gastroplasty and 34 patients who had ver
tical banded gastroplasty. In the first two
groups, stomas were reinforced with mul
tiple strands of no. 1 nylon and in the
banded group with 6-mm polytetrafluoroethylene (PTFE). The opera
tive techniques for these procedures have
already been described.2,3 Pouch
volumes in all cases were between 25 and
30 mL.
All patients were followed up routinely.
Weight loss was recorded as a percentage
of excess weight lost. Films of the upper
gastrointestinal system were obtained 60
days after operation and annually there
after. This procedure was performed by

Table 1—Patients Who Failed to Achieve Initial Loss
of 40% Excess Weight
Weight loss,%
No. of
patients
Mean
Range
5
31.6
18-39
5
28
22-39
5
27
21-33

% of total
patients
8.9
8.0
8.8
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a single radiologist, expert in the techniques of demonstrating the stoma and

of distending the pouch with gas granules
to determine its maximum size. Pouch

size, as seen radiologically, is reported in
centimetres squared and stomal diameter
in millimetres. The number of patients in
each group who had sequential roent
genography was less than the total:
horizontal gastroplasty 38, vertical gas
troplasty 45, vertical banded gastroplasty
21. Pouches that developed multiple
stomas were not included in the main
body of data but are presented
individually.
In this study, the percentage of excess
weight lost was related to pouch and
stoma sizes 2 years after operation. The
results have been arbitrarily divided into
two groups, success and failure. A patient
was considered a failure if the excess
weight loss achieved or maintained was
less than 40%. This criterion was selected
because all patients requesting further
surgery to improve weight loss had excess
losses near or less than 40%.
Our results were presented as a series
of bar graphs with pouch and stoma sizes
on the Y axis and percentage excess
weight loss on the X axis. A space at 40%
excess weight loss divides the successes
from the failures.
Results

X EXCESS WEIGHT LOSS

FIG. 2—Horizontal gastroplasty. Successes and failures related to stomal diameter.

T a b le II-- P o u c h a n d S t o m a S iz e s
G a s t r o p la s t y
p ro c e d u r e
Pou ch es, cm 2

S to m a s , m m

H o r iz o n t a l

S u c c e s s , cm

F a ilu r e , cm

M ean

Range

M ean

Range

3 3 .0 8

5 -7 6

3 0 .2 1

1 0 -9 0

V e r t ic a l

3 4 .9 4

8 -8 1

2 2 .0 8

8 -3 6

V e r t ic a l b a n d e d

3 2 .6 3

1 0 -5 8

2 1 .8 0

1 2 -4 2

H o r iz o n t a l

7 .0 8

3 -1 6

7 .5 7

4 -2 0

V e r t ic a l

6 .8 1

3 -1 2

6 .3 1

4 -1 0

V e r t ic a l b a n d e d

5 .8 1

3 -1 0

7 .0 0

3 -1 2

All patients lost weight, the maximum
loss being achieved within 12 to 18
months. However, 8% of each group
failed to lose at least 40% excess weight
(Table I). Subsequently, all patients
regained weight, some a minimal amount,
and a small number approached preoper
ative weights. Figures 1 and 2 show that
for horizontal gastroplasty there is little
difference in pouch and stoma sizes
between the successes and failures. This
is also true for vertical (Figs. 3 and 4) and
vertical banded (Figs. 5 and 6) gas
troplasties.
It is obvious from the figures that some
patients with relatively large stomas and
pouches achieved and maintained a satis
factory weight loss, while others with a
small stoma and pouch failed.
Table II compares mean sizes and
ranges for each procedure. These data
confirm the impressions obtained from
the graphs. Mean pouch size is, if any
thing, larger in the successes than the
failures for all three groups. Mean stoma
sizes are almost identical within each
group, the horizontal gastroplasties hav
ing the largest diameter and the vertical
banded the smallest. The one larger
diameter stoma (12 mm) in the latter
small group of failures skews the mean,
giving an artificially high value.
The failure of pouch and stoma size to
correlate with weight loss was further
emphasized when a few patients (Table
III) acquired a second stoma due to
staple-line failure. Of this group, six are
still deemed successes and five failures.
The failure rates of patients followed
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up roentgenographically and in the total
groups are shown in Table IV. Percent
failure rates are almost identical.
Patients in the failed group often return
seeking further treatment for persistent
obesity. In group 1,11 have undergone
gastric bypass and 2 intestinal bypass, and
1 had a vertical banded gastroplasty that
failed and was subsequently converted to
a gastric bypass (25% converted). Follow
ing vertical gastroplasty, five patients had
conversion to gastric bypasses and two to
intestinal bypasses (11% converted).
Three patients had vertical banded gas
troplasties that failed and were converted
to gastric bypasses (8% converted).

tr

D isc u ssio n

-A

If one accepts the premise that gastric
restrictive procedures induce weight loss
by limiting intake of food, then the weight
loss, other things being equal, should be
directly related to the degree of restric
tion induced. Therefore, smaller, lessdistensible pouches and small, wellsupported stomas would appear to be the
criteria necessary to produce a uniform
and lasting weight loss. In a previous
paper1 I showed that reducing pouch
volumes from 60 mL to 20 to 25 mL
helped to reduce failure rates. Neverthe
less, in this series of small-pouch horizon
tal gastroplasties, the failure rate was
33.3%. Seventy-seven percent of failures
have been converted to other types of
weight loss operations that have success
fully induced further weight loss.
In the vertical gastroplasty group,
32.4% of gastroplasties failed and 35%
of these have already been converted to
other weight loss operations. The verti
cal banded gastroplasty group has a
32.4% failure rate and 27% of the gas
troplasties have been converted to gastric
bypass. It seems appropriate to ask,
“ What failure rate is acceptable?” A 32%
rate for horizontal, vertical and vertical
banded gastroplasties is high when com
pared with long-established intestinal
bypass (1%).3 Furthermore, with each
year of follow-up the number of failures
increases.
The following technical detail is worth
noting. It had been anticipated that ver
tical gastroplasty, with a longer stoma
channel associated with the PTFE band,
might result in greater and more
prolonged weight loss vis-a-vis the stoma
banded with nylon suture. There appears
to be little difference in results to date.
Why then are there conflicting results
and a lack of correlation between weight
loss and the imposed degree of restric
tion? The experience of this clinic indi
cates that patients ultimately learn to sub
vert the restriction on solid foods by
ingesting semi-solid or high caloric
liquids. Furthermore, chewed solid food
62
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FIG. 3—Vertical gastroplasty. Successes and failures related to pouch size.
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FIG 4—Vertical gastroplasty. Successes and failures related to stom al diameter.
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Table Ill-Patients With Two Stomas
Gastroplasty
procedure

No. of
patients

Horizontal

3

Vertical
Vertical banded

1
2

Success
% final excess
weight loss

Days
postop

No. of
patients

72
43
72
44
51
52

1035
1415
1394
1107*
660
1021

3
1
1

Failure
% final excess
weight loss

Days
postop

23
22
24
35
'9

1062*
1055*
1349*
786*
589*

'Converted to gastric bypass.
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may be flushed through the stoma by con
comitant ingestion o f fluids. Once this
habit is established, few patients can be
persuaded to return to the more rational
eating habits that result in reversal of
weight gain or further weight loss.
The high early failure rate and the
number o f patients requesting further sur
gery prompted me, some years ago, to
give up horizontal, vertical and vertical
banded gastroplasties as weight loss
procedures.
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FIG. 6—Vertical banded gastroplasty. Successes and failures related to stomal diameter.

Table IV-Number of Failures in Patients Who Underwent
Roentgenography Compared With Total Group
Roentgenography
Total group
Gastroplasty
No. of
Failure,
No. of
Failure,
procedure
patients
no. (%)
patients
no. (%)
Horizontal
38
14(37)
54
18(33)
Vertical
45
13(29)
61
20 (33)
Vertical banded
21
5(24)
34
11 (32)
All patients followed up had upper gastrointestinal series. However, owing to the vagaries of clinical
research, only part had a study at 2 years. The table indicates that the failure rate was essentially
consistent across each group and that the patients who underwent roentgenography were not selected
to favour success or failure.
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So You Wanted to Do Surgery
and They Keep Talking About Research:
a Discussion for the Surgical Resident and Intern
Surgical residents and interns frequently
misunderstand the relation between sur
gery and research, and the contribution
of surgical research to clinical practice.
The problem is that the effects of
research must be viewed in the long
term. Once the resident can do this, the
importance of research to surgery is evi
dent and surgical research can be seen
for what it is, the growing surface of
surgery. Training to do surgical research
has many parallels with clinical training.
A core-training period in investigation
provides the resident with the right men
tal approaches to investigation so that
training in a specific area of research
may be done later. Surgical scientists
must be excellent clinicians as well as
scientists and so long training periods
are required. Four years of clinical prac
tice training and 3 of research training
are probably ideal. Shorter periods of
research training may be valuable for
many surgical residents, particularly
those who have had little research
experience. Training should be tailored to
the trainee's desired role in surgery.
Les residents et internes en chirurgie se
meprennent souvent sur le rapport qui
existe entre la pratique de la chirurgie et
la recherche en ce domaine, ainsi que
sur la contribution de la recherche 6 la
pratique Clinique chirurgicale. Le probleme resulte de ce que les effets de la
recherche doivent etre envisages £ long
terme. Une fois que le resident a appris a
penser de cette facon, I'importance de la
recherche pour la chirurgie devient pour
lui evidente et la recherche chirurgicale
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se revfele alors pour ce qu'elle est: l'6lement progressif de la chirurgie. La forma
tion en recherche chirurgicale offre plusieurs similitudes avec la formation
Clinique. Une p6riode de formation en
recherche procure au resident I'ouverture
d'esprit qu'il faut pour la recherche et le
prepare a entreprendre ulterieurement
une formation dans un secteur sp6cifique
de la recherche. Le chirurgien scientiste
se doit d'exceller en clinique comme en
science, de sorte que de longues p6riodes de formation sont necessaires. Quatre annees de pratique clinique et 3
annees de formation en recherche pr6sentent probablement lAquilibre ideal.
Une periode de formation plus courte en
chirurgie peut etre utile pour plusieurs
residents en chirurgie, particulierement
pour ceux qui possedent peu d'exp§rience en recherche. La formation devrait
etre modelee au role que le futur chirur
gien entend jouer dans sa speciality.

You are a clerk, intern or surgical resi
dent. You are in surgical training, are
about to enter it or are giving it serious
consid eration. You like surgical
problems, you like the direct approach of
surgery and you certainly like operating
or know that you will.
Your plans seem quite straightforward,
although you are uncertain of what will
happen at the end of your training. The
word research comes up and then keeps
coming up. On the residency application
form some schools ask you if you are
interested in research. In interviews, they
ask “ What are your long-term plans in
surgery?” Your friends say that what they
are looking for is a “ research” answer.
The word is that if you want to get into
training, you must say you are interested
in research. Already there are some pro
grams in which you have to do a year of
research. There’s talk that residents who
do research during their training have a
better chance of getting a job after.
Why is there all this talk about research
when all you want to do is surgery? It’s
annoying and confusing. If you have or

have had some of these thoughts, read on.
I shall try to give you some background
and answer some of the questions about
research that interns and residents often
raise.
W hat’s Research — What’s Surgery?
Research is a word that everyone thinks
they should know. So it’s often used by
those who don’t know what it means at
all. Moreover, the time scale of research
and its place in surgery is not understood.
People talk of surgery and research as if
they are two separate disciplines. To begin
to clear the confusion, we must under
stand the meaning and relation of these
terms.
Surgery is a discipline with several
facets. One is patient care. Another is the
training of doctors to be surgeons. The
final part of our discipline is the one that
asks and answers questions about how
good our patient care is, how good our
teaching is, and how the two may be
improved. That part of surgery, the ask
ing and answering part, is research — sur
gical research. It is not a separate dis
cipline, but an integrated, interwoven,
essential part of surgery. It is the grow
ing plate, the remodeller, the changer.
There are several reasons why this is
not obvious. Many surgeons are involved
only in the patient-care aspect of surgery.
It is easy to slip into the error of gener
alizing about the person who is your role
model to the discipline. That is somewhat
like the story of the blindfolded man feel
ing the elephant. The entire structure was
never perceived but was conceived vari
ously depending on the part felt.
Failure to appreciate the existence of
different time scales also inhibits under
standing of the role of surgical research
in the discipline of surgery. We tend to
think in short time scales. The longest
time scale experienced by a young person
is the residency training period of 4 to 7
years. But the time scale of research is
often decades. For example, 1928 was a
notable year in the history of gallbladder

VOLUME 29, NO. 1, JA N U A R Y 1986 / THE CANADIAN JOURNAL OF SURGERY

surgery since it was then that oral
cholecystography was described and gall
stones could at last be diagnosed with cer
tainty on a routine basis. But the death
rate in that year for cholecystectomy was
60 patients per 1000 operations; today, it
is only 1 to 2 patients per 1000 operations.
The change was the result of asking and
answering questions about clinical prac
tice (i.e., research). This is just one exam
ple. To fully appreciate the role and time
scale of research within surgery, take an
hour off, go to the library and examine
standard surgical texts of the 1920s and
the 1950s and compare them to a modern
text. It’s eye-opening. There were no use
ful implantable prostheses, there was no
transplantation and no nutritional sup
port, only rudimentary evaluation and
treatment of shock and cardiopulmonary
failure, no or limited antibiotics...and
on...and on. The list is long: the change
is surgical research. Oh, by the way, oral
cholecystography itself was developed by
a surgeon, Evarts Graham. There was a
real problem in the diagnosis of cholelithi
asis before 1928. Many people had
cholecystectomy for biliary colic-like
pain, but at operation were found to have
no stones. In most cases, patients were
not improved by such operations. Instead
of accepting the state of the art, Graham
asked and answered the question of how
surgical practice might be improved. The
point is that to understand the effect of
research in surgery, you must consider the
time scale of research. It is relatively long,
but its effects are far-reaching and longlasting.
Definition and Classification
of Surgical Research

Research means to look deeply into a
question (not to look “ again” ). It means
to answer a question using a group of
rules collectively referred to as the scien
tific method. There are many ways of
knowing. The scientific method is a way
of knowing about the physical world; its
advantage is that it results in conclusions
that can be accepted universally provided
its rules have been adhered to. If opera
tion A gives superior results to operation
B in Winnipeg, then, as long as the
method has been properly applied, this
will be true in Halifax, Toronto, Medi
cine Hat or Dawson or anywhere else. It
will be found to be so if it is tested again.
The advantages to patients of this way of
knowing over opinion or dogma are obvi
ous. Core training in research involves
learning this scientific method. Learning
the method is really training in thinking
or, if you like, mind training. Scientists
refer to this type of thinking as critical
thinking, as opposed to uncritical or
biased thinking.
What follows is my own classification.
It is just one possible classification; it is

structured to eliminate certain confusing
words. Surgical research is one type of
clinical research. Surgeons doing research
are surgical researchers, surgical investi
gators or surgical scientists. Clinical
research, and therefore surgical research,
differs from basic research. Clinical
research always has at its root interest in
the improvement of patient care. Basic
medical research has at its root the study
of biologic phenomena. A surgical inves
tigator interested in improving the treat
ment of shock might be studying stabili
zation of cell membranes by drugs. A
basic scientist interested in the phenome
non of cell membranes might be conduct
ing the same experiment as the surgical
investigator. But one is doing surgical
investigation, the other basic investiga
tion. The surgeon will, if his work is suc
cessful, take his findings from the labora
tory bench to the bedside treatment of
patients in shock. This is his purpose for
looking into the problem in the first place.
The basic scientist will turn his knowledge
into a better understanding of how the cell
functions. Clinicians do not do basic
science, nor are they basic scientists
because their motivations are different.
However, clinical research is very depen
dent on basic science, which is often the
source of new ideas for understanding or
attacking clinical problems.
Types o f Surgical Research
There are three kinds of clinical or sur
gical research: clinical epidemiology, tech
nologic reset,..!. <md scientific research.
Clinical epidemiology asks questions
about the natural history of disease or
about how effective our clinical methods
are. Clinical methods include diagnostic
and therapeutic techniques and also
methods of teaching doctors and patients.
We evaluate clinical methods by “ clini
cal trials” in which the new diagnostic or
therapeutic methods are tested against
standard methods. Clinical trial methods
are a form of the scientific method
referred to earlier; special training is
required to learn this type of critical
thinking. Clinical epidemiology also exa
mines the natural history of disease.
Recently, it was recognized that many
patients who have had gallstone pancrea
titis will suffer a second attack within a
short time. This attack is often severe,
sometimes fatal. This important finding
has started to change surgical practice.
Most surgeons now agree that early sur
gical treatment for gallstones after an
attack of pancreatitis is advisable. No one
surgical practitioner is likely to make such
an observation. Such observations are
made by asking and answering questions
— surgical epidemiology questions.
The second type of surgical research is
technologic research. This may be
thought of as methods and materials

development. Much surgical research is
of this type. Development and testing of
implantable materials and of new oper
ative techniques (e.g., new techniques
employing staplers) is technologic
research. Surgical researchers are fre
quently involved in developing special
instruments, often working with biomed
ical engineers. Such instruments may be
used to measure flows, test tissue
strengths or to measure structural
strength or activity of organs or tissues.
Surgeons often develop new instruments
for use in the operating room. These are
just a few examples of technologic inves
tigation. This type of investigation is
often done in laboratories; while human
subjects are frequently used in techno
logic research, it is often necessary to use
animals. For instance, when an instru
ment such as a stapler is first used, it is
tried out in a model of a human (i.e., an
animal model). If you are a bit confused
now about the two types of research dis
cussed so far, just remember that tech
nologic research is development of
methods and materials. The clinical use
fulness of such techniques is tested in that
part of clinical epidemiology referred to
as clinical trials.
The third kind of research is called
scientific research, which asks questions
about the mechanism of disease or the
norm al physiology or biochem istry
underlying that disease. If you ask “ Why
does retransfusion after prolonged
hypotension due to hemorrhage not result
in patient survival?” , you are asking a
scientific question. To answer that ques
tion, you may need to question how cells
operate normally and how they respond
to certain types of injury. Surgeons have
made many important contributions of
this type of research and these have
resulted in major clinical developments in
the treatment of shock, burns, gastroin
testinal, cardiovascular and neurologic
diseases, just to name a few. Scientific
research is powerful because understand
ing the mechanism of disease often leads
to new treatment strategies. This type of
research is performed using either humans
or animal models. Surgeons also contrib
ute to scientific research that does not
seem to relate directly to surgical
problems because their surgical training
makes them excellent at modelling. A
good example of this is Banting’s discov
ery of insulin.
Clinical epidemiology, technologic
research and scientific research may ask
different types of questions, but they are
interdependent. The products of scientific
and technologic research must be tested
by clinical trials to determine their value.
Studying the natural history of disease
often leads to questions about mechan
isms of disease (i.e., scientific research).
Technologic research often is the spring-
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board for advances in scientific research.
Study of the natural history of disease or
scientific research advances may require
new technologies. This flow back and
forth between different types of research
efforts is what investigators mean when
they talk of “ bedside to bench to bed
side” (i.e., from the patient problem to
the laboratory bench and then back to the
patient for tests of efficacy). The relation
between the various types of research is
shown in Fig. 1. The different types of
research have several features in common:
they all use the scientific method, so to
do any of them, one has to learn critical
thinking; also, clinical research of all
three types is related to, based on and
stimulates basic research.
Research Studies and
Descriptive Studies

Not everything published in the litera
ture is research. Some studies review the
research literature and draw a field
together. These reviews are often very
valuable. Some studies are termed
descriptive. Case reports, of interesting,
rare individual cases or a series of one
class (e.g., all the gastric ulcers seen in one
institution over 20 years) are descriptive
studies. Description may be one phase of
a research study. For instance, it may be
necessary to develop a data base and
begin to gather data before asking ques
tions. Descriptive studies may be valua
ble, particularly when rare or unusual
cases are described or when a surgical
field is developing rapidly. But descrip
tions of clinical case material alone do not
constitute research. Descriptive studies
can be, and unfortunately frequently are,
repetitious, adding little to what is avail
able in standard texts. A balance between
research studies and descriptive studies is
required. In my opinion, there is an
imbalance in the surgical literature. Do
not confuse research and descriptive
studies just because they are both pub
lished. If it’s good research, it will ask and
answer a question convincingly. In
descriptive studies, the questions often
come at the end of the study and can
rarely be answered decisively by the study.

find exciting. Most good researchers have
an intense desire to investigate and love
doing it. How will you know if you will
like research? Do you have the qualities
of inquisitiveness, thoroughness and per
sistence? Is the unknown a challenge to
you or do you shrink from it? Can you
sense the excitement of discovery or do
you find it difficult to imagine? Such
questions may help, but in the end, you
must really do research to know whether
it’s for you. Once you know, do it
because you like it and not as an obliga
tion or as part of getting a job; that can
be a disaster. You will be unhappy and
so will the people who brought you on.
On the other hand, if you do like it,
there are great personal rewards and satis
factions in investigation. Your abilities to
design and conduct studies will improve
with experience and you will see your
effectiveness as a surgical investigator
increase. You will develop national and
international associates, engage in
cooperative ventures and you will have
your own students. These are great pleas
ures in addition to the satisfactions of
clinical practice.
• Get trained to the level of excellence
in surgical patient care. Above and before
all else, you must be an excellent clinical
surgeon both inside and outside the oper
ating room. You must have the respect
of your peers and residents as a clinician.
Consider restricting your clinical practice
to one area within your specialty and base
that restriction upon your research

interest. In that way, you will be a clini
cal authority, as well as a research
authority.
• Take as much time in training as you
need to get the skills that you require for
your work in clinical practice and
research. Once you start in practice, it will
be difficult to get further training. If you
are inadequately trained as a clinician or
a scientist, you will probably fail.
A Training-Program Model

The training of the surgical scientist
requires parallel training in clinical prac
tice and research. These are like the two
legs of a runner; both must be well deve
loped. Each requires a period of core
training and then a period of speciali
zation.
In clinical surgery, a period of core
training is provided for learning the prin
ciples of clinical surgery. This is gener
ally a 2-year period. In surgical research,
core training is also required to learn the
scientific method, to learn critical think
ing. The training in research must be
“ hands on” like the clinical training,
except perhaps in both areas it is really
“ minds and hands on” . In research, this
is the period for learning the skeleton of
research, how to ask and answer ques
tions, what ways there are to attack a
question, to design a study, what are good
and bad questions, what are appropriate
controls and what constitutes bias. You
learn persistence, how to deal with failure

Training the Surgical Scientist

In this section, I shall describe what I
consider is the proper training of a surgi
cal scientist. This type of training may not
be for you; in fact, probably only a
minority of surgical trainees should do the
type of training I am about to describe.
But, it provides a springboard for other
types of surgical training in research.
There are several principles that I consider
very important and the training is based
upon these.
• Do what you want to do! Do what
you think you will enjoy. Do what you
66

FIG. 1—Interdependence of three types of clinical research and research in basic sciences.

VOLUME 29, NO. 1, JA N U A R Y 1986 / THE CANADIAN JOURNAL OF SURGERY

here or in the research training. The last
year of clinical training should be of a
superspecialist type and be closely linked
to your special research training.
Special research training usually
requires only 1 year, if you have already
acquired an MSc. At this time, you will
look for a laboratory that is working in
the area of your special interest. The very
specialized techniques and literature will
be learned. This is when you get to know
your “ field” .
I have given a rather specific plan, but
the important features are core training
in both clinical and investigative surgery
and special training in both areas. The
timing is less important than the time
spent and the quality of the training. In
general, at least 4 clinical and 3 research
years are required to optimize the chance
for success. For some, the correct
approach will be to do all the clinical
training first and for others, all the
research training first. The latter
approaches best suit those who know
what their ultimate subject area will be
and this type of training may be appropri
ate for a PhD. But for the majority I
would favour an introduction to surgery,
followed by core research training fol
lowed by surgical training to fellowship
level and then 2 years of special clinical
and research training. I have outlined
some of my reasons for this in Table I.
Who should do surgical scientist train
ing? As I said, only a minority of surgi
cal trainees want to get this type of train
ing. Some will know that they want to be
surgical scientists before they enter sur
gery, and structured surgical scientist pro
grams are available for them at some
schools. Others will get this kind of train
ing by a less direct route. They will start
one of the alternative training programs
described below and get “ turned o n ” by

and disappointment, how to be dispas
sionate, determined and sure, how to take
criticism and use it, how to take pride in
the work of others and how to know if
your work is conclusive. You learn criti
cal thinking and critical thinking can be
taught.
In my opinion, the best core training
in research is done in an MSc program,
particularly if you will be exposed to other
students and their studies during this
training. Your study and theirs are models
for understanding and getting a grip on
science. The course work allows you to
learn or brush up on statistics and appli
cations of computers, and the thesis
preparation and examination are also
valuable mind training.
If possible you should do your core
training in the subject area that you will
ultimately be interested in. However, core
research training is best done early,
usually after 1 year of clinical core train
ing and it is often not possible for a stu
dent to be sure of an ultimate subject
area. In my opinion, this is not of great
importance. What is important is that the
research is done in surroundings and cir
cumstances in which good core training
can be obtained. What do you look for?
The laboratory or clinical epidemiology
unit should be active, publishing, hold
ing grants; the supervisor should be avail
able, often present. The supervisor should
preferably be a member of the graduate
school and have turned out graduate stu
dents. Talk to his present and past stu
dents. What has happened to his former
students?
On the clinical side, 2 years are also
required for core training, and another 2
years are usually required to get the kind
of clinical expertise I have referred to
earlier. Some can do all the clinical train
ing in 3 years. But remember, don’t skimp

T a b le 1— O n e W a y t o T r a in a s a S u r g ic a l S c ie n t is t

R1

R e s e a r c h s tu d y

C lin ic a l s tu d y

Year

In tr o d u c tio n t o s u r g e r y . In a d d it io n t o c o re
c lin ic a l t r a in in g , t h is y e a r p ro v id e s a n
id e a o f s c o p e o f s u rg e ry a n d k n o w le d g e
of

s u rg ic a l

re s e a rc h .

It

illn e s s
a ls o

w h ic h

adds

h e lp s

m a t u r it y

in
and

r e s p o n s ib ilit y h e lp f u l in r e s e a rc h .
S tu d ie s t o M S c le v e l. C o re re s e a r c h t r a in in g .

R 2 ,3

S e le c t s u b je c t a r e a i f p o s s ib le b u t c o n 
c e n t r a t e o n le a r n in g h o w t o do r e s e a r c h
a n d t o t h in k c r it ic a lly . R e s e a r c h t r a in in g
h e re h e lp s c lin ic a l t r a in in g a n d s t i m u l a t e s
a q u e s tio n - a s k in g m o d e t h a t w ill i d e n t if y
p r o b le m s ,

h e lp in g

to

s e le c t

a re a

of

in t e r e s t .
R4

C o m p le te c o re t r a in in g

R5

C h ie f re s id e n c y -

s ta r t to c o n c e n tr a te on

s p e c ia l a r e a o f in t e r e s t . G e t f e llo w s h ip .
S p e c ia l r e s e a r c h

R6

t r a in in g .

Choose

a re a

of

s p e c ific in t e r e s t . W r it e g r a n t s if t h is is
f in a l y e a r b e f o r e s t a r t in g p r a c t ic e .
R7

C o n tin u e s p e c ia l c lin ic a l t r a in in g , R 6 a n d R 7
m a y be re v e rs e d .

their exposure to research. Then they will
design the rest of their training appropri
ately. By the way, some of the people who
think they want to become surgical scien
tists will change their minds along the way
also. There’s no shame in this and pro
grams should be flexible and understand
ing when this occurs, provided arrange
ments were made in good faith initially.
Other Research Training Plans
Many prospective surgical residents
don’t know if they will find research
interesting. In many cases, they don’t
really know what research is. It is
appropriate for many surgical residents
who are in that position to do 1 year of
research training early in their residency.
Because they are going to be practitioners,
the best type of research training in many
cases would be in clinical epidemiology.
Unfortunately, right now there are few
good positions of this type. But, as I said
earlier, research training is mind training,
and as long as you get into a good
research setting you will develop an
understanding of how research is done.
You will find out if asking questions and
then conclusively answering them turns
you on and whether you have the neces
sary qualities. Don’t be afraid to find out
if you have these qualities. Remember
that critical thinking can be taught and
that persistence is a very important attrib
ute in investigation. Imagination grows
with practice. Some of what appears to
be imagination is experience. Some of
what appears to be brilliance is thorough
reading and classification and hard study.
Don’t sell yourself short until you try.
It doesn’t really matter whether you
determine your qualities and suitability
for research by doing clinical epidemiol
ogy or working in a laboratory doing
technologic or scientific research, as long
as the research methods are good. But I
suggest that during this year you take one
of the clinical epidemiologic courses that
are now available in some schools. This
will prepare you to participate in clinical
epidemiologic studies, although without
further training it would be difficult to
design and run them.
Surgeons who have a m ajor interest in
teaching should also be familiar with
research methodology. As I said earlier,
research methods are used to test the
effectiveness of our teaching methods as
well as our diagnostic and treatment
methods, and research methodology is
used to determine whether new teaching
techniques are efficacious. One really can
not be a teaching specialist without some
understanding of these methods.
Some specialties or surgical training
courses require at least 1 research year.
Their reasoning is based on two premises.
First, some investigators would be lost
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and a wrong career path chosen if they
were not exposed to investigation.
Second, the mind training is thought to
be essential for the specialist so that he
may evaluate the literature and incor
porate changes in his specialty during his
career. There is merit in these arguments
particularly if qualified supervisors are
available. While there are some obvious
negatives to this approach, every surgi
cal resident should understand the role of
surgical research in surgery whether or
not some research training is done. The
surgical resident must have some idea of
how to evaluate changes in his specialty.
Unproven ideas should be rejected but
adequately proven ones incorporated in
practice. Furthermore, as a surgical resi
dent, you should have sufficient under

standing of the value of clinical trials to
convince you to participate in them as a
practising surgeon. Otherwise your
specialty will stagnate. Right now these
fundamental skills are not adequately
taught, and this is an area in which many
programs can improve.
In summary, you may be in one of
three positions with respect to research
training. First, you may be fairly sure that
you wish to pursue a career as a surgeon
scientist. If so, the first type of training
that I have described is what you should
be seeking. Second, you may not know
whether you like investigation or you may
feel that you cannot get an idea of what
research is like without doing some. You
may want to learn about research metho
dology and critical thinking to help your

S. Kyzer ,

md ;

I. Bayer ,

md;

approach to patients or to the literature.
If you fall into any of these groups, then
1 year of research, perhaps with an
emphasis on clinical epidemiology, is indi
cated. Finally, you may be quite sure that
research is an aspect of surgery that does
not interest you. No formal training is
then necessary, but some appreciation of
the role of research and how to evaluate
new methods will help you later.
Whatever you finally choose to do in sur
gery, remember that there are no better
or worse areas. The merit of your work
will be judged on how well you do it and
not on its subject. Those who feel that
they are somehow superior because they
do research or because they are involved
exclusively in patient care frequently fail
to impress their peers.

C h . C haimoff ,

md
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Spontaneous Rupture of the Common Bile Duct
Spontaneous rupture of the common bile
duct in adults is very rare. The authors
report only the 14th case in the Western
literature. A 25-year-old woman had
signs of peritonitis suggestive of a perfo
rated appendix, but at operation the
appendix appeared normal and a large
amount of bile was found in the
peritoneal cavity. A 2-mm tear was
found on the anterior wall of the com
mon bile duct. The patient recovered
without complications after T-tube
drainage and cholecystectomy. In this
patient none of the factors thought to
cause spontaneous rupture of the com
mon bile duct were present, so the
authors conclude that the case may be
classified as idiopathic spontaneous rup
ture of the common bile duct.

Chez I'adulte, la rupture spontanee du
choledoque est tres rare. Les auteurs
dycrivent ce qui constitue le 14e cas sig
nals seulement dans la presse medicale
occidentale. Une femme de 25 ans a
presente les signes d'une peritonite sug-

gerant la possibility d'une perforation de
I'appendice. A I'operation, I'appendice
paraissait toutefois normal et une grande
quantity de bile fut retrouvee dans la
cavite peritoneale. Une dychirure de 2
mm a ete retrouvee dans la paroi
anterieure du choledoque. La guerison a
suivi une choiycystectomie et un
drainage a I'aide d'un tube en T. On n'a
retrouve chez cette patiente aucun des
facteurs que Ton croit capable de causer
une rupture spontanee du choledoque.
Les auteurs concluent done que ce cas
peut etre ciassifie comme etant une rup
ture spontanee idiopathique du choledoque.

Compared with spontaneous rupture of
the common bile duct in infants,1 this
condition in adults is exceedingly rare.
Spira2 in 1976 summarized 11 cases,
including one of his own. Lipinski and
colleagues3 reported another two cases,
but no others have been reported in the
Western literature. In this paper we report
one more case.

Case Report
From the Department o f Surgery "A ”,
Hasharon Hospital, Petah-Tiqva, and Tel
Aviv University Medical School, Israel
Accepted fo r publication June 12, 1985
Reprint requests to: Professor Ch. Chai
moff, Department o f Surgery “A ”, Hasha
ron Hospital, Petah-Tiqva 49372, Israel
6$

A 25-year-old, otherwise healthy, unmarried
woman of Arabic origin was admitted to the
emergency room because of severe abdominal
pains that had begun 48 hours earlier. The pain
was diffuse but of highest intensity in the right
lower quadrant. She could not remember
suffering any blunt abdominal trauma. Her
temperature was 38°C and her pulse rate was

96 beats/min. On physical examination of the
abdomen, there was generalized tenderness
with signs of peritonitis, maximally located in
the right lower quadrant. The liver and spleen
were not palpable and no abdominal masses
were found.
Her hemoglobin level was 130 g/L, leuko
cyte count 21.3 x 109/L , serum urea nitrogen
level 14.3 mm ol/L urea, creatinine 62 gmol/L,
bilirubin 18.8 fimol/L, diastase 153 U/L, alka
line phosphatase 140 U /L and y-glutamyl
transferase 74 U /L .
A plain film revealed no signs of intra
abdominal free air or intestinal obstruction.
Because the suggestive diagnosis was perfo
rated appendix, the peritoneal cavity was
opened through a McBurney incision. A huge
amount of bile was present but the appendix
was intact. A perforated duodenal ulcer was
suspected so the appendix was untouched, the
McBurney incision sutured and the peritoneal
cavity reopened through an upper midline inci
sion. The lesser and greater sacs were filled with
bile and the duodenum was found intact. A
perforation (diameter 2 mm) of the anterior
wall of the common bile duct was detected,
covered by fibrin. The perforation was located
3 cm distal to the bifurcation of the right and
left hepatic ducts (Fig. 1). The common bile
duct was of normal size and no stones were evi
dent there or in the gallbladder. There were no
signs of obstruction in the papilla of Vater. A
T tube was inserted into the common bile duct
through the perforation and a cholecystectomy
was performed. A T-tube cholangiogram
demonstrated narrow hepatic ducts and com
mon bile duct without filling defects and with
free passage to the duodenum. The peritoneal
cavity was washed with normal saline, a drain
placed down to the common bile duct and the
abdomen closed.
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The postoperative course was smooth. The
T tube was closed without complication on
postoperative day 5. A T-tube cholangiogram
performed 14 days later was normal (Fig. 2).

Discussion
Although spontaneous rupture of the
common bile duct was first described in
1882 by Freeland,4 only 13 cases have so

FIG. 1—Perforation is seen in middle of
common bile duct (CBD). Perforation was ini
tially 2 mm in diameter, but due to dissection
it became wider and here is about 4 mm. GB
= gallbladder, D — duodenum.

far been described in the Western litera
ture. According to Shepherd,5 rupture of
the bile duct is classified as follows: (a)
traumatic rupture of the duct due to
penetrating or nonpenetrating injury, (b)
pathologic rupture following cholecystec
tomy or duct surgery and perforative cal
culous cholangitis, and (c) spontaneous
or unexplained rupture of the duct. Our
case belongs to the last category.
As described by Spira,2 most cases
reported in the literature were associated
with cholelithiasis, although its role in this
condition is uncertain. Probably a com
bination of factors contribute to the
development of spontaneous rupture of
the common bile duct, such as erosion
of a common-bile-duct stone,6'8 chole
dochal cyst or diverticulum,911 increased
intraductal pressure secondary to obstruc
tion at the sphincter o f Oddi,1 intra
mural infection,12,13 and necrosis of the
wall of the common bile duct second
ary to thrombosis of the intramural
vessels.14
In our case no calculi were found in the
gallbladder or in the common bile duct
and none of the factors described could
be demonstrated. Due to the narrow duct,
no biopsy was performed from the edge
of the perforation because such a maneu
ver may contribute to the future develop
ment of common-bile-duct stenosis.
Macroscopically, neither acute nor
chronic inflammation of the common bile
duct was evident.
For us the explanation of common-bileduct rupture in our case is an enigma and
in our opinion the case may be classified
as idiopathic spontaneous rupture of the
common bile duct.

References
1. L illy JR, W ein tra u b WH, A ltm an RP: Spontane
ous perforation o f the extrahepatic bile ducts and bile
peritonitis in infancy. Surgery 1974; 75: 664-673
2. SPIRA IA: Spontaneous rupture of the common bile duct.
A n n Surg 1976; 183: 433-435
3. LIPINSKI JK, G o u w s F, Don ald JC: Spontaneous per
foration o f the common bile duct. A m Surg 1977; 43:
656-659
4. F reelan d J: Rupture o f the hepatic duct. Lancet 1882;
1: 782
5. SHEPHERD JA: Surgery o f the Acute Abdom en, Living
stone, Edinburgh, 1960
6. G ans HM, REYDMAN M: Non-traumatic perforation of
the common bile duct. A m J Surg 1947; 74: 811-814
7. VERNE JM: Rupture spontanee du canal hepatique. Mem
Acad Chir 1945; 71: 76-78
8. LAPENTA VA: Perforation at the juncture o f cystic and
common ducts. Surg Gynecol Obstet 1915; 20: 552
9. BLEGEN HM, BOYER EL: Perforation o f choledochus
cyst with biliary peritonitis; report o f a case submitted
to 3-stage operation. Lancet 1946; 66: 117-183
10. TAUBE HN. HiMEL HA: Non-traumatic perforation o f
common bile duct. Can M ed Assoc J 1941; 44: 607-608
11. WERNSDORFER I: Choledochusdivertikel mit nachfolgender Perforation. Zentralbl Chir 1939; 66: 1141-1145
12. BAILEY H: Emergency Surgery. Volume 1: Abdom en
and Pelvis, W ood, Bristol, 1930
13. Vale CF, S h a p ir o H: Non-traumatic perforation of
common bile duct. A m J Surg 1932; 18: 103
14. H a r t DE: Spontaneous perforation o f common bile
duct. A n n Surg 1951; 133: 280-282

NOTICES
continued from page 53

Shock
The 9th annual conference of the Shock
Society will be held at the Camelback Inn
in Scottsdale, Ariz., June 8-11, 1986. The
scientific program chairman will be Dr.
Gerald S. Moss of Chicago.
The scientific sessions will consist of a
workshop, symposia, papers, poster
presentations, special dinner speakers and
a keynote address. Topics to be covered
include metabolism in shock-like states,
oxygen radicals, critical issues in shock
research and circulatory shock studies
from 1940 to 1950.
For more information contact Dr.
Sherwood M. Reichard, Executive Direc
tor, Shock Society, Medical College of
Georgia, Augusta, GA 30912.

Transurethral Ureteroscopy

FIG. 2—Postoperative T-tube cholangiograms demonstrating normal choledochus with no
sign of leakage. Free passage to duodenum is clearly demonstrated. Slight enlargement of
choledochus is due to injection of contrast material.

A seminar and workshop on transurethral
ureteroscopy will be held Apr. 5 and 6,
1986, at the University of California San
Diego School of Medicine and at The San
Diego Hilton Beach and Tennis Resort.
Accreditation will be 13.5 hours o f AMA
credit. The fee for physicians will be $350
and for interns and residents, $250. Dr.
Jeffry L. Huffman will be the course
director.
For further information write to the
Office of Continuing Medical Education,
Rm. M-017, University of California San
Diego School o f Medicine, La Jolla, CA
92093; or call (619) 452-3940.
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BOOK REVIEWS

CONTROVERSIES IN TRAUMA M ANA
GEMENT. Edited by Robert H. Dailey
and Michael Callaham. Clinics in Emer
gency Medicine. Vol. 6. 257 pp. Illust.
Churchill Livingstone, Edinburgh; Aca
demic Press Canada, Don Mills, Ont.,
1985. Price not stated. ISBN 0-443-08192-1.

This text, part of an ongoing series of “ Clinics
in Emergency Medicine” , is well worth own
ing. It addresses 10 issues relating to trauma
— all are relevant. The volume’s format,
presenting two sides of the issue and conclud
ing with an editorial comment, works well.
There is no shortage of meaty controversies,
as illustrated by such titles as “ load and go” ,
“ emergency department thoracotomy” and
“ organized trauma regions and the American
College of Surgeons categorization of centers” .
The illustrations are adequate only but
suffice given the nature of the book. The writ
ing from the 27 contributors is generally of
good quality and quite readable.
I would recommend this book to emergency
physicians, in particular, and to any doctor
involved in the care of seriously injured
patients, in general.

Robert Y. McMurtry , md, frcsc
Director, Regional Trauma Unit,
Sunnybrook Medical Centre,
2075 Bayview Ave.,
Toronto, Ont.
M4N 3M5

W.G. Thompson, md, frcpc

HORMONE-PRODUCING TUMORS OF
THE GASTROINTESTINAL TRACT.
Edited by Sidney Cohen and Roger D.
Soloway. Contemporary Issues in Gastro
enterology. V ol. 5. 164 pp. Illust.
Churchill Livingstone, Edinburgh; Aca
demic Press Canada, Don Mills, Ont.,
1985, $51.25. ISBN 0-443-08370-3.

This multiauthored book is cohesive and well
written. It is well presented, accurate and, but
for several spelling mistakes, well edited. The
text brings together all that the practising gas
troenterologist or general surgeon might want
to know about these rare tumours of the gut
— and more.
The opening chapter is a readable review of
the gastrointestinal regulatory peptides, the
APUD system and tumours arising from
peptide-producing cells of the intestine. Several
excellent photomicrographs and photoelectronmicrographs reflect the pathologic interests of
the Hammersmith authors.
There follow individual chapters on the
Zollinger-EUison syndrome (also the subject of
many other excellent reviews), glucagonomas
(containing 138 references), somatostatinomas
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(20 reported cases), VIPomas (comprehensive
review of watery diarrhea with hypokalemia
and achlorhydria), and pancreatic polypeptide
and mixed peptide-producing tumours (new
frontiers provided by the recognition of more
peptides).
The final two chapters review the chemother
apy and surgery applied to these tumours. The
last chapter includes a useful approach to car
cinoids.
Although I was able to read this succinct,
yet comprehensive review in less than 3 hours,
I wonder who will buy it. The practising phy
sician will find its content too remote from his
everyday experience, and the text is well beyond
the grasp of undergraduates who may never see
a case in a lifetime of non-specialist practice.
Probably the researcher will already have
access to the information contained in this
book. Some clinical teachers and postgradu
ate students might find this a useful reference
book for rounds and presentations, but the
information is already available in the form of
good reviews in several medical journals. Also,
many competing publishing houses produce
series of symposia of this type that seem to out
strip their need. None of this should detract
from the high quality of the book or the scho
larly achievement of its authors and editors.
If you need a ready source of information
about the rare endocrine tumours of the gas
trointestinal tract, this one will do nicely.

Professor of Medicine,
Assistant Dean for Clinical Affairs,
Division of Gastroenterology,
Ottawa Civic Hospital,
University o f Ottawa,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9

MAXILLOFACIAL INJURIES. 2 vol. set.
N.L. Rowe and J.LI. Williams. 1030 pp.
Illust. Churchill Livingstone, Edinburgh;
Academic Press Canada, Don Mills, Ont.,
1985. $273. ISBN 0-443-01509-0 (2 vol. set).

To review these two volumes was to me not
a chore but an exercise of educational enrich
ment. The text is easy to read and the evolu
tion of the subject matter is extremely well
organized and presented. Each chapter aroused
my curiosity as to what would be covered
sequentially. Complex problems of manage
ment are discussed comprehensively and sup
ported by many illustrations and excellent line
drawings. These diagrams effectively clarify the
text.
For health professionals involved in the
management o f maxillofacial injuries, these

two volumes are indispensable. They present
the current state of the art in the management
of such problems. Both volumes should be
available as a reference in the health profes
sional’s library, or in the library of the Health
Care Centre.
This set is a major contribution in what is
a complex field.

J.D. Baxter , md, frcsc
Professor and Chairman,
Department of Otolaryngology,
McGill University,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1

O’CONNOR’S TEXTBOOK OF ARTHRO
SCOPIC SURGERY. Edited by Heshmat
Shahriaree. 337 pp. Illust. J.B. Lippincott
Company, Philadelphia, 1984. $95. (US).
ISBN 0-397-52117-0.

This volume is based on a previous textbook
by R ichard L. O ’C onnor entitled
“ Arthroscopy” . Many have contributed chap
ters from their specific fields of expertise. The
book is well illustrated, with excellent captions.
The chapter on arthroscopic instrumentation
is superficial and could be improved. Gas
arthroscopy, not common in North America,
is well described and its use in 800 cases is
noted. The chapter on the menisci details the
anatomy and pathologic changes well.
The history of partial meniscectomy is well
outlined and precise and represents the
dynamic personality of the late Dr. O’Connor.
The chapter on meniscal lesions and their treat
ment is among the best. It is detailed, with a
good discussion of the management of
associated pitfalls. I find it unfortunate that
conservative management followed by a par
tial meniscectomy is still accepted as treatment
for hypermobile medial meniscus.
The chapter on acute knee arthroscopy by
Jan Gillquist is well written, emphasizing the
anterior approach. I believe that the chapter
on arthroscopy and the management of frac
tures of the tibial plateau will be confusing to
the inexperienced reader.
All aspects of the synovial plica of the knee
are well described. James Guhl’s chapter on
osteochondritis dissecans is of the highest
calibre.
The subject o f intra-articular adhesions and
fibrous ankylosis of the knee is well stated,
emphasizing the author’s appreciation of the
pathological characteristics in the suprapatel
lar pouch. The chapters on cystic conditions
of the knee, extra-articular sources of knee pain
and synovial disease can easily be eliminated
without any loss to the total text.
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This book is recommended to the person
interested in arthroscopic surgery. It is com
plete and well illustrated.
L eon H e l l e r , m d , f r c s c , fa cs
Department of Orthopedic Surgery,
Sir Mortimer B. DavisJewish General Hospital,
3755 C6te Ste-Catherine,
Montreal, PQ
H3T 1E2

VASCULAR A N D DOPPLER ULTRA
SOUND. Edited by C. Carl Jaffe. 311 pp.
Illust. Churchill Livingstone, Edinburgh;
Academic Press Canada, Don Mills, Ont.,
1984. $40.50. ISBN 0-443-08295-2.

This book is volume 13 in a 17-part series enti
tled “ Clinics in Diagnostic Ultrasound” . It
contains eight chapters each by a different con
tributor.
The first two chapters entitled “ Doppler
applications and limits of the method” and
“ Doppler instrumentation for the evaluation
of arterial and venous disease” serve as com
prehensive introductions to Doppler technol
ogy. Topics covered include the principles of
physics related to Doppler instruments, nondirectional versus directional systems,
continuous-wave versus pulsed Doppler, a dis
cussion of the various electronic methods used
to process the Doppler signal and the problem
of statistical variability of the signals produced.
Zierler and Strandness review the clinical use
of the Doppler velocity meter in the diagnosis
and management of peripheral arterial and
venous disease.
The role of duplex scanners (combined Bmode imaging and pulsed Doppler analysis) in
the evaluation of carotid disease is detailed
thoroughly by Driesbach.
Smith and Lawson review applications of

Doppler ultrasound in the abdomen. These
include intraoperative assessment of renal and
intestinal ischemia using sterile probes and
transcutaneous evaluation of renal transplants,
the renal vasculature, and the portal circula
tion in portal hypertension. In addition, its use
as an adjunct in better defining various struc
tures using real-time sonography is outlined.
Gill reports on the use of a complex
experimental combination of B-scanning and
pulsed Doppler flowmetry to measure the fetal
circulation noninvasively in utero. The tech
nique has been devised to diagnose intrauter
ine growth retardation and other causes of
perinatal morbidity and mortality.
The combination of Doppler ultrasound and
2-D echocardiography to produce exciting
hemodynamic-anatomic correlations in the
noninvasive diagnosis of cardiac disease is dis
cussed in detail.
The final chapter reviews the use o f Dop
pler techniques in quantitating arterial occlu
sive disease and detecting venous obstruction.
This section is somewhat redundant in that it
covers much of the material contained in
chapter 3.
Overall this monograph constitutes an excel
lent basic review of the multiple uses of Dop
pler ultrasound in medicine. Its strength lies
in the chapters on the basic physics of the tech
niques and in highlighting both the usefulness
and the current limitations o f this evolving
methodology. Although written primarily for
radiologists, it should serve well as a basic
review of Doppler for students, residents and
technicians as well as practitioners newly enter
ing the field.
J am es F . S y m es , m d , fr csc
Division of Cardiovascular
and Thoracic Surgery,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1

◄ PRESCRIBING INFORMATION ►
ANUSOL*-HC
ointment/suppositories
hemorrhoidal preparations
INDICATIONS: For the relief of the pain and dis
comfort following anorectal surgery of all types
and that which is associated with the acute phase
of common anorectal disorders. These include
hemorrhoids, internal and external (including
those accompanying pregancy) whether or not
complicated by thrombosis and prolapse; pruritis
ani; proctitis, cryptitis, fissures and incomplete
fistulas; and other congestive allergic or inflam
matory conditions.
CONTRAINDICATIONS: Should not be used in
patients with a sensitivity to any of the compo
nents. Not to be used in the presence of existing
tuberculous, fungal and viral lesions of the skin.
PRECAUTIONS: Until an adequate proctologic
examination is complete and a diagnosis made,
any preparation containing hydrocortisone
should not be used. In addition, specific measures
against infection, allergy and other causal factors
must not be neglected. Prolonged use could pro
duce systemic corticosteroid effects, although
none have been noted to date. As with all medica
tion that is applied locally, if idiosyncratic reactions
occur, medication should be discontinued. The
safe use of topical corticosteroids during preg
nancy has not been fully established. Therefore,
during pregnancy, they should not be used unne
cessarily on extended areas, in large amounts, or
for prolonged periods of time.
ADVERSE EFFECTS: Occasionally patients may
experience burning upon application, especially
if the anoderm is not intact. Local sensitivity reac
tions have been rare.
OVERDOSE: The chances of overdosage are very
rare, and no toxic reactions or side-effects have
been reported. In case of accidental ingestion,
perform gastric lavage followed by a purgative
dose of magnesium sulfate.
DOSAGE: OINTMENTS: Administer in the morn
ing and again at bedtime, and after each bowel
movement. Continue this treatment until the acute
phase of pain and discomfort passes and the
inflammation subsides.
SUPPOSITORIES: Insert 1suppository in the morn
ing and 1 suppository at bedtime and after each
bowel movement. Continue this treatment until
the acute phase of pain and discomfort passes
and the inflammation subsides.
SUPPLIED: Ointment: Available in 15 g and 30 g
tubes with a plastic applicator. Suppositories:
Available in boxes of 12 and 24 suppositories.
INGREDIENTS:
Zinc Sulfate
Monohydratef
Hydrocortisone
Acetate

SESAP IV Critique
ITEM 130

Suppositories

Ointment

10 mg

0.5%

10 mg

0.5%

TUCKS*

In the absence of obstruction, a clean cystotomy will heal satisfactorily and
does not require prolonged drainage or decompression. The suture line need
only be protected against early postoperative retention and the resultant over
distention.
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A soothing, cooling, medicated wet dressing and
cleansing pad for hemorrhoids, feminine hygiene
and personal itching problems.
DIRECTIONS: Gently wipe and cleanse affected
area. For additional relief, apply Tucks for 15-30
minutes, 3 to 4 times daily.
Soft pads medicated with Hamamelis water 50%,
glycerin 10%, distilled water, q.s.
ANUSOL*-HC
*Reg. TM. of Warner-Lambert Canada Inc.
Parke-Davis Canada Inc. auth. user
TUCKS*
*Reg. TM. of Parke, Davis & Company,
Parke, Davis & Company, Ltd. Registered user
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How do you speil
truth in
advertising?

PAAB
CCPP
This logo appearing on pharmaceutical advertisements in
professional journals means that the advertisements have
been reviewed— and cleared for publishing— by the Phar
maceutical Advertising Advisory Board/Conseii Consuttatif
de Publicity Pharmaceutique.
This unique screening system for pharmaceutical advertis
ing is the first of its kind in North America. The Board of
Directors is composed of individuals representing the fol
lowing organizations: • Association des fabricants du
Quebec de Produits Pharmaceutiques • Association des
m^decins de langue franpaise du Canada • Association of
Medical Media • Canadian Advertising Advisory Board •
Canadian Drug Manufacturers • Canadian Medical Associa
tion • Canadian Pharmaceutical Association • Consumers'
Association of Canada • Pharmaceutical Manufacturers
Association of Canada.
The Health Protection Branch of Health and Welfare Canada
acts as advisor and resource body to the board.
The program ensures the accuracy of pharmaceutical ad
vertising to the health professions, so that it may continue
to serve the ultimate best interest of the patient.
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Malliner Laboratories Inc.
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified
advertisements. The deadline is 1 month before issue date. Regular classified rates (for each insertion): $38.00
for the first 40 words or less, additional words 45C each (additional $15.00 for frame). Special Display under
75 words, 214" X 2" $95.00. $5.00 charge (first insertion only) for CJS box numbers. Display rates
available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.

SURGEON: ON — Listowel, serving a referral
population o f 18 0 0 0 people in the north end of
Perth County o f Ontario, will require a general sur
geon in 1986 to replace retiring surgeon w ho has
been in the com munity for 15 years. The tow n has
a population o f 5000 people and is the centre of
commerce fo r a prosperous dairy and cattle area.
The hospital is well equipped and operates 87
beds. There are nine family physicians in Listowel.
Excellent golf and curling facilities. One hour's
drive to Lake Huron and the University of Western
Ontario, and 1 V2 hours' to Georgian Bay and BlueMountain skiing. Time to establish practice is flex
ible. New office facilities under construction. Con
tact: Dr. F. Ellingham, Administrator, The Listowel
Memorial Hospital, 255 Elizabeth St. E., Listowel,
ON N4W 2P5.
S86-02

ICU RESEARCH FELLOW: — Ewart Angus Inten
sive Care Unit, The Wellesley Hospital. Available
July 1, 1986 fo r a one year period in an academic
Medical-Surgical Unit. Research areas include clin
ical epidemiology of ICU care, nutrition and
respiratory muscle physiology. Reply to: Dr. I.M.
Fraser, Director EAICU, 247 The Jones Bldg., 160
Wellesley St. E., Toronto, ON M4Y 1J3 (416)
926-7747.
-S86-04

HEAD
DIVISION OF
PLASTIC SURGERY
Required fo r 698 (rated) bed pediatric teach
ing hospital w ith cross-appointment in the Di
vision o f Plastic Surgery, U niversity of
Toronto. The Division provides plastic surgery
services fo r approximately 1800 inpatient and
outpatient surgical procedures each year.
Applicants must have academic standing and
interest in research as well as aptitude for
pediatric service and departm ental manage
ment. Full-time appointm ent and academic
rank commensurate w ith qualifications and
experience.
A pply to:
Administrative Assistant, and

Parke-Davis Canada Inc.
35

Anusol-HC
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Glycerin Suppositories

8

Rhone-Poulenc Pharma Inc.
Stem etil

15, 16
31

Ross Laboratories
Enrich
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-S86-03

EXPERIENCED GENERAL SURGEON: - re
quired in a unique lucrative setting. Extensive and
varied surgical material available. Please forward en
quiries to: PO Box S110 CJS.
-S85-32

Mr. C.D. Germano

Agarol

Flagyl

TRANSPLANTATION SURGEON: ON - The
University o f Toronto seeks a surgeon to direct its
multiorgan transplant program at one of its univer
s ity based hospitals. Full training in general sur
gery plus form al clinical training in multiorgan
transplantation surgery is required. The success
fu l candidate w ill also be expected to have ob
tained research training which w ill enable him/her
to conduct an independent research program and
interact w ith other faculty in the areas of trans
plant immunology and infectious diseases relat
ed to transplantation. This w ill be an annual ap
pointment, at the rank of Assistant Professor.
Salary to commensurate w ith qualifications and
experience. Qualifications: MD, FRCSC. Effective
date of appointm ent: Open. Closing date of appli
cations: February 28, 1986. Enquiries, curriculum
vitae and three letters of reference should be sent
to : Dr. R.M. Stone, Surgeon in Chief, Toronto
Western Hospital, 39 9 Bathurst St., Toronto, ON
M 5T 2S8. In accordance w ith Canadian Immigra
tion requirements, this advertisement is directed
to Canadian citizens and permanent residents.
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&
HSC

Secretary, Plastic Surgery Search
Committee
The Hospital for Sick Children
555 University Avenue
Toronto, Ontario, Canada M5G 1X8
* This advertisement is directed to persons
who are eligible to work in Canada S86-01

THE HOSPITAL FOR SICK CHILDREN
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An effective combination to relieve
the pain and itch of hemorrhoids
and other anorectal disorders
• Relieves pain, itch and inflammation
• Lubricating petrolatum base
• Colorless ointment and
suppositories
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• Soothing medicated cleansing pads

TUCKS
MEDICATED PADS

• Prevents m echanical irritation from
K S lw
toilet tissue
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• Helps prom ote proper hygiene
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Meet some members
of our family
The third i*cncrali<hi <>f
n<)iiahs4>rbable 1114>n<>filament
sutures hasjust begun...

The New Standard of Excellence

DISPOSABLE SKIN STAPLER

No hang ups!
Staples are now
immediately, automatically
and completely released
regardless of direction of
stapler movement.

AJam$&

...from the b + G wound closure system
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Davis + Geek Introduces

SurgicalO vom c Suture

Something
you’re used to
without
the problems
you’re used to

V
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You told us that you liked using catgut but you didn't like its
problems. So we took catgut and m ade it
• soft and supple
. easy to tie
. less likely to curt. “ pigtail” and tangle
« easy to handle and control

DEXON* PLUS
Excellent knot security plus superior handling
and smoother tissue passage.

quality professional products from
DAVIS+GECK
Cyanamid C anada Inc.

A TRADITION OF INNOVATION

Atria North, 2255 Sheppard Avenue East, W illowdale, (Ontario) M2J 4Y5

